SAMPLE_ID,SAMPLE_NAME,PUBCHEM_SID,PRIMARY_MOA,ASSAY_NAME,LIBRARY,CAS,ALIAS,AC50(uM),label,LOG_AC50,AUC,CURVE_CLASS2,DATA_POINTS,DRUG_NAME,EFFICACY,MAX_RESPONSE,P_HILL,R2,GENE_ID,GENE_SYMBOL,SMILES,SUPPLIER,SUPPLIER_ID,DATA0,DATA1,DATA2,DATA3,DATA4,DATA5,DATA6,DATA7,DATA8,DATA9,DATA10,DATA11,DATA12,DATA13,DATA14,CONC0(M),CONC1(M),CONC2(M),CONC3(M),CONC4(M),CONC5(M),CONC6(M),CONC7(M),CONC8(M),CONC9(M),CONC10(M),CONC11(M),CONC12(M),CONC13(M),CONC14(M)
NCGC00378604-01,ABT-333,405558941,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1132935-63-7,,12.58925412,0,-4.9,39.48904639,3,4,,62.17612269,53.75375375,0.013507805,0.999887484,,,COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C,MedChem Express,HY-13998,-0.47709924,0.18286311,0.57606703,53.75375375,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095029-08,NCGC00095029-08,,Staphylococcus aureus Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,0.223872114,1,-6.65,68.36341295,1.4,4,,36.01470932,-1.33715377,1,0.912886266,,,CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]2CC[C@](O)(CC)[C@H](C)O2)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC3=C(C([O-])=O)C(=C(C)C=C3)O,Analyticon,NP-009923,1.40515222,37.52042961,26.65216209,-1.33715377,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183005-01,Zanapezil fumerate,144206802,Acetylcholinesterase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),263248-42-6,CIPLUS_775863; Zanapezil Fumarate; ,11.22018454,0,-4.95,70.01672195,3,4,CIPLUS_775863;ZANAPEZIL;Zanapezil Fumarate;CIPLUS_3882440;CIPLUS_3882439;zanapezilum;,100.7720304,91.98529412,0.012922948,0.999896987,,,O=C(O)/C=C/C(=O)O.O=C(CCC2CCN(Cc1ccccc1)CC2)c3ccc4CCCCNc4c3,Pharmaron,PH-NIH-100582,-0.22681452,0.87516088,1.76273083,91.98529412,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00166241-02,"2,6-DIIODO-4-NITROPHENOL",225144276,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),305-85-1,,12.58925412,0,-4.9,38.47711978,3,4,,55.57039425,48.18529131,0.038299136,0.999094621,,,OC1=C(I)C=C(C=C1I)[N+]([O-])=O,SIGMA,145416,1.03044496,-0.67709549,0.43513734,48.18529131,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00274060-01,Posaconazole,170464963,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),171228-49-2,,2.238721139,1,-5.65,53.78947568,3,5,,39.41593873,10.14198783,0.04287197,0.998865683,,CYP51A1,C[C@H](O)[C@H](CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OCC6C[C@@](Cn5cncn5)(OC6)c7ccc(F)cc7F,Selleck,S1257,0.51282051,-0.6573957,1.28300025,36.22876286,10.14198783,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00014483-16,Pamelor,405559064,Norepinephrine transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),894-71-3,,12.58925412,0,-4.9,111.218832,3,4,,122.1980268,96.79031834,0.012684841,0.999900747,,,CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2,SIGMA,N7261,1.5496368,1.85696361,0.83607803,96.79031834,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00274067-01,Eltrombopag olamine,174006931,Thrombopoietin Receptor (TpoR) Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),496775-61-2,Eltrombopag,11.22018454,0,-4.95,32.62596414,3,5,,54.36254882,43.56997972,0.000888307,0.999555842,4352,MPL,O=C(O)c1cccc(c1)c4cccc(N\N=C2\C(=O)N(N=C2C)c3ccc(C)c(C)c3)c4O,Selleck,S2229,-0.17094017,-0.8596713,-1.18430792,2.58435032,43.56997972,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015851-10,Protriptyline hydrochloride,170465077,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1225-55-4,,12.58925412,0,-4.9,75.09062688,3,5,,118.0639173,101.3387424,0.000152006,0.999923997,,,Cl.CNCCCC2c3ccccc3C=Cc1ccccc12,Microsource,1505984,-0.07326007,-1.011378,-0.49346163,0.76573343,101.3387424,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015964-17,Spiperone,170465856,Dopamine D4 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),749-02-0,,12.58925412,0,-4.9,89.65138183,3,4,,107.010407,83.24096068,0.041894606,0.998915973,,,Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3,Enzo,AC807,-1.34180791,1.8789144,-0.45896328,83.24096068,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015563-13,Imipramine,170464777,Serum paraoxonase/arylesterase 1 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),50-49-7,,8.912509381,1,-5.05,101.11093,3,4,,114.589084,94.94869771,0.004252457,0.999988847,5444,PON1,CN(C)CCCN2c3ccccc3CCc1ccccc12,Enzo,AC813,-1.01694915,-1.00376412,-0.43070687,94.94869771,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00094819-07,Hexetidine,170465729,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),141-94-6,,3.548133892,1,-5.45,98.1189742,3,4,,90.44433168,89.31222167,0.00683366,0.999971197,,,CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1,Microsource,1500633,-0.24166264,-0.76467686,1.08176901,89.31222167,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015368-11,Dicyclomine,170464896,Muscarinic acetylcholine receptor M3 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),77-19-0,,11.22018454,0,-4.95,22.56567627,3,4,,34.07459678,30.80882353,0.040791286,0.998973658,,,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,Microsource,1500240,-0.47883065,0.66924067,0.41969782,30.80882353,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00507682-01,Emodepside,405558968,synaptic transmission Modulator,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),155030-63-0,,7.079457844,1,-5.15,53.29133528,2.2,4,,67.74792593,61.747851,0.028142603,0.999511316,174419,,CC(C)C[C@@H]1N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC2=CC=C(C=C2)N3CCOCC3)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC4=CC=C(C=C4)N5CCOCC5)OC1=O,AdvChemBlocks,M15352,-0.37470726,-1.47093159,13.05412021,61.747851,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00179625-03,Thioproperazine dimethanesulfonate,170465871,Serotonin 2a (5-HT2a) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2347-80-0,,11.22018454,0,-4.95,62.21963306,3,4,,95.68070018,80.53179191,0.005352249,0.999982333,,,CS(=O)(=O)O.CS(=O)(=O)O.CN(C)S(=O)(=O)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2,Prestwick,Prestw-149,-0.30848329,-0.13034411,4.15898921,80.53179191,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181103-02,Propiverine hydrochloride,170466036,Muscarinic acetylcholine receptor Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),54556-98-8,,12.58925412,0,-4.9,74.83998603,3,4,,67.24715488,57.59524988,0.05303055,0.998262019,,,Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3,Sequoia,54556-98-8,4.39826003,2.34336458,1.78173719,57.59524988,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016101-10,Xylometazoline hydrochloride,170465470,alpha2A/B/C-Adrenoceptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1218-35-5,; Otrivine-Antistin; ;XYLOMETAZOLINE HYDROCHLORIDE;Xylometazoline hydrochloride; Xylometazoline hydrochloride; Neo-Synephrine II; Xilometazolina; Otrivin hydrochloride,14.12537545,0,-4.85,21.83646525,2.4,5,,34.09117014,27.99188641,0.009551711,0.995197194,150,ADRA2A,Cl.CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2,Microsource,1500614,1.1965812,-0.8091024,-0.14803849,-0.90930845,27.99188641,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00263572-01,Deferasirox,170464723,Iron Chelating Agent,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),201530-41-8,,12.58925412,0,-4.9,28.47397785,3,5,,43.62930714,37.72819473,0.004335576,0.997827057,,CAT,O=C(O)c1ccc(cc1)n3nc(nc3c2ccccc2O)c4ccccc4O,Sequoia,201530-41-8,-0.12210012,-0.7585335,1.33234641,0.14357502,37.72819473,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00161419-07,Trimetrexate,404904680,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),[82952-64-5],,10,0,-5,36.26879652,3,4,,56.05338926,48.3983984,0.01314857,0.999893403,1719,DHFR,COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC,NCGCChem,NCGC00161419-05pur,-0.57251908,-0.54858934,2.77559571,48.3983984,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159481-03,Sofalcone,170466017,Prostaglandin Synthesis and Regulation Modulator,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),64506-49-6,,12.58925412,0,-4.9,54.26281409,3,4,,60.4152668,49.01341752,0.015997254,0.999842195,,,C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C,Bionet,KS-1141,0.3874092,-0.35131744,0.0253357,49.01341752,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015838-06,Propionylpromazine hydrochloride,170466841,Trypanothione reductase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),7681-67-6,,12.58925412,0,-4.9,96.91721351,3,4,,112.799661,90.58142594,0.024175558,0.999639361,,,Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1,SIGMA,P7780,0.14527845,-0.95357591,-1.95084875,90.58142594,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00018102-12,Flunarizine,170466037,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),52468-60-7,"Sibelium; ; Flu Narizine;Flunarizine dihydrochloride; Hydrochloride, Flunarizin;Flunarizine; Flunarizin; Flunarizina; Flunarizine",11.22018454,0,-4.95,79.51379933,3,4,,92.88827204,76.00631413,0.028777183,0.999488937,,,Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4,Enzo,CA225,-1.50121065,0.40150565,-1.2921206,76.00631413,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015774-06,Oxatomide,170466059,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),60607-34-3,,12.58925412,0,-4.9,78.60364065,3,4,,91.70793338,73.7925574,0.008202685,0.999958504,3269,HRH1,O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4,Enzo,EI114,-0.63559322,-0.48712596,-0.78293736,73.7925574,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00161831-04,Mefloquine hydrochloride,170465100,antimalarial agents; Inhibtion of heme crystallization,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,51773-92-3,,1.412537545,1,-5.85,63.74354057,3,5,,52.29054823,-6.46648045,0.069793098,0.996984773,,GJD2,Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3,SIGMA,M2319,-4.27311436,-0.88407421,2.01489803,49.00334643,-6.46648045,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00183837-01,Monatepil,124894552,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),103377-41-9,Monatepil; Monatepil,12.58925412,0,-4.9,71.48095506,3,4,"CIPLUS_696267;AJ 2615;MONATEPIL;monatepil, (S)-isomer;monatepil, (+-) monatepil;LS-172819;LS-172817;Monatepil Maleate;monatepil maleate;LS-173001;maleate;LS-171860;11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate;1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1);CIPLUS_3853864;MONATEPIL MALEATE;monatepil;Monatepil maleate;CIPLUS_197056;monatepil x maleate;monatepil, (R)-isomer;monatepilum;LS-173055;AJ-2615;N-(6,11-DIHYDRODIBENZO(B.E)THIEPIN-11-YL)-4-(4-FLUOROPHENYL)-1-PIPERAZINEBUTYRAMIDE MALEATE, DL-;LS-173056;",103.5671283,94.26589595,0.011333309,0.999920773,,,Fc1ccc(cc1)N2CCN(CC2)CCCC(=O)NC3c5ccccc5SCc4ccccc34,Pharmaron,PH-NIH-152406,0.30848329,0.39103233,-0.05264543,94.26589595,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00238452-03,Enzastaurin,170465609,"PKCa, PKCb, PKCg inhbitor",SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),170364-57-5, Enzastaurin;LY-317615;Enzastaurin,12.58925412,0,-4.9,39.04051739,3,5,,63.92694571,54.60446247,0.000230404,0.999884825,5578,PRKCA,Cn2cc(c1ccccc12)C=3C(=O)NC(=O)C=3c7cn(C5CCN(Cc4ncccc4)CC5)c6ccccc67,Selleck,S1055,-0.31746032,-0.7585335,-0.83888478,-0.09571668,54.60446247,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00180461-02,Hydroquinidine HCl,405558746,Sodium channel alpha subunit Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1476-98-8,,12.58925412,0,-4.9,66.89166049,3,4,,97.18998603,84.79273405,0.011895739,0.999912717,,,CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3,Prestwick,Prestw-NAT-0284,0.59585492,1.29205266,1.5605336,84.79273405,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00021122-08,Alverine citrate,170466248,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),5560-59-8,,5.011872336,1,-5.3,40.89916744,3,4,,43.41559536,37.27966325,0.039583301,0.99903319,,,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2,Microsource,1500109,-1.3559322,0.30112923,2.20420573,37.27966325,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016338-10,Dibucaine,170464829,Sodium channel protein type X alpha subunit Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),85-79-0,,12.58925412,0,-4.9,91.90125789,3,5,,124.4693306,114.7261663,0.000168228,0.999915884,,,CCN(CC)CCNC(=O)c1cc(OCCCC)nc2ccccc12,Microsource,1500236,1.83150183,1.6687737,0.78953861,1.48360852,114.7261663,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00090782-06,Nelfinavir mesylate,170465351,HIV Protease Inhibitors,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,159989-65-8," Mesylate, Nelfinavi;; ; Viracept; Nelfinavir mesylate;Nelfinavir mesylate;Nelfinavir; Viracept 250mg; Nelfinavir mesilate; Nelfinavir Mesilate",1.584893193,1,-5.8,120.4638433,3,5,,86.00063463,13.75558036,0.054598651,0.998157005,,,CS(=O)(=O)O.Oc1cccc(c1C)C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C,Tocris,3766,0.83147183,-3.42369861,3.36611719,82.24725127,13.75558036,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00016012-12,Triflupromazine hydrochloride,170465325,Muscarinic acetylcholine receptor M2 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1098-60-8,,12.58925412,0,-4.9,53.69421788,3,4,,63.1093304,50.66798615,0.01641789,0.999833778,1129,CHRM2,Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1,Microsource,1503118,-0.77332044,0.024667,-0.4454343,50.66798615,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00014482-03,Methdilazine hydrochloride,124878446,ion channel,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,7.079457844,1,-5.15,61.20622487,2.2,4,Methdilazine hydrochloride,75.93717783,67.76504298,0.029536217,0.999461652,,,CN1CC[C@@H](C1)CN2C3=C(SC4=C2C=CC=C4)C=CC=C3,NCGC,NSC-169091,-0.04683841,-1.09736166,16.37204243,67.76504298,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00532496-01,P-T-BUTYL-M-CRESOL,405558633,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,2.511886432,1,-5.6,49.69989457,3,4,,40.74182659,0.30057803,1,0.999991798,,,CC1=CC(=CC=C1C(C)(C)C)O,SIGMA,A000011660,-0.35989717,-0.02606882,35.00921295,0.30057803,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00162150-04,Cilnidipine,170465867,Voltage-gated N-type calcium channel alpha-1B subunit Inhibitor,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,132203-70-4,,11.22018454,0,-4.95,26.78431447,3,5,,57.62856214,45.92633929,0.000530926,0.999734577,,,CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3,Prestwick,Prestw-1376,-2.59369571,-2.73641339,-1.84236044,0.67042102,45.92633929,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015735-11,Niclosamide,170465184,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),50-65-7, Yomesan;Niclosamide; Niclosamida;NICOLSAMIDE; ; Bayluscide;NICLOSAMIDE; Niclocide; Phenasal; Fenasal; Niclosamid; Radewerm; Bayer 73; Bayer 2353; Niclosamide; Clonitralide; Niclosamidel; Devermine; Niclosamide-olamine; Tr??d??mine,0.141253755,1,-6.85,77.99511393,2.4,4,,34.9261754,22.75006598,0.48094549,0.823252001,6774,STAT3,Clc2cc(ccc2NC(=O)c1cc(Cl)ccc1O)[N+]([O-])=O,Vitas,STK396676,-0.54143126,0.34794711,44.62742981,22.75006598,,,,,,,,,,,,1.60E-08,8.00E-08,4.00E-07,1E-05,,,,,,,,,,,
NCGC00015608-11,Loperamide hydrochloride,170464852,mu-Opioid Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),53179-11-6," ;LOPERAMIDE; Hydrochloride, Loperamid;Loperamide; Loperamide Hcl;Loperamide hydrochloride; Loperamide hydrochloride; Loperamida",5.623413252,1,-5.25,108.1855148,3,4,,103.1170135,98.12615466,0.006571895,0.999973361,4988,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4,Enzo,ALX-550-253,-0.02354049,-0.48712596,0.89092873,98.12615466,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00017063-07,Amodiaquin dihydrochloride dihydrate,405558845,Antimalarial; Histamine N-methyl Transferase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),6398-98-7,,1.584893193,1,-5.8,126.3810264,1.3,4,,87.39539065,69.56956957,0.326532376,0.927868267,,,CCN(CC)CC1=C(O)C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl,Prestwick,Prestw-309,1.52671756,-1.01880878,101.8591254,69.56956957,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00178860-06,Ethopropazine hydrochloride,170465065,Butyrylcholinesterase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1094-08-2,,12.58925412,0,-4.9,32.05115435,3,4,,35.5,30.58058058,0.040007636,0.999012996,,,Cl.CCN(CC)C(C)CN1c3ccccc3Sc2ccccc12,Microsource,1500293,2.43320611,1.38453501,2.88033517,30.58058058,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018163-10,Bithionol,170465515,Adenylate cyclase type 10 Inhibitor,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,97-18-7,,10,0,-5,12.75972833,2.4,5,,32.73062238,28.76674107,0.0061572,0.996911125,,,Oc2c(Sc1cc(Cl)cc(Cl)c1O)cc(Cl)cc2Cl,Specs,AN-153/J117612,-2.271035,-3.52551865,-1.39908575,-1.55537678,28.76674107,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00181088-01,Melitracen hydrochloride,144206258,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),10563-70-9,Melitracen hydrochloride; Melitraceno; Trausabun; Deanxit; Metrisil; ,11.22018454,0,-4.95,86.04281579,3,4,"Melitracen Hydrochloride;LS-20367;n,n,10,10-tetramethyl-delta(sup 9(10h)),gamma-anthracenepropylamine hydrochloride;melitracenum;Melitracene;Melitracen hydrochloride;Metrisil;Trausabun;9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene (Italian);melitracene hydrochloride;N,N-dimethyl-3-(9,10-dihydro-10,10-dimethylanthracen-9-yliden)propylamine;CIPLUS_670601;melitracene;CIPLUS_168125;Melitracen;LS-20365;Melitracenum;MELITRACEN;MELITRACEN HYDROCHLORIDE;Melitraceno;",123.0756447,103.9159503,0.005989639,0.999977872,,,Cl.CN(C)CC\C=C2/c1ccccc1C(C)(C)c3ccccc23,NCI,NSC-78229,0.93676815,1.37753911,7.17976611,103.9159503,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017112-10,Ciclopirox,170464708,Antifungal Agent,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),41621-49-2,; Dafnegin-CSC;Ciclopirox ethanolamine; Ciclopirox ethanolamine; Penlac;Ciclopirox; Batrafen; Loprox;ciclopirox; ciclopirox,12.58925412,0,-4.9,57.4336685,3,4,,72.3782992,55.43278085,0.027277882,0.999540925,,CAT,CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO,Microsource,1500189,-1.2590799,0,-0.98809222,55.43278085,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015817-14,Promethazine,170465107,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),60-87-7,,12.58925412,0,-4.9,100.9652602,3,4,,107.2107867,87.97624938,0.013355038,0.999889984,,,CN(C)C(C)CN1c3ccccc3Sc2ccccc12,Enzo,AC765,1.49830836,1.45535274,0.63633471,87.97624938,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00509905-01,Eliglustat (Tartrate),405558462,Ceramide glucosyltransferase Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),491833-29-5,,12.58925412,0,-4.9,27.62022261,3,4,,41.25113897,35.02890173,0.049904441,0.998462355,7357,UGCG,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C2=CC=C3OCCOC3=C2,Selleck,S7852,-0.10282776,1.43378519,1.00026323,35.02890173,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163157-05,Mesoridazine,170465272,D(2) dopamine receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),5588-33-0,,12.58925412,0,-4.9,87.81723818,3,4,,106.233292,82.05735333,0.015897659,0.999844098,1813,DRD2,CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2,"Prestwick Chemical, Inc.",Prestw-529,-0.2905569,-0.35131744,-1.34279199,82.05735333,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00386213-04,Rupatadine (Fumarate),405558713,Platelet activating factor receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),182349-12-8,,12.58925412,0,-4.9,18.69616286,2.4,4,,35.29562982,29.71098266,0.042763146,0.998871898,,,CC1=CN=CC(=C1)CN2CCC(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C35,MedChem Express,HY-13511A,-1.07969152,-0.13034411,-0.94761779,29.71098266,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018098-07,Iodoquinol,170465640,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),83-73-8,,4.466835922,1,-5.35,55.90351181,3,4,,55.78849122,51.62311956,0.010853067,0.999927371,,,Oc1c(I)cc(I)c2cccnc12,Vitas,STK070581,-1.10640301,-0.48712596,1.59287257,51.62311956,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015718-12,Naftopidil,170466026,alpha1-Adrenoceptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),57149-07-2,;Naftopidil;Naftopidil dihydrochloride; Flivas; KT-611 dihydrochloride; Naftopidil,12.58925412,0,-4.9,74.78194127,3,4,,86.08788598,65.82211665,0.009622854,0.999942894,148,ADRA1A,OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34,Tocris,597,0.9180791,0.48712596,0.51295896,65.82211665,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00091455-09,Celecoxib,170464693,Cyclooxygenase-2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),169590-42-5,; 5   Celecoxib (Celebrex);Celecoxib; Celecoxib; Celebrex;CELECOXIB,10,0,-5,67.79468418,3,4,,71.41706725,63.43394359,0.03663353,0.99917153,5743,PTGS2,NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(C)cc2)C(F)(F)F,Microsource,1503678,0.38666022,-0.81401085,-1.84537066,63.43394359,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00351603-13,Ceritinib,405558669,ALK Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1032900-25-6,,10,0,-5,66.68119179,3,4,,94.76043295,89.06399236,0.006914388,0.999970513,,ALK,CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4,MedChem Express,HY-15656,-0.56206089,-0.07004436,2.28447104,89.06399236,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00013495-15,Benztropine mesylate,405558618,Dopamine transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),132-17-2,,9.840111058,1,-5.007,41.01964668,3,4,,64.66589721,59.64660936,0.00849917,0.999955455,,,CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,APExBIO,B1554,-1.17096019,-1.1440579,0.32635301,59.64660936,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015747-09,Nicardipine,170465173,Ca channel blocker - DHP class,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),55985-32-5, ;Nicardipine hydrochloride; YC-93 hydrochloride; Dagan;Nicardipine?HCl;Nicardipine; Nicardipine; Cardene/SR; Nicardipino,10,0,-5,60.29789563,3,4,,63.5876566,56.50667986,0.022845762,0.999678041,,,CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC,Enzo,AC108,-0.04833253,-0.46867292,-1.20903595,56.50667986,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015264-13,Clomipramine hydrochloride,170464702,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),303-49-1, 7   Clomipramine; ; Chlomipramine;; Hydiphen;CLOMIPRAMINE HYDROCHLORIDE; Anafranil;Clomipramine; Anafranil hydrochloride; Chloripramine;Clomipramine?HCl; Clomipramina; 8   Clomipramine Hcl;Clomipramine hydrochloride; Clomipramine hydrochloride,10,0,-5,71.87672915,3,4,,81.23082861,67.74533018,0.017421466,0.999812788,6532,SLC6A4,CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12,Microsource,2300061,-0.2905569,-1.30489335,-0.93742083,67.74533018,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015819-15,Propafenone hydrochloride,170464755,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),54063-53-5,"Propafenona; ;Propafenone; Propafenone Hcl; Propafenone;Propafenone hydrochloride; Rythmol;Propafenone?HCl; Propafenone, (S)-Isomer; Rhythmol; Propafenone, (R)-Isomer",12.58925412,0,-4.9,82.71322372,3,4,,97.21110645,75.53444181,0.020900463,0.999730508,,KCNK3,CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1,SigmaAldrich,P-4670,0.35310734,0.27835769,-0.94492441,75.53444181,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00159337-04,Efavirenz,170464810,Reverse Transcriptase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),154598-52-4," Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer",12.58925412,0,-4.9,87.16446053,3,4,,100.1675188,80.39060438,0.020142605,0.999749696,7015,TERT,FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23,Vitas,STK582240,0.35310734,-0.97425191,-0.94492441,80.39060438,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00159325-05,Desloratadine,170464781,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),100643-71-8,,11.22018454,0,-4.95,100.5163596,3,4,,105.7789144,91.31697018,0.026880463,0.999554096,,,Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2,Vitas,STK586537,-0.21186441,1.67014614,-0.4049676,91.31697018,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00024778-02,Bifemelane,170465900,Monoamine oxidase B Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),90293-01-9,,12.58925412,0,-4.9,100.0308597,3,4,,115.2326794,92.77585354,0.022111127,0.999698345,,,CNCCCCOc2ccccc2Cc1ccccc1,Tocris,767,0.19333011,-0.41933892,-1.71810372,92.77585354,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015856-10,Prochlorperazine dimaleate,170464761,Dopamine D2 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1984/2/6,"; ;Prochloperazine dimaleate; Proclorperazina; Prochlorperazine dimaleate; Compazine syrup;Prochlorperazine; Compro; Compazine;Prochlorperazine dimaleate; Maleate, Prochlorperazin",8.912509381,1,-5.05,113.0818938,3,4,,129.3326259,104.776986,0.004209937,0.999989068,1813,DRD2,O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23,"Prestwick Chemical, Inc.",Prestw-399,-0.82391714,-0.90466249,0.29697624,104.776986,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00179676-03,Lynestrenol,170465984,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),52-76-6,,12.58925412,0,-4.9,19.41973073,2.4,4,,32.42664092,28.45588235,0.019031743,0.99977686,,,C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C,"Prestwick Chemical, Inc.",Prestw-95,-0.42842742,-0.77220077,-0.3077784,28.45588235,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015340-14,Desipramine hydrochloride,170465424,Serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),58-28-6,,11.22018454,0,-4.95,100.6893236,3,4,,105.9692424,91.24195943,0.01643951,0.999833281,,,Cl.CNCCCN2c3ccccc3CCc1ccccc12,Microsource,1500227,0.43499275,0.66600888,-0.63633471,91.24195943,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00159519-14,Tolterodine Tartrate ,,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),124937-52-6,,12.58925412,0,-4.9,45.78858558,3,4,,73.62253707,65.47277937,0.020044445,0.999752155,,,[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O,Bosche,T0008,-0.46838407,-1.37753911,-1.41419636,65.47277937,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181168-01,Trifluomeprazine 2-butenedioate,144206322,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),71609-19-3,Trifluomeprazine; Trifluomeprazina; ,10,0,-5,61.93390427,3,4,Trifluomeprazinum;Trifluomeprazine;CIPLUS_214394;trifluomeprazine;TRIFLUOMEPRAZINE;trifluomeprazinum;Trifluomeprazina;TRIFLUOMEPRAZINE MALEATE;,92.79253203,86.67621777,0.013855487,0.999881583,,,O=C(O)C=CC(=O)O.FC(F)(F)c1cc2N(CC(C)CN(C)C)c3ccccc3Sc2cc1,NCI,NSC-170991,-1.45199063,-0.35022181,1.57737286,86.67621777,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016013-06,Trimipramine maleate,170465260,Serotonin 2 (5-HT2) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),521-78-8,,10,0,-5,83.94331232,3,5,,123.4066956,109.7768763,9.84839E-05,0.99995076,,,O=C(O)/C=C\C(=O)O.CN(C)CC(C)CN2c3ccccc3CCc1ccccc12,Microsource,1503117,-0.31746032,-1.1630847,-0.78953861,5.50370902,109.7768763,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00253585-01,Cyclomethycaine,170465528,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),139-62-8,,12.58925412,0,-4.9,96.06136854,3,4,,114.6904389,89.05551171,0.006871231,0.99997088,,,CC3CCCCN3CCCOC(=O)c2ccc(OC1CCCCC1)cc2,GVK,FFS-11-286-NCI-76,-0.33898305,-0.70263488,-0.48137826,89.05551171,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015826-13,Perphenazine,170464834,Muscarinic acetylcholine receptor M1 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),58-39-9,,12.58925412,0,-4.9,106.282811,3,4,,120.5381647,97.42173112,0.015569892,0.999850453,1128,CHRM1,OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23,Microsource,1503934,0.3874092,-0.45169385,-0.93742083,97.42173112,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00022680-05,Chlormadinone acetate,170465776,Androgen receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),302-22-7,,12.58925412,0,-4.9,25.22474043,3,5,,43.18380384,36.34888438,0.000544293,0.999727993,367,AR,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C,Prestwick,Prestw-1374,-0.56166056,-0.6573957,-0.34542314,-0.28715004,36.34888438,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00090774-05,Nitazoxanide,170465090,antiprotozoal agent,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),55981-09-4,Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide,5.011872336,1,-5.3,58.53337876,3,4,,60.33212713,54.80136806,0.011412737,0.999919682,,,O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O,Vitas,STK395664,-1.2590799,-0.55207026,1.08943501,54.80136806,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015252-12,Cyproheptadine hydrochloride,170465127,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),129-03-3,; ; Cyproheptadine hydrochloride;Cyproheptadine hydrochloride; Dihexazin; 1   Cyprohetadine;Cyproheptadine;CYPROHEPTADINE HYDROCHLORIDE; Viternum; 9   Cyproheptadine; Ciproheptadina; Periactin; Peritol; Antergan,3.981071706,1,-5.4,82.20142838,3,4,,79.30657449,77.48639287,0.006001322,0.999977788,9704,HRH1,CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23,Vitas,STK802098,-0.8699855,-1.30735076,-0.25453388,77.48639287,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015998-06,THIOTHIXENE,405558925,dopamine secretion Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),"5591-45-7, 3313-26-6 [//Z//]",,12.58925412,0,-4.9,72.37746826,3,4,,101.1196004,92.49249249,0.018181553,0.999796065,,,CN(C)[S+]([O-])(=O)C1=CC2=C(SC3=C(C=CC=C3)\C2=C/CCN4CCN(C)CC4)C=C1,Microsource,1500576,1.04961832,0.86206897,-0.05236973,92.49249249,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016549-05,Dosulepin hydrochloride,405558989,Serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),897-15-4,,12.58925412,0,-4.9,61.73548121,3,4,,91.43837527,83.30228225,0.010838998,0.999927537,,,CN(C)CC\C=C1/C2=C(CSC3=C1C=CC=C3)C=CC=C2,Prestwick,Prestw-488,-0.38860104,0.41443198,0.25169897,83.30228225,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015004-13,Amoxapine,170465376,5-HT2A Antagonists?,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),14028-44-5, Amoxapina; ; Asendin; Amoxapine; 2   Amoxapine;Amoxapine;AMOXAPINE;,8.912509381,1,-5.05,76.02976202,3,4,,69.73990499,65.82211665,0.038593995,0.999080372,3356,HTR2A,Clc1ccc2Oc4ccccc4N=C(c2c1)N3CCNCC3,Enzo,AC814,0.25894539,2.64439805,1.43088553,65.82211665,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00181016-04,Bexarotene,170465308,Retinoid RXR Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),153559-49-0, ; LG69 compound; Bexarotene;Bexarotene;Targretin; Elan brand of bexarotene; Bexarotene (Targretin); 3-methyl-TTNEB,8.912509381,1,-5.05,32.62613723,2.4,4,,32.5,29.82982983,0.040979769,0.998964548,6256,RXRA,O=C(O)c1ccc(cc1)C(=C)c2cc3c(cc2C)C(C)(C)CCC3(C)C,CiVentiChem,CV-1209,2.14694656,1.22779519,5.7083006,29.82982983,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00024928-23,Tamoxifen,170465425,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),54965-24-1,"Soltamox; ""Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife",1.77827941,1,-5.75,42.45451901,3,4,,32.9375,-2.86764706,1,0.999846237,2099,ESR1,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc1ccc(cc1)/C(c2ccccc2)=C(/CC)c3ccccc3,Microsource,1500557,-0.78125,0.30888031,30.58198097,-2.86764706,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346435-13,MK-4827,,PARP Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,12.58925412,0,-4.9,52.64150295,3,4,,81.26470588,68.50490196,0.009367689,0.999945881,,,NC(=O)C1=CC=CC2=CN(N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4,Bio Vision,May-62,0.07560484,0.41184041,1.37101287,68.50490196,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379082-01,Anidulafungin,405558984,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),166663-25-8,,5.623413252,1,-5.25,82.84324468,3,4,,87.13692369,79.19117647,0.009210659,0.999947676,,,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC=C(O)C=C7)C(C)O,MedChem Express,HY-13553,-0.07560484,-0.72072072,0.69949636,79.19117647,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00164543-02,Lomerizine dihydrochloride,170466010,Ca channel blocker - benzhydryl class,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),101477-54-7, ; Terranas; Lomerizine HCl; LOMERIZINE DiHCl;Lomerizine; Lomerizine,11.22018454,0,-4.95,27.89210671,2.4,4,,35.61135039,28.38726651,0.030975368,0.999408599,,,Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC,Sequoia,SRP01568l,-0.72639225,-0.70263488,-1.34279199,28.38726651,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00167550-08,Narasin,405558485,Nf-kappa B Signaling Pathway Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),55134-13-9,,0.501187234,1,-6.3,115.1443438,2.4,4,,43.66956759,-2.24450812,1,0.999940524,,,CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C)C(O)=O,Enzo,NP198,16.01873536,27.76091525,37.91134077,-2.24450812,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183830-01,Lemildipine,144206840,Voltage-gated calcium channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),94739-29-4,,12.58925412,0,-4.9,29.51876027,3,5,"CIPLUS_208006;NPK 1886;isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;lemildipine;Lemidipine;Lemildipine;LS-131203;LEMILDIPINE;NB-818;NPK-1886;CIPLUS_701996;NB 818;lemildipinum;",46.90113564,41.94726166,0.000674803,0.999662661,,,O=C(OC)C1=C(C)NC(COC(N)=O)=C(C1c2cccc(Cl)c2Cl)C(=O)OC(C)C,Pharmaron,PH-NIH-152804,-0.26862027,-0.6573957,-0.29607698,-0.95716679,41.94726166,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015428-15,(+/-) -Fluoxetine,170465374,Serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),54910-89-3,,4.466835922,1,-5.35,102.9158635,3,4,,96.22347668,92.9242949,0.002116733,0.999997237,,,FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2,Vitas,STK734483,-0.19333011,-0.27133695,1.46356984,92.9242949,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00371130-03,Vilazodone Hydrochloride,405558674,Sodium-dependent serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),163521-08-2,,10,0,-5,61.71161387,3,4,,89.54332686,86.58070678,0.040791146,0.998972389,6532,SLC6A4,NC(=O)C1=CC2=CC(=CC=C2O1)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3,APExBIO,A3919,-1.82669789,1.56432407,0.81588251,86.58070678,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016710-05,Clemastine fumarate,170465318,Histamine H1 Receptor Antagonists,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),14976-57-9, ;CLEMASTINE FUMARATE; Clemastine fumarate salt; Meclastine;Clemastine fumarate; Corto-Tavegil; Clemastine fumarate; Tavist; Tavegyl;CLEMASTINE; Clemastina,11.22018454,0,-4.95,67.30973208,3,4,,104.2022059,90.07352941,0.00840702,0.999956407,9704,HRH1,CN3CCC[C@@H]3CCO[C@](C)(c1ccccc1)c2ccc(Cl)cc2.O=C(O)/C=C/C(=O)O,Microsource,1500191,-0.78125,-0.1029601,2.93788472,90.07352941,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00168786-02,Deserpidine,144206653,Synaptic vesicular amine transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),131-01-1,Deserpidine,12.58925412,0,-4.9,51.94347935,3,4,"deserpidinum;CIPLUS_151707;LS-178544;CIPLUS_743119;deserpidine;reserpidine;ORETICYL FORTE;Deserpidine;METHYCLOTHIAZIDE;LS-7299;3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester);Deserpidina;Deserpidinum;LS-178610;DESERPIDINE;",75.24869855,65.26526527,0.018519341,0.999788449,,,COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC,GVK,GVK-NIH-19,1.0019084,-0.07836991,0.94265515,65.26526527,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015708-15,Maprotiline hydrochloride,170464778,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),10262-69-8, ; Ciba 34276 Ba;MAPROTILINE HYDROCHLORIDE; Maprotilene Hydrochloride; Maprotiline hydrochloride;Maprotiline hydrochloride; Maprotilline HCl; Ludiomil; Maprotilina;Maprotiline,12.58925412,0,-4.9,103.6688063,3,4,,120.4360874,96.96489839,0.011477643,0.999918741,,SLC6A2,CNCCCC24CCC(c1ccccc12)c3ccccc34,Vitas,STK711156,-0.49435028,-0.55671538,-1.32289417,96.96489839,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00181913-02,Difeterol,144206884,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),14587-50-9,Difeterol; Difeterol Phosphate; Difeterol Hydrochloride; ,12.58925412,0,-4.9,116.8719872,3,4,CIPLUS_783660;DIFETEROL;Difeterol;difeterolum;difeterol;Difeterol Phosphate;Difeterol Hydrochloride;,127.9080902,104.776986,0.028857217,0.999486036,,,OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3,Pharmaron,PH-NIH-2,0.11770245,2.50521921,-0.02699784,104.776986,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00025155-07,Omacetaxine mepesuccinate,405558996,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),26833-87-4,,0.398107171,1,-6.4,65.44733921,2.4,4,,32.23409802,-0.06936416,1,0.999995153,,RPL3,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]\1[C@H]2C3=CC4=C(OCO4)C=C3CCN5CCC[C@]25\C=C1OC,MedChem Express,HY-14944,12.59640103,41.37122002,6.31745196,-0.06936416,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00420892-01,NKH477,405558797,Adenylate cyclase Activator,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,11.22018454,0,-4.95,18.5919711,2.4,4,,36.66580977,28.55491329,0.038581954,0.999082132,,,CN(C)CCC(=O)OC1C(OC(C)=O)C2(C)OC(C)(CC(=O)C2(O)C3(C)C(O)CCC(C)(C)C13)C=C,Bio Vision,May-27,-1.38817481,-0.44316997,1.57936299,28.55491329,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00253604-01,Rescimetol,170465875,smooth muscle contraction Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),73573-42-9,,12.58925412,0,-4.9,62.31618707,3,4,,95.93915388,82.58258258,0.018845898,0.999780893,,,Oc1ccc(cc1OC)/C=C/C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC,GVK,FFS-11-286-NCI-194,0.38167939,-0.96656217,0.41895784,82.58258258,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370823-03,Pitolisant (hydrochloride),405558641,Histamine H3 receptor Inverse Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),903576-44-3,,14.12537545,0,-4.85,30.5982577,3,4,,38,32.68268268,0.080386022,0.99599827,,,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,MedChem Express,HY-12199B,1.19274809,3.10867294,1.36161299,32.68268268,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00188864-02,Iloperidone,170465198,Dopamine D2 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),133454-47-4,Iloperidone,12.58925412,0,-4.9,59.54246554,3,4,,95.87934411,85.86399627,0.004697628,0.99998639,1813,DRD2,CC(=O)c4ccc(OCCCN1CCC(CC1)c3noc2cc(F)ccc23)c(OC)c4,Bosche,I2337,-1.32124352,-1.04826914,-0.7550969,85.86399627,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00253658-01,Dapoxetine,170466555,Serotonin Transporter (SERT) Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),119356-77-3,Dapoxetine hydrochloride (Priligy);Dapoxetine,12.58925412,0,-4.9,68.36787464,3,4,,100.8036796,87.91336749,0.020608175,0.99973798,6532,SLC6A4,CN(C)[C@@H](CCOc2cccc1ccccc12)c3ccccc3,GVK,FFS-12-73-NCI-1987,0.18134715,1.68210629,1.45985401,87.91336749,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00178213-05,Nafronyl oxalate,170465616,Serotonin 2 (5-HT2) receptor Antagonist,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,3200/6/4,,12.58925412,0,-4.9,23.57557495,3,5,,55.86583209,45.5078125,0.000938001,0.999530924,,,O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3,Microsource,1503419,-3.06527674,-1.8454881,-2.72890982,-2.2257978,45.5078125,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00167488-08,Sorafenib,170465175,VEGFR-1/2/3 Inhibitor,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,475207-59-1,;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar,3.16227766,1,-5.5,74.60482395,3,5,,42.9608091,-1.69399648,0.198049715,0.975025885,2321,FLT1,O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1,Sequoia,284461-73-0,8.32514735,1.95571956,4.20729264,37.92667509,-1.69399648,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00177979-05,Azelastine hydrochloride,170465172,Histamine H1 Receptor Antagonists,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,79307-93-0,; Astelin; Azelastina;AZELASTINE HYDROCHLORIDE; Azelastine Hydrchloride,11.22018454,0,-4.95,47.55476651,3,5,,83.86552131,64.49383385,0.002196325,0.998900359,9704,HRH1,Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4,Microsource,1505340,-2.67681729,-0.57810578,-0.22706024,6.97850822,64.49383385,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015273-19,Chlorpromazine,170465371,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),50-53-3,,11.22018454,0,-4.95,69.5306654,3,4,,68.75339905,60.16823355,0.045069756,0.998745383,,,CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12,Vitas,STK182870,1.25664572,2.1953626,-0.31816736,60.16823355,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00161621-03,Cepharanthine,170465994,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),481-49-2,,1.995262315,1,-5.7,118.3200811,3,4,,83.63766089,5.80882353,1,0.999994855,,,COc8ccc1cc8Oc7ccc(C[C@H]4c5c(Oc3cc2c(CCN(C)[C@@H]2C1)cc3OC)c6OCOc6cc5CCN4C)cc7,Vitas,STK801907,0.63004032,2.36808237,79.54672636,5.80882353,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016003-10,Trihexyphenidyl hydrochloride,170464756,Muscarinic acetylcholine receptor M5 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),52-49-3,,11.22018454,0,-4.95,59.60111783,3,4,,68.54097494,56.80084188,0.010148861,0.999936485,,,Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3,Microsource,1500592,-0.92009685,-0.40150565,-0.68406385,56.80084188,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00164576-04,Lopinavir,170464773,HIV Protease Inhibitors,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),192725-17-0,;ABT-738; Lopinavir/Ritonavir;Lopinavir;LOPINAVIR; Lopinavir,12.58925412,0,-4.9,56.8551346,3,4,,66.55945274,53.53785255,0.026724281,0.999559394,,,CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O,Bosche,L2844,0,-0.86334484,-1.20903595,53.53785255,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00185767-01,Spiramycin II,144207139,Bacterial 70S ribosome Binding Agent,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),24916-51-6,,12.58925412,0,-4.9,66.4091709,3,4,,107.9968311,92.62254902,0.005579255,0.999980801,,,CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C,Toronto Research,A187800,-1.03326613,-0.56628057,0.3077784,92.62254902,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018271-07,Homochlorcyclizine,170465786,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),848-53-3,,5.011872336,1,-5.3,99.97199797,3,4,,97.20512755,92.89660616,0.004934725,0.999984981,,,Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3,Enzo,AC927,-1.0653753,-0.65244667,0.48137826,92.89660616,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00013841-09,Cyclobenzaprine hydrochloride,170464953,5-HT2A Receptor Ligands,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),6202-23-9, Lisseril; ; Flexeril; Ciclobenzaprina;CYCLOBENZAPRINE HYDROCHLORIDE; Cyclobenzaprine hydrochloride;Cyclobenzaprine hydrochloride,12.58925412,0,-4.9,92.44965897,3,4,,108.1660894,86.84556696,0.008838017,0.999951823,3356,HTR2A,Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12,Microsource,1503207,-0.4842615,-1.10414053,-1.08943501,86.84556696,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016634-04,Acetopromazine maleate,170465731,,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,3598-37-6,,12.58925412,0,-4.9,62.15599511,3,5,,105.4006125,93.73898902,0.000434608,0.999782655,,,O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1,"Prestwick Chemical, Inc.",Prestw-576,-2.25933202,-1.80811808,-1.08187525,-2.42730721,93.73898902,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00021146-09,Ketanserin,170466645,5-HT2A Antagonists?,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,74050-98-9,Ketanserin tartrate;Ketanserin;KETANSERIN TARTRATE,12.58925412,0,-4.9,15.93129038,2.4,5,,30.38659794,23.18638393,0.019477645,0.990138288,3356,HTR2A,Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4,Enzo,NS515,0.01241003,-2.40549828,0.29089902,0.08045052,23.18638393,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00389554-01,DORAMECTIN,405558736,chloride transmembrane transport Activator,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),117704-25-3,,12.58925412,0,-4.9,30.33739659,3,4,,44.29132948,37.80346821,0.023600175,0.999656611,,,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2[C@H](C)O[C@@H](C[C@@H]2OC)O[C@H]\3[C@@H](C)\C=C\C=C\4CO[C@@H]5C(O)\C(=C/[C@@H](C(=O)O[C@H]6C[C@@H](C/C=C3C)O[C@@]\7(C6)O[C@@H]([C@@H](C)\C=C7)C8CCCCC8)[C@]45O)C,Microsource,1505902,0.20565553,1.01668405,1.21084496,37.80346821,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00249914-01,Bencyclane,170465760,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2179-37-5,,12.58925412,0,-4.9,68.20715883,3,4,,83.91008089,64.4235527,0.025657211,0.99959384,,,CN(C)CCCOC1(CCCCCC1)Cc2ccccc2,GVK,FFS-11-286-NCI-166,-0.43499275,-0.07400099,-1.52720331,64.4235527,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00095086-04,PERICIAZINE,405558569,Dopamine D2 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2622-26-6,,10,0,-5,47.22934077,3,4,,63.80793228,57.13294798,0.036135243,0.999194021,,,OC1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(C=C24)C#N)CC1,Microsource,MS-01503936,1.02827763,-0.86027112,3.57988944,57.13294798,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016600-08,Clofazimine,387065713,DNA Binding Agent,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2030-63-9,,3.548133892,1,-5.45,30.33373486,2.4,4,,31.4527845,28.91344383,0.014992427,0.99986154,,,CC(C)\N=C\1/C=C\2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)\N=C2\C=C1NC5=CC=C(Cl)C=C5,SIGMA,C8895,-1.21065375,-0.70263488,1.2921206,28.91344383,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016397-04,Benzydamine hydrochloride,170465576,prostaglandin production involved in inflammatory response Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),132-69-4,,12.58925412,0,-4.9,70.83968105,3,4,,84.80308487,65.95744681,0.028342604,0.999504305,,,Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23,Vitas,STK711092,-0.57999033,0.71534287,-0.8908686,65.95744681,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00386699-01,Fluphenazine decanoate dihydrochloride,405558673,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2376-65-0,,12.58925412,0,-4.9,51.88057915,3,4,,83.00651913,69.67526266,0.013550176,0.999886756,,,CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1,Axon Medchem,2127,-0.51522248,0.35022181,1.25101985,69.67526266,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00164559-03,Duloxetine hydrochloride,170465319,Serotonin Transporter (SERT) Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),136434-34-9, ; Duloxetine hydrochloride;Duloxetine hydrochloride; Cymbalta;DULOXETINE HYDROCHLORIDE;Duloxetine HCl; DULOXETINE HCl; 0   Duloxetine Hcl,8.912509381,1,-5.05,57.58431444,3,4,,79.05614354,75.66176471,0.017043022,0.999820826,6532,SLC6A4,Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3,Sequoia,SRP05005d,-0.07560484,-1.18404118,2.93788472,75.66176471,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016618-04,Dimethisoquin hydrochloride,170465516,Neuronal acetylcholine receptor; alpha4/beta4 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),2773-92-4,,12.58925412,0,-4.9,41.49543909,3,4,,52.98235294,47.37745098,0.016652174,0.99982902,,,Cl.CN(C)CCOc2nc(cc1ccccc12)CCCC,"Prestwick Chemical, Inc.",Prestw-630,1.58770161,1.02960103,1.87465025,47.37745098,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181091-01,Bunamidine hydrochloride,144206260,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1055-55-6,Bunamidine hydrochloride; Bunamidina; Scolaban; ,3.16227766,1,-5.5,93.88513155,3,4,"bunamidinum;bunamidine monohydrochloride;N,N-DIBUTYL-4-(HEXYLOXY)-1-NAPHTHAMIDINE MONOHYDROCHLORIDE;bunamidine;LS-174664;Scolaban;CIPLUS_738221;CIPLUS_157296;Bunamidinum;N,N-dibutyl-4-(hexyloxy)-1-naphthamidine monohydrochloride;LS-95153;NSC-106571;1-Naphthamidine, N,N-dibutyl-4-hexyloxy-, monohydrochloride;CIPLUS_3885993;1-naphthalenecarboximidamide, n,n-dibutyl-4-(hexyloxy)-, hydrochloride;BUNAMIDINE HYDROCHLORIDE;Bunamidine hydrochloride;Bunamidina;BUNAMIDINE;Bunamidine;",90.02367226,-3.05305305,1,0.99977772,,,Cl.CCCCN(CCCC)C(=N)c1ccc(OCCCCCC)c2ccccc12,NCI,NSC-106571,-0.85877863,-1.90700104,67.34747316,-3.05305305,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181099-01,Siccanin,144206268,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),22733-60-4,Siccanin; Ladar; Sicanina; Piadar; ,12.58925412,0,-4.9,38.23332983,3,4,"Siccaninum;LS-173961;siccanine;Siccanine;Siccanin;Ladar;SICCANIN;CIPLUS_214175;Sicanina;Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester, mixt. with (4aS-(4aalpha,6aalpha,11balpha,13aR*,13balpha))-1,2,3,4,4a,5,6,6a,11b,13b-decahydro-4,4,6a,9-tetramethyl-13H-benzo(a)furo(2,3,4-mn)xanthen-11-ol;CIPLUS_769555;siccaninum;Piadar;siccanin;",58.1163425,52.62254902,0.034947938,0.99924621,,,Cc1cc2O[C@@]4(C)CC[C@H]5C(C)(C)CCCC53CO[C@@H](c2c(O)c1)[C@H]34,NCI,NSC-135048,-0.63004032,0.92664093,-0.19585898,52.62254902,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183858-01,Blonanserin,144206818,Serotonin 2a (5-HT2a) receptor Antagonist,SARS-CoV-2_CPE_SRI,2019_NPC-2.2,132810-10-7,,5.623413252,1,-5.25,34.71007794,3,5,"AD-5423;BLONANSERIN;blonanserin;AD 5423;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[B]PYRIDINE;blonanserinum;Blonanserin;blonanserine;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;CIPLUS_702318;",49.34455605,43.77790179,0.000745072,0.999627468,,,CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3,Pharmaron,PH-NIH-148160,-3.06527674,-3.7037037,-2.72890982,-2.76213462,43.77790179,,,,,,,,,,,1.60E-08,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,
NCGC00015619-13,Loratadine,170464867,Histamine H1 Receptor Antagonists,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),79794-75-5, Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;,11.22018454,0,-4.95,32.55767621,3,4,,42.71764706,39.28921569,0.017432479,0.999812666,9704,HRH1,Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3,Vitas,STK574925,0.88205645,0.30888031,1.03525462,39.28921569,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00262942-01,Etifelmine hydrochloride,170465899,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1146-95-8,Etifelmine;Etifelmine,11.22018454,0,-4.95,29.63047682,2.4,4,,30.31073447,27.02560042,0.035445039,0.999225644,,,Cl.CCC(\CN)=C(/c1ccccc1)c2ccccc2,GVK,FFS-11-286-NCI-209,-0.25894539,0.6263048,0.02699784,27.02560042,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00159476-09,Tribromsalan,170465542,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1987/10/5,,8.912509381,1,-5.05,25.56205139,2.4,5,,30.1068268,27.42393509,0.013475936,0.993205139,,,Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2,SIGMA,R416568,1.88034188,-0.505689,-0.44411547,3.20650873,27.42393509,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00167493-04,Manidipine,174006297,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),89226-75-5,; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride,10,0,-5,35.1437158,3,4,,33.57765391,32.01789003,0.033312513,0.999315723,,,Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5,Selleck,S2481,0.43583535,-0.40150565,-0.48137826,32.01789003,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00163169-05,Pizotifen,170466311,Antimigraine drugs,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),15574-96-6, Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran,12.58925412,0,-4.9,98.97649386,3,4,,117.0868011,90.94975007,0.017620907,0.999808452,,CHRM1,CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23,BIOMOL,NS740,0.0968523,0.25094103,-1.08943501,90.94975007,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016642-04,Piperacetazine,170465363,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),3819-00-9,,12.58925412,0,-4.9,105.0322975,3,4,,118.9024986,95.99208313,0.026505951,0.999566434,,,CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2,Prestwick,Prestw-1048,0.91831803,-0.61667489,-1.46356984,95.99208313,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00179665-04,Danazol,170464884,Androgen Receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),17230-88-5,,12.58925412,0,-4.9,30.73450488,3,4,,41.13791582,37.75722543,0.03362679,0.999302504,,,C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C,Prestwick,Prestw-105,0.97686375,-0.13034411,0.1579363,37.75722543,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509862-02,Fluralaner,405558651,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),864731-61-3,,11.22018454,0,-4.95,20.21748024,3,4,,39.07377049,30.65902579,0.026561785,0.99956515,,,CC1=C(C=CC(=C1)\C2=N\OC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F,MedChem Express,HY-16973,-1.31147541,-0.53700677,1.46858852,30.65902579,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00164127-07,"4-(1,1,3,3-Tetramethylbutyl)phenol",170465157,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),140-66-9,,11.22018454,0,-4.95,26.0290611,3,5,,43.41994035,38.37728195,0.000798972,0.999600601,,,Oc1ccc(cc1)C(C)(C)CC(C)(C)C,SIGMA,290823,-0.51282051,-1.3147914,-0.74019245,-0.38286671,38.37728195,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00165957-07,Amlodipine,225144262,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),88150-42-9,,12.58925412,0,-4.9,63.09499585,3,4,,102.3418227,87.53753754,0.011966673,0.999911671,,,CCOC(=O)C/1=C(COCCN)/N\C(=C(C1C2=C(Cl)C=CC=C2)\C(=O)OC)C,Prestwick,Prestw-1219,-0.47709924,-1.22779519,-0.36658811,87.53753754,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378574-01,Brexpiprazole,405558789,Dopamine D3 receptor Partial Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),913611-97-9,,11.22018454,0,-4.95,38.53324849,3,4,,66.80581345,59.10910911,0.006291011,0.999975595,,,O=C\1NC2=C(\C=C1)C=CC(=C2)OCCCCN3CCN(CC3)C4=C5C=CSC5=CC=C4,MedChem Express,HY-15780,-1.71755725,-1.48902821,-0.31421838,59.10910911,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015155-11,Bepridil,170465240,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),64706-54-3," ; Bepridil, (-)-Isomer; Bepridil;Bepridil; Vascor;Bepridil hydrochloride; Bepridil, (+)-Isomer",12.58925412,0,-4.9,104.3581049,3,4,,120.1563163,96.70097651,0.008725976,0.999953035,,KCNT1,CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,BIOMOL,AC104,-0.25894539,-0.34794711,-0.94492441,96.70097651,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00249891-01,Bromodiphenhydramine,170465292,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),118-23-0,,12.58925412,0,-4.9,51.06049312,3,4,,82.33261318,73.52352352,0.008339149,0.999957111,,,Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2,GVK,FFS-11-286-NCI-046,-0.85877863,-1.38453501,-1.04739461,73.52352352,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00182081-04,Zotepine,170465934,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),26615-21-4,,12.58925412,0,-4.9,32.89956546,3,4,,46.72700915,39.58958959,0.046792434,0.998648131,3269,HRH1,CN(C)CCOC1=Cc3ccccc3Sc2ccc(Cl)cc12,Prestwick,Prestw-1368,1.14503817,-0.60083595,1.15213407,39.58958959,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00408859-01,Cetilistat,405559027,Pancreatic lipase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),282526-98-1,,10,0,-5,64.7608768,3,4,,96.35690456,87.88788789,0.006332816,0.999975265,,,CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1,Glixx,GLXC-06700,-0.71564885,-1.17554859,2.46137732,87.88788789,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165740-05,Benazepril,170465003,Angiotensin-I Converting Enzyme Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),86541-74-4,; Briem; Benazepril Free base; BENAZEPRIL HCl; Lotensin HCT 20/12.5mg;Benzapril; Labopal; Benazepril Hcl; Cibacen; Lotensin; Benzapril;Benazepril hydrochloride; Cibac???ne,10,0,-5,95.80830215,3,4,,109.3841845,89.65858486,0.008761982,0.999952648,1636,ACE,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@H]3CCc2ccccc2N(CC(=O)O)C3=O,Microsource,1505200,-1.01498308,-0.27133695,-0.4454343,89.65858486,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00016016-18,Triamterene,170464706,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),396-01-0,,7.079457844,1,-5.15,49.53015047,3,4,,49.90901406,46.92531011,0.023568002,0.999657418,,,Nc2nc(N)nc1nc(N)c(nc12)c3ccccc3,Vitas,STK300348,-0.87099812,0.13917884,-0.4049676,46.92531011,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00178069-05,Cloperastine hydrochloride,170465832,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),14984-68-0,,3.16227766,1,-5.5,32.56718416,3,4,,33.58768267,31.98733175,0.03263924,0.999343095,,,Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3,"Prestwick Chemical, Inc.",Prestw-793,-0.87099812,-1.73973556,0.29697624,31.98733175,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015096-17,Amiodarone hydrochloride,170464920,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1951-25-3,; Ancaron; Kordaron; Amiodarone;Amiodarone; Amiodarona;Amiodarone hydrochloride;Amiodarone?HCl,11.22018454,0,-4.95,88.69704415,3,4,,93.84768601,80.60174188,0.02466633,0.99962458,,CHRM3,CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC,Microsource,2300165,0.87099812,-0.48712596,-0.94492441,80.60174188,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00167507-04,Lapatinib,170465125,EGFR Inhibitor,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,231277-92-2,;Lapatinib; Lapatinib;GW-572016F?; Lapatinib base;LAPATINIB DITOSYLATE; Tykerb;Tykerb,10,0,-5,26.10708775,3,5,,45.52091461,38.88060713,0.013081466,0.993399458,1956,EGFR,Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5,Sequoia,231277-92-2,0.44204322,-3.01353014,-3.21891278,0.83438685,38.88060713,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00166312-02,Closantel,170466628,,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,57808-65-8,,11.22018454,0,-4.95,39.65904082,3,5,,84.12160013,63.05865922,0.001752803,0.999122709,,,Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2,Vitas,STK378904,-4.18187348,-2.15415266,-1.892783,4.45220428,63.05865922,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00016391-13,Clioquinol,170465019,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),130-26-7,,10,0,-5,48.93119955,3,5,,66.54913812,62.39350913,0.001033057,0.999483239,,,Oc1c(I)cc(Cl)c2cccnc12,Microsource,1505114,1.001221,-0.4551201,-0.5428078,1.62718354,62.39350913,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00091250-12,Reserpine,170465405,Alkaloid anitpsychotic,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),50-55-5,,11.22018454,0,-4.95,74.31978429,3,5,,106.4287387,98.90466531,7.27369E-05,0.999963634,,SLC18A2,COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC,Vitas,STK801975,-0.17094017,0.2528445,0.04934616,0.71787509,98.90466531,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015829-12,Promazine hydrochloride,170464766,Serotonin 2a (5-HT2a) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),53-60-1,,10,0,-5,83.23274931,3,5,,118.9085839,109.7768763,3.53887E-05,0.999982307,,,Cl.CN(C)CCCN1c3ccccc3Sc2ccccc12,Microsource,1500509,-0.31746032,-0.7079646,-0.39476931,3.63723379,109.7768763,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00091195-08,Hexachlorophene,170464690,Glucose-6-phosphate dehydrogenase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),70-30-4,,0.891250938,1,-6.05,64.46566274,2.2,4,,41.61997511,41.54169955,0.020415226,0.99974304,,,Clc2c(Cc1c(O)c(Cl)cc(Cl)c1Cl)c(O)c(Cl)cc2Cl,Vitas,STK377478,-0.1937046,0.15056462,18.26703826,41.54169955,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00167489-03,Sarpogrelate hydrochloride,174006666,5HT(2A) and 5HT(2B) inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),135159-51-2, ; Sarpogrelate;Sarpogrelate; Anplag; Sarpogrelate HCl,12.58925412,0,-4.9,58.77887586,3,4,,69.27932023,53.68629391,0.036967274,0.999156466,,,Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C,Tocris,3739,0.33832769,0.5673409,-1.08176901,53.68629391,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00159456-11,Imatinib,170465393,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),220127-57-1,GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec,5.623413252,1,-5.25,102.7290955,3,4,,100.0691578,94.63299132,0.007111968,0.999968803,25,ABL1,CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5,Prestwick,Prestw-1290,-0.3874092,-1.00376412,0.32936407,94.63299132,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015500-19,Haloperidol,170464841,Dopamine D2 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),52-86-8,; ;Haloperidol; Haloperidol hydrochloride; Haloperidol Lact;Haloperidol..HCl; Vesadol;HALOPERIDOL;Haloperidol?HCl;Haloperidol hydrochloride; Haloperidol metabolite II; Haloperidol Dec; Haldol,11.22018454,0,-4.95,29.44024041,3,4,,34.29080497,30.62840178,0.048137292,0.998569794,1813,DRD2,Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3,Enzo,AC250,-0.96665056,-0.51800691,-1.90900414,30.62840178,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00386387-01,Buclizine HCl,405558507,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),129-74-8,,12.58925412,0,-4.9,42.88362316,3,4,,71.0949283,63.41929322,0.008714755,0.999953164,,,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)C=C1,Selleck,S4140,-1.264637,-0.86388046,-0.97905902,63.41929322,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00013683-06,Chlorprothixene,170465069,Serotonin (5-HT) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),113-59-7,,8.912509381,1,-5.05,47.30777423,3,4,,50.31970623,46.06682452,0.049827389,0.998466308,3269,,CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12,Microsource,1503203,-1.5496368,0.60225847,-0.73473524,46.06682452,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00024595-08,Carbetapentane,170465562,Sigma-1 receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),77-23-6,,14.12537545,0,-4.85,15.28453098,2.4,4,,30.10800224,24.82843137,0.026527937,0.99956653,,,CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2,Enzo,NO103,-0.83165323,-0.72072072,-0.9233352,24.82843137,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00178737-05,Trimeprazine tartrate,170465278,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),4330-99-8,,12.58925412,0,-4.9,102.8850719,3,4,,112.5777833,89.26274122,0.010885546,0.999926912,,,O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12,Microsource,1500593,1.20831319,1.99802664,1.27266942,89.26274122,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00167449-02,Desogestrel,225144285,Progesterone receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),54024-22-5,,11.22018454,0,-4.95,31.44104203,3,4,,54.87132858,45.22445081,0.033518836,0.999306773,,,CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/CCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,SIGMA,32809,-1.45199063,0.02334812,1.90372586,45.22445081,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016256-17,Pyrimethamine,170464930,Dihydrofolate Reductase (DHFR) Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),58-14-0,Pirimetamina; ; Daraprim; Tindurine; Fansimef; Chloridin;Pyrimethamine; Suldox; Maloprim; Pyrimethamine; A.E.S. mixture; Folaprim; Malocide,11.22018454,0,-4.95,31.4146497,3,5,,35,30.10141988,0.003983251,0.99800569,1719,DHFR,CCc1nc(N)nc(N)c1c2ccc(Cl)cc2,Microsource,1500520,1.24542125,2.73072061,2.26992351,4.45082556,30.10141988,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015095-15,Amitriptyline hydrochloride,170464758,Sodium-dependent serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),549-18-8,,12.58925412,0,-4.9,101.3357335,3,4,,116.8801732,94.26026719,0.01967419,0.999761193,6532,SLC6A4,Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12,Microsource,1500117,-0.67665539,0.5673409,-1.14540248,94.26026719,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00249921-01,Omoconazole,170465847,,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,74512-12-2,,14.12537545,0,-4.85,20.32248769,2.4,5,,34.53903624,27.24860335,0.00754576,0.996211876,,,C\C(=C(\OCCOc1ccc(Cl)cc1)c2ccc(Cl)cc2Cl)n3ccnc3,GVK,FFS-11-286-NCI-199,0.56265207,-1.2825302,0.13432654,-0.40739124,27.24860335,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015254-20,Clozapine,170464853,Dopamine D4 Antagonist,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,5786-21-0,;Clozapine; ; clozapine N-glucuronide;CLOZAPINE; Leponex; Clozaril; Clozapine; Clozapina; Clo-Glu,12.58925412,0,-4.9,22.49920789,3,5,,38.75469946,35.05895108,0.047362795,0.975466549,1815,DRD4,CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23,Enzo,D107,-2.21021611,3.23493235,0.41405102,-3.08470291,35.05895108,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00179384-10,Chlorcyclizine,405558456,Hepatitis C virus Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),GRT00368,,12.58925412,0,-4.9,44.12860533,3,4,,75.73721537,64.53431373,0.032351074,0.999354056,,,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3,SIGMA,SMl1473,-1.48689516,0.25740026,-0.69949636,64.53431373,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00021268-04,Hydroxyprogesterone caproate,170465210,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),630-56-8,,7.943282347,1,-5.1,41.74798916,3,5,,56.39465275,52.65720081,0.000477855,0.999761097,,,CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C,Bosche,H1727,-0.07326007,-0.7585335,-0.98692327,5.360134,52.65720081,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00014648-04,Spiclomazine hydrochloride,405558575,Adrenergic receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,12.58925412,0,-4.9,26.87149791,3,4,,38.93536952,34.21052632,0.046673116,0.998655447,,,ClC1=CC2=C(SC3=C(C=CC=C3)N2CCCN4CCC5(CC4)NC(=O)CS5)C=C1,NCI,NSC-290956,-0.07772021,1.34080936,0.8054367,34.21052632,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351599-02,Abemaciclib,405558877,CDK4/6 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1231930-82-7,,7.943282347,1,-5.1,38.45317225,2.2,4,,59.44011662,47.51671442,0.021581294,0.999712771,,CDK4,CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2,Selleck,S7158,-2.06088993,-0.39691805,12.12945336,47.51671442,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167576-02,Aprindine hydrochloride,170465842,Calmodulin Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),33237-74-0,,8.912509381,1,-5.05,33.25363502,3,4,,50.59216698,47.70773639,0.009480107,0.99994459,,,Cl.CCN(CC)CCCN(c1ccccc1)C2Cc3ccccc3C2,Key Organics,KS-1222,-1.07728337,-0.86388046,1.35980419,47.70773639,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379007-02,Retapamulin,405558888,70S ribosome Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),224452-66-8,,12.58925412,0,-4.9,33.605684,3,4,,51.85371052,46.9132948,0.022179368,0.999696615,,,C[C@@H]1CCC23CCC(=O)[C@H]2C1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4C[C@@H]5CC[C@H](C4)N5C,MedChem Express,HY-17010,-0.46272494,0.13034411,-0.52645433,46.9132948,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00179370-05,Methotrimeprazine maleat salt,405559100,Serotonin 2 (5-HT2) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),7104-38-3,,12.58925412,0,-4.9,67.07999936,3,4,,102.1767653,88.42571029,0.012471754,0.999904057,,,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1,Prestwick,Prestw-797,-0.23316062,0.75572891,1.51019381,88.42571029,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015767-10,Oxybutynin chloride,405559139,Muscarinic Antagonists,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),1508-65-2, Oxibutinina; ;; Oxytrol; Tropax;Oxybutynin Chloride; Esoxybutynin Chloride; Ditropan; Oxybutinin;OXYBUTYNIN CHLORIDE; Oxybutynin Hcl; Oxybutynin Chloride;Oxybutynin chloride,3.548133892,1,-5.45,33.35018731,2.4,4,,31.42372881,28.92583795,0.010563378,0.999931275,,CHRM1,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2,SIGMA,O2881,-0.35310734,-0.34794711,2.40280778,28.92583795,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00179250-03,Halofantrine,170465140,antimalarial agents,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),36167-63-2,; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine,11.22018454,0,-4.95,64.16025705,3,4,,103.6063938,86.91499522,0.00720879,0.999967949,,,Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F,"Prestwick Chemical, Inc.",Prestw-1031,-0.98360656,-1.1440579,3.58988306,86.91499522,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095264-04,Chloroxine,170465084,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),773-76-2,; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine,12.58925412,0,-4.9,62.2036718,3,5,,94.79368173,85.27383367,7.56083E-05,0.9999622,,,Oc1c(Cl)cc(Cl)c2cccnc12,Vitas,STK075368,-0.26862027,-0.505689,-0.5428078,-0.43072505,85.27383367,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00090753-06,Azithromycin,405558826,50S Ribosomal Protein Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),83905-01-5,; Azithromycin hydrate; ADES azithromycin; N-desmethylazithromycin; Zitromax; Zithromax  (azithromycin); NDES azithromycin;Azithromycin (AZ);Azithromycin; Azithromycin (AZ); Azithromycin Hydrate,11.22018454,0,-4.95,53.92451699,3,5,,83.5884989,73.59026369,0.000586976,0.99970645,,,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,FLUKA,57947,-0.21978022,-1.6182048,-0.39476931,1.05288346,73.59026369,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00015256-12,Chloroquine,170464753,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),50-63-5," ;Chloroquine (CQ); Chloroquine (CQ); Aralen hydrochloride;Chloroquine Diphosphate; Aralen; Chloroquine Sulphate; Cloquiante; Contramibial;Arequin; Cloroquina; Khingamin; Chlorochin; Arechine; Aralen phosphate; Cloquinato; Chingamin;Chloroquine diphosphate; ChloroquineSulphate; Sulfate, Chloroquin; Sulphate, Chloroquin",3.981071706,1,-5.4,139.7114655,3,4,,116.6121547,98.15837937,0.006876636,0.999970833,,,O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,Specs,AN-153/J116554,0.43583535,0.05018821,1.69749177,98.15837937,,,,,,,,,,,,1.60E-08,8.00E-08,4.00E-07,1E-05,,,,,,,,,,,
NCGC00167492-03,Lercanidipine hydrochloride,170465587,Voltage-gated L-type calcium channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),132866-11-6,,11.22018454,0,-4.95,29.26639836,3,4,,41.3252149,36.10315186,0.020889538,0.999731017,,,Cl.CC=3NC(C)=C(C(C=3C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c2ccccc2)c4cccc(c4)[N+]([O-])=O)C(=O)OC,Sequoia,132866-11-6,0.09367681,0.58370301,2.3388632,36.10315186,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00021145-11,Loxapine succinate,170465094,Muscarinic acetylcholine receptor M1 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),27833-64-3,,10,0,-5,28.87084306,3,5,,48.13775408,42.59634888,0.001009785,0.999495061,1128,CHRM1,O=C(O)CCC(=O)O.CN1CCN(CC1)C3=Nc4ccccc4Oc2ccc(Cl)cc23,Microsource,2300242,-0.9035409,-1.8710493,-0.78953861,0.81359177,42.59634888,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00167586-03,Piroctone Olamine,225144295,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),68890-66-4,,7.943282347,1,-5.1,46.21492832,3,4,,57.40786127,53.34104046,0.014471294,0.999870864,,,CC(CC/1=C/C(=C\C(=O)N1O)C)CC(C)(C)C,Bosche,P6136,0.35989717,0.02606882,7.73887865,53.34104046,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00249414-01,Fonazine,144206752,Serotonin (5-HT) receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),7456-24-8,,28.18382931,0,-4.55,38.7873684,3,4,,103.7806715,88.25433526,0.014556576,0.999869293,3269,,CN(C)S(=O)(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1,NCGCChem,DJM10-019,-0.41131105,0.75599583,0.05264543,88.25433526,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00015771-13,Orphenadrine dihydrogen citrate,170464910,Muscarinic Antagonists,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),4682-36-4,; ; Mebedrol; Norgesic forte; Orphenadrine citrate salt; Orfenadrina; Orphenadrine Hcl;ORPHENADRINE CITRATE;Orphenadrine dihydrogen citrate; Orphenadrine hydrochloride;Orphenadrine hydrochloride,3.16227766,1,-5.5,35.82443515,3,4,,32.0624075,31.7169718,0.027126917,0.999546412,,CHRM1,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C,Microsource,1500447,0.33832769,-0.46867292,0.69996818,31.7169718,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00344544-01,Cabergoline,170464667,Serotonin 2b (5-HT2b) receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),81409-90-7,,12.58925412,0,-4.9,68.72586133,3,4,,102.3549074,88.57803468,0.011370636,0.999920252,,,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CC=C)c34,SIGMA,C0246,0.71979434,-0.2346194,1.21084496,88.57803468,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00164493-02,Dipyrithione,170465699,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),3696-28-4,,4.466835922,1,-5.35,37.29444277,2.4,4,,33.46361355,27.28229413,0.027173312,0.999545042,,,[O-][n+]2ccccc2SSc1cccc[n+]1[O-],Labotest,LT00452770,-0.0968523,-0.80301129,-0.12667849,27.28229413,,,,,,,,,,,,1.60E-08,8.00E-08,4.00E-07,1E-05,,,,,,,,,,,
NCGC00482976-01,Vorapaxar Sulfate,405558904,Proteinase-activated receptor 1 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),705260-08-8,,8.912509381,1,-5.05,53.51015068,2.2,4,,75.19328029,63.41929322,0.016909292,0.999823649,2149,F2R,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3C([C@@H](C)OC3=O)[C@H]2\C=C\C4=NC=C(C=C4)C5=CC(=CC=C5)F,DC Chemicals,DC8229,-0.18735363,-0.58370301,10.00815883,63.41929322,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018158-09,Doxazosin mesylate,170465395,alpha1-Adrenoceptor Antagonists,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),77883-43-3,; Doxazosin Mesilate; Doxazosin mesylate salt;Doxazosin mesylate; Doxazosin mesilate; Doxazosin hydrochloride;DOXAZOSIN MESYLATE,12.58925412,0,-4.9,81.5172529,3,4,,115.0095588,100.6127451,0.030773065,0.999415479,148,ADRA1A,CS(=O)(=O)O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4,Microsource,1505976,1.13407258,3.24324324,1.65081142,100.6127451,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387301-01,Timiperone,405558737,serotonin receptor signaling pathway Modulator,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),,,10,0,-5,36.75729849,3,4,,48.92941176,45.75980392,0.010449149,0.999932688,,,FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)N3C(=S)NC4=C3C=CC=C4,Toronto Research,T443110,0.32762097,0.36036036,2.09848909,45.75980392,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390625-02,Maropitant,405558794,Substance-P receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),147116-67-4,,11.22018454,0,-4.95,64.52717351,3,4,,109.1813567,87.5245098,0.013951783,0.999879931,403815,TACR1,COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)(C)C,MedChem Express,HY-10053,-1.68850806,-0.61776062,5.51203134,87.5245098,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183024-01,Proglumetacin,144206876,Cyclooxygenase-2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),57132-53-3,Proglumetacin; Miridacin; Proglumetacina; ,12.58925412,0,-4.9,105.5738805,3,4,"LS-82118;proglumetacine;Proglumetacinum;proxil;Proglumetacina;Proglumetacin Maleate;Proglumetacin;Proglumetacine;CIPLUS_182770;proglumetacin;Proglumetacin maleate;METACINE-P;LS-175816;Miridacin;PROGLUMETACIN MALEATE;PROTACINE;3'-(4-(2-(1-p-chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate;PROGLUMETACIN;proglumetacinum;CIPLUS_685564;3-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)PROPYL DL-4-BENZAMIDO-N,N-DIPROPYLGLUTARAMATE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETATE;",120.0952508,97.08065314,0.021642215,0.999711006,,,CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5,Pharmaron,PH-NIH-183347,0.04833253,0.5673409,-1.3363029,97.08065314,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00386347-01,Ospemifene,405558829,Selective Estrogen Receptor Modulators (SERM),SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),128607-22-7,,12.58925412,0,-4.9,20.06164468,2.4,4,,32.06559308,28.52852853,0.020149855,0.999749865,2100,ESR2,OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3,Selleck,S4285,-0.28625954,-0.28735632,-0.47132757,28.52852853,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090749-12,Diethylstilbestrol,170464803,Estrogen Receptor (ER) Agonist,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),6898-97-1,"; ;DIETHYLSTILBESTROL;Diethylstilbestrol; Diethylstilbesterol; pseudo-DES; (Z,E)-Diethylstilbestrol; 5   Diethylstilbestrol; Dietilestilbestrol; (E)-Diethylstilbestrol; Stilbestrol; Diethylstilbestrol [DES]",4.466835922,1,-5.35,39.5244192,3,4,,38.32064555,36.12073231,0.02814615,0.999511513,2099,ESR1,Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2,Microsource,1500244,-0.67665539,0.32067094,0.8908686,36.12073231,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00167832-06,Carvedilol tartrate,170465440,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),NOCAS_45916,"; carvedilol, 14C-labeled; 8   Carvedilol;Carvedilol; Coreg; carvedilol, (S)-isomer; Carvedilol; carvedilol, (R)-isomer",12.58925412,0,-4.9,102.5261482,3,4,,118.0960122,95.2498763,0.028025142,0.999515278,153,ADRB1,O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23,Microsource,1504257,-0.09666506,0.41933892,-1.97263761,95.2498763,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,2E-05,,,,,,,,,,,
NCGC00015889-11,Raloxifene hydrochloride,170465341,,SARS-CoV-2 cytopathic effect (CPE),Approved Drugs Collection (NPC),82640-04-8, ; Keoxifene;Evista; Raloxifene Lilly Bran; Evista;RALOXIFENE HYDROCHLORIDE; Lilly Brand of Raloxifene; Raloxifene hydrochloride;Raloxifene hydrochloride,2.238721139,1,-5.65,60.48292955,3,4,,48.8780067,4.63235294,1,0.999072229,2099,ESR1,Cl.Oc1ccc(cc1)c3sc2cc(O)ccc2c3C(=O)c5ccc(OCCN4CCCCC4)cc5,Microsource,1505622,-1.48689516,0.77220077,44.06827084,4.63235294,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095978-06,Lufenuron,170465736,,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,103055-07-8,,11.22018454,0,-4.95,28.11155331,3,5,,38.08840864,30.7223201,0.015843843,0.991994474,,,Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F,Microsource,1505355,-0.07367387,0.30750308,3.031922,4.22250316,30.7223201,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00179578-03,Mometasone furoate,170464666,Corticosteroid,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,83919-23-7,; 2-Furoate;Mometasone furoate; Nasonex; Mometasone Fuorate; Elocon; Sch 32088,12.58925412,0,-4.9,19.02819981,3,5,,34.94597249,30.66811221,0.007750525,0.996107038,,CYP3A4,ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23,"Prestwick Chemical, Inc.",Prestw-572,-2.03831041,-0.13530135,0.20034727,-0.22756005,30.66811221,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00273481-01,Metixene hydrochloride,170465287,Muscarinic acetylcholine receptor Antagonist,SARS-CoV-2_CPE_SRI,2019_NPC-3.2,1553-34-0,,11.22018454,0,-4.95,75.47334457,2.1,5,,109.7477888,84.4273743,0.002535696,0.998729978,,,Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23,"Prestwick Chemical, Inc.",Prestw-491,-0.25851581,0.41090773,3.62681646,14.34599156,84.4273743,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,
NCGC00159337-04,Efavirenz,170464810,Reverse Transcriptase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,154598-52-4," Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer",12.58925412,0,-4.9,56.35073806,3,4,,101.7667516,84.1761116,0.016395955,0.999834167,7015,TERT,FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23,Vitas,STK582240,-2.30460922,-1.04868914,0.07649939,84.1761116,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183808-18,ML324,434147059,JMJ Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,7.943282347,1,-5.1,37.61180847,3,4,,43.96940418,41.78826896,0.06671914,0.997246291,,JARID2,CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O,NCGCChem,GRB059-084,1.42343638,-1.12114153,5.04594065,41.78826896,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346888-03,UK-383367,363677552,Procollagen C-Endopeptidase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,348622-88-8,,12.58925412,0,-4.9,22.57186518,3,4,,39.10778919,33.4620887,0.148251315,0.986209158,,,NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO,Selleck,S2224,-1.6534867,2.86837507,-0.3163127,33.4620887,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386232-01,Cathepsin Inhibitor 1,363680160,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,225120-65-0,,0.281838293,1,-6.55,284.3484155,1.3,4,,82.11625273,101.130186,0.203614395,0.973530723,,,C[N]1N=C(C=C1C(=O)N[C@@H](CC2=CC=CC(=C2)Cl)C(=O)NCC#N)C(C)(C)C,Selleck,S2847,33.74550683,86.56086197,88.82361801,101.130186,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346683-02,YM-201636,384568907,PIKfyve Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,371942-69-7,,1.122018454,1,-5.95,54.60428648,3,4,,38.34984858,8.65963855,1,0.999885437,,PIKFYVE,NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6,Selleck,S1219,-1.20702268,6.40574612,36.78740639,8.65963855,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00388427-02,Tizoxanide,434146885,Trichomonas vaginalis Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,173903-47-4,,3.16227766,1,-5.5,50.18521511,1.4,4,,39.30635415,39.59604766,0.057545522,0.997953411,,,OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O,MedChem Express,HY-12687,-0.55825938,1.67790262,29.81946144,39.59604766,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00161662-08,"Calpain Inhibitor I, ALLN",406861843,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,110044-82-1,,1.122018454,1,-5.95,154.506118,1.3,4,,97.99476897,102.0778843,0.084977818,0.995519509,,,CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C=O,APExBIO,A2602,0.501002,16.71910112,93.34455324,102.0778843,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00411883-01,NCGC00411883-01,,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,7.079457844,1,-5.15,98.34252046,2.1,4,,113.7176582,104.4899738,0.035547033,0.999219849,,,COCCNC(=O)NC1=CC2=C(C=C1)N=C(C3=CC=CS3)C(=N2)C4=CC=CS4,NCGCChem,MLS000534714-02pur,1.35986258,-0.92883895,24.92350061,104.4899738,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015273-15,Chlorpromazine hydrochloride,124879758,Histamine H1 receptor Antagonist,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,69-09-0,,8.912509381,1,-5.05,38.7829629,3,4,CHLORPROMAZINE HCl,59.85894577,53.37625179,0.019999326,0.999753313,,,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2,BIOMOL,AC749,-1.59597412,-0.65521258,4.89531556,53.37625179,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018158-11,Doxazosin Mesylate,434146894,alpha1-Adrenoceptor Antagonists,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,77883-43-3,,12.58925412,0,-4.9,72.02288094,3,4,,109.6921263,98.81258941,0.0619871,0.997622619,,,COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N,Selleck,S1324,-0.35945363,2.11124054,-3.41918964,98.81258941,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163432-05,Calpeptin,406861847,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,117591-20-5,,0.316227766,1,-6.5,263.5027684,1.3,4,,110.3452485,112.8596338,0.101554399,0.993584805,,,CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O,Cayman,14593,14.58631549,99.2659176,103.74847,112.8596338,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167328-03,Aloxistatin,363676654,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,88321-09-9,,7.079457844,1,-5.15,41.3143495,3,4,,57.53913553,53.17596567,0.014335561,0.999873273,,CAPN1,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,Selleck,S7393,-1.27965492,-1.49970879,8.41994276,53.17596567,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159456-06,Imatinib,124892208,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,152459-95-5,GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec,10,0,-5,69.59553157,3,4,STI571;Imatinib mesilate;IMATINIB;CIPLUS_700313;Imatinib Mesilate;4-(4-(4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-PHENYL)BENZAMIDE MESYLATE;CIPLUS_670910;Imatinib mesylate;HS_649;imatinib;CPG-57148B;Glivec;Imatinib base;Genpharm brand of imatinib mesylate;IMATINIB MESILATE;Gleevec;CGP-57148;CGP 57148;imatinib mesylate;Imatinib;IMATINIB MESYLATE;CGP57148B;STI 571;imatinibum;Imatinib base(IMA-3);Novartis brand of imatinib mesylate;STI-571;,92.09910857,86.32664923,0.0335327,0.999305873,25,ABL1,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5,Sequoia,IMATINIB,1.5316347,-1.16853933,2.83047736,86.32664923,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378936-01,Letermovir,363678286,Tripartite terminase subunit UL28 homolog Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,917389-32-3,,10,0,-5,23.53542386,3,4,,42.03258718,33.63376252,0.031775625,0.999377399,3077457,TRM1,COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F,MedChem Express,HY-15233,-1.42343638,-0.42224811,3.32881458,33.63376252,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386330-03,Z-FA-FMK,406861859,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,197855-65-5,,0.316227766,1,-6.5,299.5043457,1.1,4,,85.55994582,101.4735336,0.021988036,0.999701753,,,C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)CF,DC Chemicals,DC7567,35.90222861,87.40535818,101.4158759,101.4735336,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00180839-02,Penta-O-galloyl-??-D-glucose hydrate,434147057,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,14937-32-7 (anhydrous),,7.079457844,1,-5.15,22.9982646,2.4,4,,39.50179727,29.05579399,0.011606087,0.999917034,,,OC1=C(O)C(=CC(=C1)C(=O)OC[C@H]2O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC(=O)C4=CC(=C(O)C(=C4)O)O)[C@@H](OC(=O)C5=CC(=C(O)C(=C5)O)O)[C@@H]2OC(=O)C6=CC(=C(O)C(=C6)O)O)O,SIGMA,G7548,-2.08483106,-0.59697146,10.04669378,29.05579399,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00246387-06,Arbidol,434146926,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,131707-23-8,,12.58925412,0,-4.9,68.55556741,3,4,,100.7029217,87.39457831,0.004697481,0.999986391,,,CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br,MedChem Express,HY-14904A,0.62179956,0.65963061,1.69646951,87.39457831,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247556-02,Fangchinoline,434147067,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,436-77-1,,2.818382931,1,-5.55,70.61443028,3,4,,52.83452693,-5.6223176,1,0.995817033,,,COC1=C2OC3=CC=C(C[C@@H]4N(C)CCC5=CC(=C(OC6=C(O)C(=CC7=C6[C@H](CC(=C2)C=C1)N(C)CC7)OC)C=C45)OC)C=C3,DC Chemicals,DCF-007,2.2573688,-0.94641817,45.29296581,-5.6223176,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090782-17,Nelfinavir Mesylate,406861837,HIV Protease Inhibitors,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,159989-65-8,,3.16227766,1,-5.5,157.9656368,3,4,,148.695204,3.47639485,1,0.999987064,,,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C,APExBIO,A3653,-1.25089863,-1.23762376,112.0198825,3.47639485,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015264-24,Clomipramine hydrochloride,384567835,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,17321-77-6,,11.22018454,0,-4.95,73.82668742,3,4,,107.4539361,101.3304721,0.006944518,0.999970254,,SLC6A4,CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2,MedChem Express,HY-B0457,-0.79079799,-0.16016308,0.3163127,101.3304721,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00094047-16,Ivermectin,434147263,Glutamate-gated Chloride Channel Activator,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,70288-86-7,,1.258925412,1,-5.9,62.60848625,3,4,,38.07038056,-5.76807229,1,0.999962305,,,[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2,MedChem Express,HY-15310_cm1,0.91441112,5.99530929,38.77426257,-5.76807229,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00686670-01,GS-441524,,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1191237-69-0,,1.77827941,1,-5.75,145.4119007,1.1,4,,96.39041724,95.28614458,0.045464831,0.99872291,,,NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N,MedChem Express,HY-103586,2.15801024,0.98211668,97.27953538,95.28614458,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017159-23,Curcumin,384567975,NF-kappaB Activation Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,458-37-7,,12.58925412,0,-4.9,21.08459538,3,4,,43.22906057,36.89334496,0.049155357,0.998507934,,NFKB1,COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC,MedChem Express,HY-N0005,-2.10420842,-0.38951311,-1.20869033,36.89334496,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379057-02,TMC353121,434146905,Respiratory syncytial virus Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,857066-90-1,,12.58925412,0,-4.9,38.07239401,3,4,,52.25401781,46.97762278,0.079711165,0.996062366,,,CC1=CC=C(CCCO)C(=C1)NCC2=CC=C3N=C(NCCCN4CCOCC4)[N](CC5=NC(=CC=C5O)C)C3=C2,MedChem Express,HY-11097,1.81792156,-1.22846442,-1.17809058,46.97762278,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015608-22,Loperamide hydrochloride,384567873,mu-Opioid Antagonist,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,34552-83-5,,12.58925412,0,-4.9,66.89188801,3,4,,110.1459363,98.78397711,0.032197933,0.999360047,,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4,MedChem Express,HY-B0418A,-2.57368799,0.48048923,-1.00918813,98.78397711,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163469-10,Sodium Monensin,434146872,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,22373-78-0,,0.112201845,1,-6.95,110.0042826,2.4,4,,34.26897185,16.2598082,1,0.999833026,,,[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C,Selleck,S2324,4.82393358,11.44569288,38.63219094,16.2598082,,,,,,,,,,,,1.60E-08,8.00E-08,4.00E-07,0.000002,,,,,,,,,,,
NCGC00346716-03,Dabrafenib,,Raf kinase B Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1195765-45-7,,12.58925412,0,-4.9,49.33292855,3,4,,69.9694915,58.57308922,0.103270338,0.993365768,,BRAF,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F,ChemieTek,CT-DABRF,2.70541082,-3.11610487,1.17809058,58.57308922,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378604-04,ABT-333,377020340,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1132935-63-7,,10,0,-5,70.33502557,3,4,,99.67476465,88.59343214,0.039656066,0.999028851,,,COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C,MedChem Express,HY-13998,0.81591755,-2.33707865,5.24785802,88.59343214,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016622-11,Hycanthone,434146889,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,3105-97-3,,12.58925412,0,-4.9,32.39138228,3,4,,49.43397018,42.66566265,0.015407109,0.999853652,,,CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3,Prestwick,Prestw-355,0.15849793,-0.39577836,0.53492282,42.66566265,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017251-06,alpha-MANGOSTIN,434146890,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,6147/11/1,,2.238721139,1,-5.65,64.24303298,3,4,,45.50275103,-4.86445783,1,0.998881203,,,COC1=C(CC=C(C)C)C2=C(OC3=C(C(=C(CC=C(C)C)C(=C3)O)O)C2=O)C=C1O,Microsource,MS-01504015,0.329188,2.56523014,42.59513984,-4.86445783,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378713-01,Nirogacestat,363678166,g-Secretase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1290543-63-3,,12.58925412,0,-4.9,20.26627237,3,4,,38.87210474,33.40486409,0.070792113,0.996899223,,NOTCH1,CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C,MedChem Express,HY-15185,-0.81955428,-0.97553873,-2.75643922,33.40486409,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018261-09,Perhexiline,384568001,mitochondrial carnitine palmitoyltransferase-1 inhbitior,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,"6724-53-4, 6621-47-2 [perhexiline]",,2.818382931,1,-5.55,43.25351993,3,4,,41.11231967,-6.96018599,1,0.99989337,,,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,Microsource,1503227,-1.58889207,-1.61797753,33.49143207,-6.96018599,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379165-02,IT1t dihydrochloride,434147114,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1092776-63-0,,3.981071706,1,-5.4,100.3553125,2.3,4,,85.81971365,84.24892704,0.073054473,0.996694055,,,CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C4CCCCC4)=CSC2=N1,Glixx,GLXC-01713,2.45866283,-1.15026209,45.65446603,84.24892704,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095196-07,TILORONE,,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,"27591-69-1, 27591-97-5 [tilorone]",,10,0,-5,33.35864297,3,4,,57.51210881,44.13447783,0.082284235,0.995803168,,,CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC,Microsource,2300009,-2.37239396,1.44146768,7.75719235,44.13447783,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510794-01,KIN1408,406861860,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1903800-11-2,,1.122018454,1,-5.95,121.5311894,2.4,4,,77.45338213,-2.87553648,1,0.999897904,,,COC1=CC=C2SC(=NC2=C1)NC(C3=CC=C(OC(F)F)C=C3)C4=CC=C5C=CC=NC5=C4O,SIGMA,SML1866,-0.30194105,15.85614444,76.89411056,-2.87553648,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
MLS000543798-03,MLS000543798-03,406861831,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,7.079457844,1,-5.15,337.2469283,5,4,,-46.92489053,42.82185411,0.633612577,0.624647082,,,C1CN(CCO1)C2=NC(NC3=CC=CC=C3)=NC(N\N=C\C4=CNC5=C4C=CC=C5)=N2,Specs,AG-205/33155024,67.5207558,108.7640449,81.25764994,42.82185411,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095987-05,NCGC00095987-05,434147001,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,12.58925412,0,-4.9,6.371459298,2.4,4,,35.53370786,26.37314734,0.02553001,0.999598317,,,CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C,Analyticon,NP-007859,-3.53564271,-4.19475655,-3.93206854,26.37314734,,,,,,,,,,,,1.44E-07,7.20E-07,0.0000036,0.000018,,,,,,,,,,,
NCGC00263093-14,Apilimod mesylate,434146923,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,870087-36-8,,12.58925412,0,-4.9,431.2339097,5,4,,-72.18310014,42.44405696,0.447512217,0.851742425,,,CC1=CC=CC(\C=N\NC2=NC(OCCC3=CC=CC=N3)=NC(=C2)N4CCOCC4)=C1,AChemBlock,O33823,93.31520183,104.659176,125.994492,42.44405696,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346542-10,Hesperadin,434147090,Aurora Kinase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,422513-13-1,,12.58925412,0,-4.9,1.825522589,2.4,4,,30.7659286,23.8769671,0.049322624,0.998498871,,AURKA,CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1,Glixx,GLXC-03283,-3.69518332,-4.61560862,-4.8049405,23.8769671,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017363-18,Cycloheximide,434146939,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,66-81-9,,0.501187234,1,-6.3,99.58695366,1.4,4,,32.39191012,29.25021796,0.541870994,0.759866349,,,[H][C@]1(C[C@@H](C)C[C@H](C)C1=O)[C@H](O)CC2CC(=O)NC(=O)C2,SIGMA,1810_cm3,9.23275122,49.07865169,37.01040392,29.25021796,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00346435-07,Niraparib,384568775,PARP Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1038915-60-4,,12.58925412,0,-4.9,56.85852263,3,4,,83.90858369,65.19313305,0.028071743,0.999513761,,PARP1,NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4,MedChem Express,HY-10619,0.73328541,2.40244613,6.5521916,65.19313305,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163413-03,Lycorine HCl,434147015,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,2188-68-3,,2.238721139,1,-5.65,84.74125679,3,4,,61.74442522,11.20171674,1,0.999368629,,,O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23,Prestwick,Prestw-NAT-0046,-0.07189073,2.40244613,57.55384847,11.20171674,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00389393-01,Lopinavir,434147138,HIV Protease Inhibitors,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,192725-17-0,,12.58925412,0,-4.9,54.49062494,3,4,,91.1929876,80.92989986,0.04755989,0.998602391,,,CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4,APExBIO,A8204,-1.27965492,-0.27664531,-3.63006477,80.92989986,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017376-12,Tetrandrine,434146967,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,518-34-3,,1.584893193,1,-5.8,63.46881437,3,4,,46.86696772,-5.6223176,1,0.999903587,,,COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(=C(OC)C(=C4)OC)OC5=C(OC)C=C6CCN(C)[C@@H](CC7=CC=C(OC1=C2)C=C7)C6=C5,Prestwick,Prestw-NAT-0181,-0.99209202,1.76179383,44.78084049,-5.6223176,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378589-01,Merimepodib,363678106,Inosine-5'-monophosphate dehydrogenase 2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,198821-22-6,,12.58925412,0,-4.9,54.06001915,3,4,,72.27791699,62.93228713,0.070323214,0.996938048,,,COC1=CC(=CC=C1C2=CN=CO2)NC(=O)NC3=CC(=CC=C3)CNC(=O)O[C@H]4CCOC4,MedChem Express,HY-13986,2.93444031,-0.71910112,0.04589963,62.93228713,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00178090-03,Pristimerin,406861848,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1258-84-0,,1.122018454,1,-5.95,207.4164577,5,4,,-75.59249838,-5.59370529,0.013027691,0.999895315,,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)\C4=C\C=C\5\C(=C(\O)C(=O)\C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C,SIGMA,P0020,69.51833214,54.79033197,-6.04006628,-5.59370529,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351072-01,ML414,406861855,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,1.258925412,1,-5.9,116.0850606,1.3,4,,82.06046257,63.67668097,0.353901593,0.913800619,,,CN(C)[S+]([O-])(=O)C1=CC(=C(C=C1)N2CCCC2)C(=O)NC3=NC=C(C)S3,NCGCChem,YSM004-073,-1.56721783,6.27548049,97.4393734,63.67668097,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165875-04,PB-28,384568294,sigma1/2 Receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,172907-03-8,,10,0,-5,64.57275768,3,4,,91.19094484,83.36194564,0.024568678,0.999627544,,SIGMAR1,COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1,Axon Medchem,1272,0.50323508,-1.38322656,2.78656424,83.36194564,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090774-05,Nitazoxanide,170465090,antiprotozoal agent,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,55981-09-4,Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide,3.16227766,1,-5.5,54.30323462,2.2,4,,53.16278643,50.40057225,0.017941933,0.999801467,,,O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O,Vitas,STK395664,-2.28612509,-2.75189284,34.89983431,50.40057225,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00024936-06,N-Desmethylclozapine,406861836,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,6104-71-8,,8.912509381,1,-5.05,58.96395565,3,4,,87.52186867,79.87124464,0.015634373,0.999849223,,,ClC1=CC2=C(NC3=C(C=CC=C3)C(=N2)N4CCNCC4)C=C1,Adooq,A13762,-1.71099928,-0.5678509,5.76894111,79.87124464,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00182390-05,NCGC00182390-05,406861849,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,11.22018454,0,-4.95,38.93569788,3,4,,69.9342314,52.6037196,0.025175491,0.999609028,,,C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O,NCGCChem,SPA014-029,-1.76851186,-0.30576587,6.22081639,52.6037196,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016382-09,Oxethazaine,434146954,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,126-27-2,,12.58925412,0,-4.9,10.3204315,2.4,4,,30.26547673,23.84835479,0.038510999,0.999085844,,,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2,APExBIO,A8494,-1.68224299,-2.28596389,-2.30456394,23.84835479,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015817-17,Promethazine HCl,434146948,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,58-33-3,,8.912509381,1,-5.05,67.86085208,3,4,,100.8145078,95.40772532,0.025756513,0.99959062,,,CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C,Selleck,S4293,-2.2573688,0.04368084,3.26856454,95.40772532,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015619-13,Loratadine,170464867,Histamine H1 Receptor Antagonists,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,79794-75-5, Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;,10,0,-5,25.0777027,3,4,,40.1809244,35.06437768,0.022102135,0.999698868,9704,HRH1,Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3,Vitas,STK574925,-0.50323508,-1.17938264,1.40081338,35.06437768,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017375-03,Berbamine dihydrochloride,406861834,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,6078-17-7,,1.412537545,1,-5.85,90.20408014,1.2,4,,63.09264613,62.90322581,0.022988048,0.999673974,,,COC1=CC2=C3C=C1OC4=C(OC)C(=CC5=C4[C@@H](CC6=CC=C(O)C(=C6)OC7=CC=C(C[C@@H]3N(C)CC2)C=C7)N(C)CC5)OC,Prestwick,Prestw-NAT-0350,-1.04494704,5.00374532,60.60281518,62.90322581,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167465-07,Calcipotriol,434147225,Vitamin D receptor Activator,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,112965-21-6,,12.58925412,0,-4.9,68.57351184,3,4,,96.19177711,83.93072289,0.013222456,0.99989216,,,C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(CCC[C@]23C)=C\C=C/4C[C@@H](O)C[C@H](O)C4=C,MedChem Express,HY-10001,1.52401853,1.24596892,1.54363442,83.93072289,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346531-06,Oligomycin A,406861853,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,579-13-5,,3.16227766,1,-5.5,131.6722824,3,4,,127.2844677,29.27927928,1,0.999314609,,,[H][C@@]1(C)[C@@H]2CC[C@@H](CC)\C=C/C=C\C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@]([H])(O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)\C=C\C(=O)O[C@H]1[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O2,APExBIO,A5588,-0.95906098,-3.74531835,94.5379437,29.27927928,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263102-06,Degrasyn,384568591,Jak2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,856243-80-6,,1.995262315,1,-5.7,57.88700144,3,4,,49.62903346,-5.6795422,1,0.999987114,,JAK2,CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2,MedChem Express,HY-13264,-2.60244428,-2.02387886,45.594216,-5.6795422,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015412-21,Ebselen,406861832,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,60940-34-3,,12.58925412,0,-4.9,47.24710315,3,4,,70.78123005,64.33476395,0.041860058,0.998917906,,,[O]=[C]1[N]([Se]C2=C1C=CC=C2)C3=CC=CC=C3,Bio Vision,2169,-0.73328541,1.64531159,-0.1656876,64.33476395,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250410-11,GSK-650394,384568558,SGK1 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,890842-28-1,,7.943282347,1,-5.1,36.30650449,3,4,,51.60446401,44.59459459,0.025924765,0.999585483,,SGK1,OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5,MedChem Express,HY-15192,-0.67277412,-1.34831461,8.0630355,44.59459459,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163654-01,HARRINGTONINE,26757033,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,0.251188643,1,-6.6,72.20583434,3,4,"Harringtonine;harringtonine hydrochloride;CIPLUS_701701;HARRINGTONINE;LS-52750;NCGC00163654-01;LS-177419;LS-176258;harringtonine, (S)-isomer;harringtonin;CIPLUS_214594;harringtonine;harringtonine, (R)-isomer;LS-176636;",56.23370786,-5.04213891,1,0.999999764,,,[H][C@]12[C@H](OC(=O)[C@](O)(CCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]13CCCN3CCC4=CC5=C(OCO5)C=C24,BIOMOL,BIOMOL_NP-435,7.429144,58.03745318,23.51591187,-5.04213891,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263625-09,AnacardicAcid,434147227,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,16611-84-0,,2.238721139,1,-5.65,155.6943844,1.1,4,,108.4163034,109.1979076,0.003037292,0.99999431,,,CCCCCCCCCCCCCCCC1=C(C(O)=O)C(=CC=C1)O,Bio Vision,1849,0.90180361,2.48689139,100.1988984,109.1979076,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016012-08,Triflupromazine hydrochloride,124881619,Muscarinic acetylcholine receptor M2 Antagonist,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,7.079457844,1,-5.15,61.5805058,2.4,4,"Triflupromazinum;NCGC00094410-03;triflupromazinum;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-;Triflupromazine Hcl;NCGC00094410-02;NCGC00094410-01;CIPLUS_208142;Triflupromazine Hydrochloride;NCGC_Prestw-53;Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-, monohydrochloride;Trifluopromazine;NCGC00016012-02;NCGC00016012-01;NCGC00024300-04;Triflupromazina;TRIFLUPROMAZINE HYDROCHLORIDE;TRIFLUPROMAZINE;TRIFLUPROMAZINE MALEATE;trifluopromazine;Triflupromazine;LS-105501;Vesprin;Triflupromazine hydrochloride;LS-105500;10-3-(DIMETHYLAMINO)PROPYL-2-(TRIFLUOROMETHYL)PHENOTHIAZINE;triflupromazine;Vesprin hydrochloride;10-(3-(DIMETHYLAMINO)PROPYL)-2-(TRIFLUOROMETHYL)PHENOTHIAZINE MONOHYDROCHLORIDE;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE;CIPLUS_170810;10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-;CIPLUS_152129;",75.2518245,68.36675385,0.065291964,0.997361898,1129,CHRM2,CN(C)CCCN1C2=C(SC3=C1C=C(C=C3)C(F)(F)F)C=CC=C2,SIGMA,T-2896,0.75866018,-2.84644195,15.07037944,68.36675385,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00024683-20,NCGC00024683-20,434147247,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,10,0,-5,62.38837643,3,4,,89.99373842,83.85643708,0.014633197,0.999867915,,,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1,BIOMOL,T-113,-0.15745777,-1.19850187,1.36168911,83.85643708,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00161621-13,Cepharanthine,406861842,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,481-49-2,,2.238721139,1,-5.65,130.1301083,3,4,,96.07830477,-6.90206335,1,0.999998739,,,[H][C@@]12CC3=CC(OC4=CC=C(C[C@]5([H])N(C)CCC6=C5C(OC7=CC1=C(CCN2C)C=C7OC)=C8OCOC8=C6)C=C4)=C(OC)C=C3,APExBIO,N2771,0.04294303,0.8988764,89.45838433,-6.90206335,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00091231-18,NCGC00091231-18,434146987,Antimalarial Agents; Cytochrome P450 Cyp2d6 Inhibitors,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,12.58925412,0,-4.9,31.01212938,3,4,,40.88411017,34.83547926,0.169633914,0.981838075,,,[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3,BIOMOL,AC-129,2.8612509,-2.86837507,-0.46693779,34.83547926,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247668-03,LDN-57444,384568515,"Reversible, competitive Inhibitor of UCH-L1 deubiquitinase",SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,668467-91-2,,8.912509381,1,-5.05,72.01761961,3,4,,109.4476375,102.8183119,0.007925614,0.999961255,,,CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13,XcessBio,M60204-2s,-2.17109993,-1.61619103,2.63593915,102.8183119,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00162073-12,H-89,384568218,AKT Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,130964-39-5,,10,0,-5,21.02639649,3,4,,41.3094768,36.29470672,0.009089746,0.999949078,,AKT1,[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23,MedChem Express,HY-15979A,-1.85478073,-1.90739662,-0.04518753,36.29470672,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00261043-01,Desipramine hydrochloride,312344483,Serotonin transporter Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,,,8.912509381,1,-5.05,18.95069119,3,4,,38.69688195,33.55129323,0.03876196,0.999073046,,,Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2,SIGMA,D 3900,-1.67477813,-2.90636704,0.26009792,33.55129323,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00094792-17,Tioguanine,434147214,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,154-42-7,,14.12537545,0,-4.85,30.38985739,2.4,4,,30.5,28.53915663,0.02869087,0.999492868,,HPRT1,NC/1=N/C2=C([NH]C=N2)C(=S)N1,MedChem Express,HY-13765,2.27993172,2.50659631,2.12440776,28.53915663,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00686694-01,Remdesivir,406861862,RNA-dependent RNA polymerase inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,1809249-37-3,,8.912509381,1,-5.05,97.76264353,3,4,,133.0922101,126.9384836,0.021601541,0.999712075,,,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4,MedChem Express,HY-104077,0.35945363,-2.14036109,4.9555656,126.9384836,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159554-09,Salubrinal,406861841,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,405060-95-9,,12.58925412,0,-4.9,44.47377082,3,4,,76.86901737,65.1409474,0.007149574,0.999968477,,,ClC(Cl)(Cl)C(NC(=O)\C=C\C1=CC=CC=C1)NC(=S)NC2=C3N=CC=CC3=CC=C2,SIGMA,SML0951,-1.10220441,-1.52808989,-0.47429621,65.1409474,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017063-13,Amodiaquine,434146962,Antimalarial; Histamine N-methyl Transferase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,86-42-0,,8.912509381,1,-5.05,83.38225142,2.1,4,,109.7081953,88.33188027,0.01097516,0.999925705,,,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,Cayman,15954_cm1,0.58688806,1.25842697,21.43512852,88.33188027,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00178913-14,Celastrol,434146903,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,[34157-83-0],,0.316227766,1,-6.5,76.61298779,2.4,4,,76.33520248,-6.8148794,1,0.999997408,,,CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O,Tocris,3203,14.7580876,68.13483146,-5.15605875,-6.8148794,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00685392-02,Cenicriviroc Mesylate,,,SARS-CoV-2 cytopathic effect (CPE),Anti-infectives,497223-28-6,,8.912509381,1,-5.05,46.73561661,3,4,,68.33497252,64.85033421,0.007699908,0.999963438,,,CCCCOCCOC1=CC=C(C=C1)C2=CC=C3N(CC(C)C)CCCC(=CC3=C2)C(=O)NC4=CC=C(C=C4)[S@@+]([O-])CC5=CN=CN5CCC,MedChem Express,HY-14882A,-0.87317492,-0.8988764,1.60648715,64.85033421,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387775-03,D-942,363680662,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,849727-81-7,,12.58925412,0,-4.9,54.66989488,3,4,,59.05196309,48.38092434,0.173955621,0.980868616,,PRKAA1,OC(=O)C1=CC=C(CCCC2=CC=C(OCCC3=CC=C(F)C=C3)C=C2)O1,Bio Vision,2341,6.48033977,-1.083804,3.8887227,48.38092434,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386433-04,CH-5183284,384569140,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,11.22018454,0,-4.95,48.24984434,3,4,,85.17166036,70.78986587,0.047403299,0.998611695,,FGFR1,CC1=NC2=C([NH]1)C=C(C=C2)[N]3N=CC(=C3N)C(=O)C4=CC5=C([NH]4)C=CC=C5,Selleck,S7665,-2.67782427,0.56877713,2.54699818,70.78986587,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00017363-15,Cycloheximide,384567988,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,66-81-9,,0.251188643,1,-6.6,114.153184,1.4,4,,44.39636475,31.30980861,0.55248464,0.746860777,,GSK3B,C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2,Adooq,A10036,6.0768673,59.69146174,47.94338788,31.30980861,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165875-04,PB-28,384568294,sigma1/2 Receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,172907-03-8,,11.22018454,0,-4.95,75.06288687,3,4,,100.2892691,86.10207833,0.011899889,0.999912656,,SIGMAR1,COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1,Axon Medchem,1272,1.56163626,2.55703568,7.05745115,86.10207833,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263166-10,Obatoclax,384568636,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,803712-79-0,,2.238721139,1,-5.65,175.2677336,2.4,4,,38.79986731,13.12799043,1,0.989243776,,BCL2L1,COC\1=C\C(=N/C1=C/C2=C(C)C=C(C)[NH]2)C3=CC4=CC=CC=C4[NH]3,Adooq,A10665,25.56925308,30.30395601,61.38876603,13.12799043,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095597-05,Andrographolide,384568158,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[5508-58-7],,11.22018454,0,-4.95,37.36598679,3,4,,62.13808247,47.01891151,0.029772159,0.999453188,,TNF,C[C@@]1(CO)C(O)CC[C@]2(C)C(C/C=C/3C(O)COC3=O)C(=C)CCC12,Tocris,4626,-1.1313817,0.27493508,7.03865243,47.01891151,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387310-02,A-196,384569158,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[1982372-88-2],,12.58925412,0,-4.9,48.42812667,3,4,,43.94979266,41.49249338,0.255822355,0.957357798,,,ClC1=C(Cl)C=C2C(=C1)C(=NN=C2C3=CC=NC=C3)NC4CCCC4,Tocris,6167,7.5215783,-1.75545718,-0.80765779,41.49249338,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263128-02,PD-0220245,384568609,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,640736-79-4,,12.58925412,0,-4.9,53.49971609,3,4,,68.85649991,64.16919301,0.125803305,0.990111857,,CXCR1,CCN(CC)CCCCNC1=NC2=CC(=C(Cl)C=C2N=C1C3=CC=C(S3)C4=CC=CS4)Cl,Axon Medchem,1501,1.55564984,4.82663815,-2.58685517,64.16919301,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510111-01,VLX-600,384569409,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,327031-55-0,,2.511886432,1,-5.6,100.3245885,1.2,4,,67.81262888,68.84654251,0.034592852,0.999261284,,,CC1=CC=CC2=C1[NH]C3=C2N=NC(=N3)N\N=C(/C)C4=NC=CC=C4,Glixx,GLXC-06213,2.03648706,-0.18329006,62.6560385,68.84654251,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390649-02,Bay-65-1942 hydrochloride,384569206,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,600734-06-3,,11.22018454,0,-4.95,67.84565424,3,4,,91.28611858,76.75109665,0.069486039,0.99701054,,NFKB,OC1=C(C(=CC=C1)OCC2CC2)C3=CC(=C4COC(=O)NC4=N3)[C@@H]5CCCNC5,MedChem Express,HY-50948,0.26352288,5.20196751,8.82872278,76.75109665,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00189130-07,UNC-0631,384568458,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1320288-19-4,,14.12537545,0,-4.85,8.935006231,2.4,4,,31.98684769,23.66103652,0.034953927,0.999247115,10919,EHMT2,COC1=C(OCCCN2CCCCC2)C=C3N=C(N=C(NC4CCN(CC4)CC5CCCCC5)C3=C1)N6CCCN(CC6)C(C)C,MedChem Express,HY-13808,-2.48903974,-1.68015885,-1.74462325,23.66103652,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00347280-04,IKK-2 Inhibitor VIII,363677574,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,406209-26-5,,10,0,-5,67.80988237,2.3,4,,97.86070932,81.72368991,0.062698462,0.997567768,,IKBKB,NC1=C(C#N)C(=CC(=N1)C2=C(OCC3CC3)C=CC=C2O)C4CCNCC4,MedChem Express,HY-13060,-1.66878801,3.26867267,12.45300045,81.72368991,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346483-02,AC-480,384568793,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,5022,,12.58925412,0,-4.9,55.8482001,3,4,,113.0223699,93.70578894,0.018763703,0.999782789,,EGFR,CC1=C2[N](C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)[N](CC6=CC(=CC=C6)F)N=C5,Tocris,5022,-3.36586056,-4.12402627,-3.88028275,93.70578894,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016256-20,Pyrimethamine,384567926,Dihydrofolate Reductase (DHFR) Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,58-14-0,,4.466835922,1,-5.35,39.83564669,2.2,4,,41.63061798,39.81524249,0.046358113,0.998673226,,DHFR,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(Cl)C=C2,Selleck,S2006,-0.4789407,-0.03037667,16.19668414,39.81524249,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346940-03,CGP-60474,384568974,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[164658-13-3],,11.22018454,0,-4.95,142.7028368,2.4,4,,73.11447573,71.40229234,0.21835852,0.969402905,,CDK1,OCCCNC1=CC(=CC=N1)C2=NC(=NC=C2)NC3=CC=CC(=C3)Cl,Tocris,5471,17.65603329,28.99090774,34.31430253,71.40229234,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242478-04,Alvespimycin hydrochloride,384568491,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,1.412537545,1,-5.85,114.1702384,3,4,,80.27477031,1.7585693,1,0.999911123,,HSP90AB1,CO[C@H]1C[C@H](C)C\C2=C(/NCCN(C)C)C(=O)\C=C(\NC(=O)\C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)\C(=C/[C@H](C)[C@H]1O)C)C)C2=O,Selleck,S1142,-0.86471409,5.74764257,77.68344451,1.7585693,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384181-09,SP-2509,,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,2.818382931,1,-5.55,60.12366206,2.2,4,,58.56103788,51.354136,0.015330213,0.999855082,,,C\C(=N/NC(=O)C1=CC=CC(=C1)[S+]([O-])(=O)N2CCOCC2)C3=CC(Cl)=CC=C3O,Bio Vision,May-46,-2.23318263,5.96855442,33.293449,51.354136,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00487085-02,CFI-400945,384569282,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1338806-73-7,,12.58925412,0,-4.9,46.4384769,3,4,,93.63806603,81.23344127,0.021296881,0.99972017,,PLK4,COC1=CC=C2NC(=O)[C@@]3(C[C@H]3C4=CC5=C(C=C4)C(=N[NH]5)/C=C/C6=CC=C(CN7C[C@@H](C)O[C@@H](C)C7)C=C6)C2=C1,ChemieTek,CT-CFI400_cm1,-3.3566242,-3.5567089,-4.60664074,81.23344127,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390582-04,RGB-286638,384569197,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,784210-88-4,,4.466835922,1,-5.35,89.68545404,2.4,4,,97.25792336,78.18464584,0.138997687,0.987892882,,CDK1,COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=N[NH]C4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6,MedChem Express,HY-15504A,-2.66721946,15.66375746,38.78681831,78.18464584,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263158-07,Amuvatinib,363677235,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,850879-09-3,,11.22018454,0,-4.95,31.45656367,3,4,,61.08317188,51.39337952,0.045689567,0.998710714,,PDGFRA,S=C(NCC1=CC2=C(OCO2)C=C1)N3CCN(CC3)C4=NC=NC5=C4OC6=C5C=CC=C6,MedChem Express,HY-10206,-2.70460628,-0.42527339,0.35425818,51.39337952,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263088-02,BAG-956,384568582,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[853910-02-8],,0.794328235,1,-6.1,37.33899364,1.4,4,,37.83054393,28.76304024,0.124431056,0.990336538,,PIK3CA,CC1=NC2=CN=C3C=CC(=CC3=C2[N]1C4=CC=C(C=C4)C(C)(C)C#N)C#CC5=CN=CC=C5,Tocris,3606,-6.10878661,13.02200269,31.95876289,28.76304024,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090782-17,Nelfinavir Mesylate,406861837,HIV Protease Inhibitors,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,159989-65-8,,2.238721139,1,-5.65,131.9273185,3,4,,103.9014973,0.11922504,1,0.999995172,,,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C,APExBIO,A3653,-1.92468619,-0.92800479,95.05761067,0.11922504,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00091455-13,Celecoxib,363676552,Cyclooxygenase-2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,169590-42-5,,12.58925412,0,-4.9,34.17877961,3,4,,71.22839647,59.09580194,0.018066732,0.999798673,,PTGS2,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S+](N)([O-])=O)C(F)(F)F,Selleck,S1261,-2.91368884,-1.87177598,-1.77715092,59.09580194,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390618-03,UNC2025 (hydrochloride),384569201,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,2.818382931,1,-5.55,61.18841707,3,4,,61.00296638,-5.72748268,1,0.999372302,,,CCCCNC1=NC=C2C(=N1)[N](C=C2C3=CC=C(CN4CCN(C)CC4)C=C3)[C@@H]5CC[C@@H](O)CC5,MedChem Express,HY-12344A,-2.59191435,-3.94896719,48.78843701,-5.72748268,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015962-25,SB-202190,384567911,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,152121-30-7,,11.22018454,0,-4.95,100.0549046,3,4,,117.7283673,109.3835715,0.048995012,0.9985165,,MAPK14,OC1=CC=C(C=C1)C2=NC(=C([NH]2)C3=CC=C(F)C=C3)C4=CC=NC=C4,MedChem Express,HY-10295,2.88502333,7.72873072,7.91096405,109.3835715,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346542-12,Hesperadin,384568828,Aurora Kinase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,422513-13-1,,12.58925412,0,-4.9,19.18976288,3,4,,59.6375531,48.92449834,0.039811919,0.999021473,,AURKA,CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1,MedChem Express,HY-12054,-3.81841324,-5.40705667,-5.50458716,48.92449834,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00356417-05,LLY-507,384569030,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,11.22018454,0,-4.95,97.97939148,3,4,,136.4506697,116.1200924,0.012550907,0.999902828,,SMYD2,CC1=C[N](CCN2CCN(CC2)C3=C(C=CC=C3)C4=CC(=CC(=C4)C#N)C(=O)NCCCN5CCCC5)C6=C1C=CC=C6,Tocris,5365,1.49316805,2.46051033,8.09125691,116.1200924,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00475734-01,Patidegib,384569234,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1037210-93-7,,3.16227766,1,-5.5,54.31920935,3,4,,44.98181418,-6.30566945,1,0.985113891,,SHH,C[C@@H]1CN[C@H]2[C@@H](C)[C@@]3(CC[C@H]4[C@@H]5CC[C@@H]6C[C@@H](CC[C@]6(C)[C@H]5C\C4=C(C)\C3)N[S+](C)([O-])=O)O[C@@H]2C1,ActiveBioChem,A-1062,2.44610282,-2.37329659,34.3832021,-6.30566945,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00508861-01,GSK-2981278,384569365,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1474110-21-8,,12.58925412,0,-4.9,55.19936063,3,4,,58.82421927,55.08270889,0.1379744,0.988075594,,RORC,CCC1=CC=C(C=C1)N(CC(C)C)[S+]([O-])(=O)C2=CC=C(OCC3CCOCC3)C(=C2)CO,Bio Vision,B1195,5.48645661,1.48522431,-1.45815106,55.08270889,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159544-04,Zaldaride maleate,384568186,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[109826-27-9],,12.58925412,0,-4.9,77.91069064,3,4,,118.2117134,106.3198077,0.037594173,0.999127279,,CALM1,CC1(CN2CCC(CC2)N3C(=O)NC4=C3C=CC=C4)OCC5=CC=CC=C5[N]6C=CC=C16,Tocris,2255,-0.23493643,0.99525341,-2.36220472,106.3198077,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00484061-01,APTO-253,363681154,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,916151-99-0,,1,1,-6,36.2748438,3,4,,49.39656387,4.69014301,1,0.999990858,9314,,CC1=C(C2=NC3=C([NH]2)C4=CC=CN=C4C5=NC=CC=C35)C6=C([NH]1)C=CC(=C6)F,MedChem Express,HY-16291,-1.09950522,41.48857775,11.90409027,4.69014301,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00476204-01,PFI-4,363681102,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[900305-37-5],,10,0,-5,20.58467074,3,4,,39.27615063,31.29657228,0.054057189,0.998195575,,BRPF1,COC1=C(C=CC=C1)C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCC4,Tocris,5576,-1.89679219,-0.20954947,3.12310491,31.29657228,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510200-01,MRT-83,384569415,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1263131-92-5,,12.58925412,0,-4.9,65.55383019,3,4,,104.9607752,90.13725768,0.013677531,0.999884604,,SHH,COC1=C(OC)C(=CC(=C1)C(=O)NC(=N)NC2=CC=C(C)C(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)OC,Glixx,GLXC-90537,-0.90152566,0.19376956,0.50029429,90.13725768,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247878-08,NVP-AUY922,384568519,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,747412-49-3,,0.316227766,1,-6.5,121.368193,1.4,4,,41.64573621,-0.10105385,1,0.999974557,,HSP90AB1,CCNC(=O)C1=NOC(=C1C2=CC=C(CN3CCOCC3)C=C2)C4=C(O)C=C(O)C(=C4)C(C)C,MedChem Express,HY-10215_CM1,12.84118229,36.71910799,43.49526245,-0.10105385,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018268-14,Itraconazole,,cytochrome inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,84625-61-6,,0.891250938,1,-6.05,58.28362625,3,4,,40.26641131,7.91377983,1,0.999877584,,,CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4,MedChem Express,HY-17514,-1.60585998,1.94410693,34.64645033,7.91377983,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00017112-14,Ciclopirox,384567974,Antifungal Agent,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,41621-49-2,,8.912509381,1,-5.05,53.71346071,2.4,4,,80.72438688,64.29210134,0.066644977,0.997251159,,,CC/1=C/C(=O)N(O)/C(=C1)C2CCCCC2,Prestwick,Prestw-541,-2.62203626,2.39485107,15.28198908,64.29210134,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351480-16,GSK-343,384569008,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1346704-33-3,,12.58925412,0,-4.9,53.91322872,3,4,,97.71372108,86.11028316,0.037984981,0.999109066,,EZH2,CCCC\1=C(/CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC(=NC=C4)N5CCN(C)CC5)C(=O)NC(=C1)\C,SIGMA,SML0766,-2.9567643,-0.68851968,-3.45664039,86.11028316,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379167-01,CYM 9484,363678394,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[1383478-94-1],,11.22018454,0,-4.95,43.14416937,3,3,,59.19657143,54.37142857,1,0.999970419,,,CN(C)[S+]([O-])(=O)C1=CC=C(NC(=S)N2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4)C=C1,Tocris,4606,0.41218228,1.66666667,54.37142857,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00387732-02,VPS34-IN1,,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,1383716-33-3,,0.316227766,1,-6.5,310.3258575,1.3,4,,113.5671169,7.92733278,1,0.999964151,,,CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC(=C4)Cl,Selleck,S7980,30.48623316,95.73374454,114.4646124,7.92733278,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370856-01,ATC 0065,363677888,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,3359,,3.16227766,1,-5.5,32.02549212,3,3,,75.99277998,-2.77927685,1,0.999996306,2847,MCHR1,CN(C)C1=NC(=NC2=CC=CC=C12)N[C@@H]3CC[C@@H](CC3)NCCC4=C(OC(F)(F)F)C=C(Br)C=C4,Tocris,3359,-1.60808638,56.27310821,-2.77927685,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386219-06,SB 271046 hydrochloride,363680155,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,209481-24-3,,12.58925412,0,-4.9,52.51696571,3,3,,59.82285714,55.91428571,1,0.996883943,,,COC1=CC=C(N[S+]([O-])(=O)C2=C(C)C3=CC(=CC=C3S2)Cl)C=C1N4CCNCC4,Glixx,GLXC-05951,3.29745821,0,55.91428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00389591-02,HTH-01-015,363680812,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1613724-42-7,,12.58925412,0,-4.9,102.7194906,3,3,,96.4544,87.2,1,0.985410649,,,CN1C(=O)C2=CC3=CC=CC=C3C=C2N(C)C4=NC(=NC(=C14)C)NC5=C[N](N=C5)C6CCNCC6,MedChem Express,HY-12334,11.22051752,1.5,87.2,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00348156-03,Cysmethynil,,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,851636-83-4,,10,0,-5,63.94134748,3,4,,90.81720244,85.07135016,0.010113983,0.999936907,,,CCCCCCCC[N]1C=C(CC(N)=O)C2=C1C=CC(=C2)C3=CC(=CC=C3)C,Cayman,14745,-0.24561404,-0.80952381,2.21744389,85.07135016,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263551-06,P7C3,363677283,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,301353-96-8,,12.58925412,0,-4.9,64.33885878,3,3,,90.02412753,82.24903059,1,0.999956335,,,OC(CNC1=CC=CC=C1)C[N]2C3=C(C=C(Br)C=C3)C4=C2C=CC(=C4)Br,Glixx,GLXC-11102,0.78017439,0.46683047,82.24903059,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386524-01,(R)-(-)-BMS 204352,363680316,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,187523-36-0,,12.58925412,0,-4.9,21.20851424,3,3,,38.67175728,33.87907511,1,0.999786752,,,COC1=C(C=C(Cl)C=C1)[C@@]2(F)C(=O)NC3=C2C=CC(=C3)C(F)(F)F,Axon Medchem,1309,-0.96374484,-1.4004914,33.87907511,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00380981-01,NCGC00380981-01,363678901,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,3.548133892,1,-5.45,48.7655222,3,4,,32.02896452,33.07505318,0.14959517,0.985957266,,,CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2CC[C@]4(C)O\C5=C(/C[C@@H]34)C(=O)\C=C(C)/O5)C1(C)C,Analyticon,NP-020165,4.28483732,-0.0241371,6.37047485,33.07505318,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00485134-01,SBI-0087702,363681238,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,864431-36-7,,12.58925412,0,-4.9,66.90967073,3,4,,102.1280856,92.06915477,0.011945004,0.999911989,1386,ATF2,COC1=CC=C(CCNCC2=CC=C(OC)C3=C2C=CC=C3)C=C1,SIGMA,SML1054,-0.33918129,-0.66666667,-0.81978229,92.06915477,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384574-01,NCGC00384574-01,363679252,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,1.77827941,1,-5.75,127.929708,3,4,,88.16870147,22.65268915,1,0.999744827,,,C[C@H]1[C@H]2OC(=O)[C@@H]1[C@@]3(C)C([C@H]2O)[C@@]4(C)[C@H](O)C(=O)\C=C(C)/[C@@H]4CC3=O,Analyticon,NP-015944,0.78778927,-0.41033068,77.97367184,22.65268915,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00386928-01,NCGC00386928-01,363680512,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,10,0,-5,67.78931686,3,4,,85.90175631,81.66849616,0.013182291,0.999892815,,,CC1=NC2=C(C=CC=C2)C(=C1)N3CCN(CC3)C(=O)OC4=NC=C(C=C4)C5=CC=CC=C5,Evotec,MLS003874819,1.55555556,0.57142857,3.40008063,81.66849616,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370903-02,PD 161570,363677922,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,192705-80-9,,8.912509381,1,-5.05,24.49404729,3,3,,37.26940692,32.02857143,1,0.999995919,,,CCN(CC)CCCCNC1=NC=C2C=C(C(=NC2=N1)NC(=O)NC(C)(C)C)C3=C(Cl)C=CC=C3Cl,Axon Medchem,2098,-0.64117243,3.77777778,32.02857143,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00387818-01,BZ-423,363680677,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,216691-95-1,,12.58925412,0,-4.9,51.81568977,3,4,,91.6995491,75.78023875,0.011080947,0.999924268,,,CN1C(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=C/4\C=C/C(=O)/C=C4)C5=C1C=CC(=C5)Cl,ChemieTek,CT-BZ423,-1.62543325,-0.89866749,-0.06509569,75.78023875,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380665-01,NCGC00380665-01,363678700,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,2.818382931,1,-5.55,63.70791755,1.2,4,,42.68969118,44.09965687,0.015694234,0.999848136,,,CC1CCC/C=C/C(=O)C2=C(O)C=C(O)C=C2CC(=O)O1,Analyticon,NP-001263,1.81212525,1.74724749,35.62099264,44.09965687,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00169882-02,NCGC00169882-02,363676903,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,11.22018454,0,-4.95,39.03504865,3,4,,55.35521751,47.73981799,0.033647393,0.999301406,,,CC1CCCC[C@@H]2[C@@H](CC(=O)O1)[C@@H](O)\C=C/C2=O,Analyticon,NP-003088,0.85276482,-0.55050263,2.23224887,47.73981799,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379110-01,TC-C 14G,363678360,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,[656804-72-7],,12.58925412,0,-4.9,34.40041578,3,3,,41.41921586,36.89501652,1,0.998853079,,,FC1=CC=C(C=C1)C2(OC3=C(O2)C=C(C(=C3)F)C(=O)N4CCOCC4)C5=C(Cl)C=C(Cl)C=C5,Tocris,4345,1.88159706,1.00737101,36.89501652,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00159337-12,Efavirenz,406861840,Reverse Transcriptase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,154598-52-4,,12.58925412,0,-4.9,71.90923423,3,4,,122.4462997,109.2572659,0.030927858,0.999409562,,,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#CC3CC3,Glixx,GLXC-04867,-3.18856515,-0.10316875,-2.20028209,109.2572659,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015252-17,Cyproheptadine hydrochloride,384567832,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,969-33-5,,12.58925412,0,-4.9,63.92068268,3,4,,107.259098,95.20221436,0.022412528,0.999690058,,HRH1,CN1CCC(CC1)=C2C3=C(C=CC=C3)\C=C/C4=C2C=CC=C4,APExBIO,B3309,-1.37438153,-2.28445099,-3.04654443,95.20221436,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346936-13,GNF-5837,384568971,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1033769-28-6,,2.818382931,1,-5.55,152.0096276,3,4,,100.6226516,-6.19713978,1,0.999497021,,NTRK1,CC1=CC=C(NC(=O)NC2=CC(=CC=C2F)C(F)(F)F)C=C1NC3=CC4=C(C=C3)C(=C/C5=CC=C[NH]5)/C(=O)N4,MedChem Express,HY-13491,6.62451897,4.61311717,91.17066291,-6.19713978,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242505-01,Deacetyl cortivazol,137275859,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,4906-84-7,deacetyl cortivazol,1.122018454,1,-5.95,70.76398649,3,4,,47.00391467,-3.90050044,1,0.99989185,,NRC31,C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)C=N[N]5C6=CC=CC=C6,NCGCChem,deacetyl cortivazol,-0.67132484,7.12868264,46.66467245,-3.90050044,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370962-01,UK 78282 hydrochloride,363677959,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3829,,10,0,-5,59.47604653,3,3,,80.15828572,75.68571429,1,0.999970997,,,COC1=CC=C(CCCN2CCC(CC2)COC(C3=CC=CC=C3)C4=CC=CC=C4)C=C1,Tocris,3829,0.32058621,2.66666667,75.68571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00402234-02,RU-505,363680991,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1314206-29-5,,12.58925412,0,-4.9,79.78457587,3,3,,116.123581,104.9428571,1,0.999688361,,,CN(C)CCN(CC1=CC=CC=C1)C(=O)C2=NC3=CC(=N[N]3C(=C2)C4=CC=C(F)C=C4)C(C)(C)C,Glixx,GLXC-05569,0.64117243,-1.05555556,104.9428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00402235-03,SMANT hydrochloride,363680992,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1177600-74-6,,12.58925412,0,-4.9,30.66117028,3,3,,53.48969491,45.25348269,1,0.999971065,,,C[C@@H]1C[C@H](C)CN(CCC(=O)NC2=CC=C(Br)C=C2)C1,Glixx,GLXC-01563,-0.87195961,-0.46683047,45.25348269,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00345853-03,JNJ-28312141,384568768,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,885692-52-4,,10,0,-5,71.40150824,3,4,,99.27207011,93.61822556,0.007888702,0.999961616,,CSF1R,CN(C)CC(=O)N1CCC(CC1)C2=CC=C(NC(=O)C3=NC(=C[NH]3)C#N)C(=C2)\C4=C\CCCC4,Activate Scientific,AS10255,-0.29126214,0.28320167,2.82519129,93.61822556,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167493-04,Manidipine,174006297,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,89226-75-5,; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride,8.912509381,1,-5.05,41.19854344,3,4,,60.88008974,52.59430331,0.045453927,0.998724011,,,Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5,Selleck,S2481,-0.16903789,-2.2782503,5.5972793,52.59430331,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00344111-03,BTP2,363677330,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,223499-30-7,,10,0,-5,32.66872921,3,3,,43.25542858,38.48571429,1,0.999938473,,,CC1=C(SN=N1)C(=O)NC2=CC=C(C=C2)[N]3N=C(C=C3C(F)(F)F)C(F)(F)F,Glixx,GLXC-01531,0.41218228,3.66666667,38.48571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00093700-05,DAPH,90341268,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,10,0,-5,53.09965763,3,4,,78.24099106,68.33150384,0.020691324,0.999735892,5579,PRKCB,O=C1NC(=O)C2=C1C=C(NC3=CC=CC=C3)C(=C2)NC4=CC=CC=C4,SigmaAldrich,Lopac-D-3943,-0.1160362,-1.28571429,4.60959548,68.33150384,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485987-01,Tubeimoside II,363681466,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,115810-12-3,,5.011872336,1,-5.3,74.42658665,3,4,,59.36663008,59.8518112,0.004956955,0.999984849,,,CC1OC2OC3C(O)C(O)COC3OC(=O)C45CCC(C)(C)CC4\C6=C\CC7C8(C)CC(O)C(OC9OC(CO)C(O)C(O)C9OC%10OCC(OC(=O)CC(C)(O)CC(=O)OC1C(OC%11OCC(O)C(O)C%11O)C2O)C(O)C%10O)C(C)(CO)C8CCC7(C)C6(C)CC5O,MedChem Express,HY-N0891,3.0994152,2.85714286,3.85700847,59.8518112,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00169804-02,NCGC00169804-02,363676891,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,,,12.58925412,0,-4.9,42.64347794,3,4,,59.56393348,54.51548165,0.013269563,0.999891418,,,C\C1=C\CC\C2=C/C(OC2=O)C(C)(C)\C=C/C1=O,Analyticon,NP-013779,0.5521733,0.02364066,0.67340067,54.51548165,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387794-01,PX-13-17OH ,377020486,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,884539-95-1,,0.281838293,1,-6.55,144.0525397,2.4,4,,80.31749271,11.61574456,1,0.796048389,,,COC[C@@H]1OC(=O)C(=C\N(C)CCCN(C)C)/C2=C(\O)C(=O)\C3=C([C@H](C[C@]4(C)[C@@H](O)CC[C@H]34)OC(C)=O)/[C@]12C,Chemdea,CD0305,-0.65612185,97.58416859,53.59504714,11.61574456,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00487402-01,IQ-1S,377020497,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,23146-22-7 (free acid),,6.309573445,1,-5.2,34.97710676,2.4,4,,39.30597235,37.40710157,0.147042588,0.986436055,,,O/N=C/1C2=C(C=CC=C2)C3=NC4=CC=CC=C4N=C13,SIGMA,SML0605,-1.57000586,3.52094577,12.25552272,37.40710157,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00161410-03,CCT-018159,384568207,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[171009-07-7],,12.58925412,0,-4.9,59.07204304,3,4,,67.940389,62.71737594,0.133471025,0.988851383,,HSP90AB1,CCC1=C(O)C=C(O)C(=C1)C2=N[NH]C(=C2C3=CC4=C(OCCO4)C=C3)C,Tocris,2435,5.48645661,-0.93400704,-1.66229221,62.71737594,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00507892-01,"VPS34 Inhibitor 1 (Compound 19, PIK-III analogue)",384569355,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1383716-46-8,,1.122018454,1,-5.95,145.3114802,1.3,4,,88.36276131,76.78648766,0.281884829,0.947547162,,PIK3C3,CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC=C4,Selleck,S8456,1.44251167,16.6488468,103.8652429,76.78648766,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386631-01,Kv1.3 Channel blocker 42,363680363,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,N.A.,,12.58925412,0,-4.9,72.01711519,3,3,,101.3002857,92.71428571,1,0.999864959,,,CC(CCOC1=C2OC(=NC2=C(C)C(=C1OCCN3CCCCC3)C(C)=O)C)C4=CC=C(F)C=C4,Axon Medchem,1735,0.82436455,0.05555556,92.71428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00402289-04,LDN-192960 DIHYDROCHLORIDE,377020181,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,184582-62-5 (free base),,12.58925412,0,-4.9,28.23947255,3,4,,40.63139408,34.82436883,0.067518468,0.997180449,,,COC1=CC2=C(SCCCN)C3=CC(=CC=C3N=C2C=C1)OC,SIGMA,SML0755,1.15789474,-1,-0.06719527,34.82436883,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00188689-09,Asenapine maleate,384568450,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,85650-56-2,,10,0,-5,65.80170821,2.1,4,,112.6961172,89.03129657,0.046148991,0.998684202,,DRD1,CN1C[C@H]2[C@H](C1)C3=CC(=CC=C3OC4=C2C=CC=C4)Cl,MedChem Express,HY-11100,-3.84937238,0.53884149,12.46209824,89.03129657,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263102-06,Degrasyn,384568591,Jak2 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,856243-80-6,,2.818382931,1,-5.55,41.72729727,3,4,,37.46929891,-6.48923445,1,0.99596344,,JAK2,CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2,MedChem Express,HY-13264,-0.21754895,-2.47441576,30.42901371,-6.48923445,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386347-02,Ospemifene,384569127,Selective Estrogen Receptor Modulators (SERM),SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,128607-22-7,,12.58925412,0,-4.9,67.67866472,3,4,,90.21003258,82.43264049,0.047573138,0.998601616,2100,ESR2,OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3,APExBIO,B4871,2.62008734,-0.85054678,-0.04251098,82.43264049,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345854-05,CEP-33779,384568769,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1257704-57-6,,12.58925412,0,-4.9,20.13585429,3,4,,37.7600243,32.147806,0.040548559,0.998985619,,JAK2,CN1CCN(CC1)C2=CC=CC(=C2)NC3=N[N]4C=CC=C(C5=CC=C(C=C5)[S+](C)([O-])=O)C4=N3,APExBIO,A4146,-0.64797859,-1.88335358,-1.31784044,32.147806,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386638-01,"2-(6-((E)-2-((3R,3aS,4S,5R,6S,7aR)-3,5,6-trimethyl-1-oxooctahydroisobenzofuran-4-yl)vinyl)pyridin-3-yl)Benzonitrile",363680367,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,735288-21-8,,12.58925412,0,-4.9,25.34921705,3,3,,46.03612615,39.68571429,1,0.999953434,,,C[C@H]1C[C@@H]2[C@@H]([C@@H](C)OC2=O)[C@@H](\C=C\C3=CC=C(C=N3)C4=CC=CC=C4C#N)[C@@H]1C,Axon Medchem,1764,-1.09915274,-1.05555556,39.68571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00013822-04,NSC-75503,384567789,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[64048-12-0],,8.912509381,1,-5.05,24.37767597,3,4,,46.12384813,35.35022355,0.036050753,0.999198317,,SHH,S1C(=C(C2=CC=NC=C2)C(=C1C3=CC=NC=C3)C4=CC=NC=C4)C5=CC=NC=C5,Tocris,3889,-2.45467225,-0.74839096,6.79199515,35.35022355,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247668-03,LDN-57444,384568515,"Reversible, competitive Inhibitor of UCH-L1 deubiquitinase",SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,668467-91-2,,8.912509381,1,-5.05,93.07270011,2.3,4,,103.225615,92.51862891,0.077892346,0.996239323,,,CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13,XcessBio,M60204-2s,5.52301255,-0.62864841,14.67556095,92.51862891,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370967-01,YIL 781,363677963,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3959,,11.22018454,0,-4.95,69.60118073,3,3,,100.9902621,95.11428571,1,0.999995605,2693,GHSR,CC(C)N1CCC[C@@H](C1)CN2C(=N/C3=CC=C(OC4=CC=C(F)C=C4)C=C3C2=O)\C,Tocris,3959,-0.45798031,0,95.11428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00179817-06,Andrographolide,384568383,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,5508-58-7,,14.12537545,0,-4.85,48.24835096,3,4,,34,30.59289656,0.346191217,0.918057832,,,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CC[C@H]12,MedChem Express,HY-N0191,9.30651872,0.28320167,2.03060624,30.59289656,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00183677-03,Hypothemycin,174006434,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,76958-67-3,Hypothemycin,8.912509381,1,-5.05,40.13636347,3,4,,70.83092153,65.17973149,0.004177961,0.999989236,5604,MAP2K1,COC1=CC(=C2C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)CC3OC3C2=C1)O,ChemieTek,CT-HPTM,-2.71531608,-2.59660913,0.24063769,65.17973149,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378943-01,DB-07268,363678291,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,929007-72-7,,12.58925412,0,-4.9,38.27880735,3,4,,70.47820867,60.28708134,0.080017718,0.996030915,,MAPK8,NC(=O)C1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC(=C3)O,MedChem Express,HY-15737,-3.00217549,1.64961051,-0.38331122,60.28708134,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371028-01,EC 23,363677998,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,4011,,10,0,-5,73.63242564,3,3,,105.4625162,92.07238259,1,0.999936411,,,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C#CC3=CC=C(C=C3)C(O)=O,Tocris,4011,0.09178522,6.46191646,92.07238259,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00510498-01,Adomeglivant,384569460,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1488363-78-5,,2.238721139,1,-5.65,82.35392292,3,4,,58.16005384,11.94765204,1,0.99985167,,,CC1=C(C(=CC(=C1)O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)C)C3=CC=C(C=C3)C(C)(C)C,MedChem Express,HY-19904,0.84518946,2.33900365,54.31486467,11.94765204,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00025307-02,Demethylasterriquinone B1,377020354,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,[78860-34-1],,2.238721139,1,-5.65,111.8609941,3,4,,87.71221129,1.59643319,1,0.999986618,,,CC(C)=CCC1=CC=CC2=C1[NH]C=C2\C3=C(O)\C(=O)C(=C(O)/C3=O)\C4=C([NH]C5=C4C=CC=C5)C(C)(C)C=C,Tocris,1819,-1.03116944,0.03098853,79.14334071,1.59643319,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385241-01,NCGC00385241-01,363679613,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,1.995262315,1,-5.7,157.4880838,3,4,,109.6897258,102.2996715,0.039503627,0.999036269,,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)CO[C@@H](O[C@H]3[C@H](C)O[C@@H](O[C@@H]4[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]4OC(=O)[C@]56CCC(C)(C)C[C@H]5C/7=C/CC8[C@@]9(C)C[C@H](O)[C@H](O[C@@H]%10O[C@@H](C)[C@H](O)[C@@H](O)[C@H]%10O)[C@@](C)(CO)C9CC[C@@]8(C)[C@]7(C)C[C@H]6O)[C@H](O)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,Analyticon,NP-019454,1.76436279,0.30651341,-1.51656556,102.2996715,,,,,,,,,,,,2.72E-08,1.36E-07,6.80E-07,3.4E-06,,,,,,,,,,,
NCGC00378585-01,TRPC6 inhibitor,363678102,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,1333207-63-8,,12.58925412,0,-4.9,49.12176679,3,4,,70.82366495,63.39094415,0.068050537,0.99713345,,,N[C@@H]1CCCN(C1)[C@@H]2CC3=CC=CC=C3[C@H]2OC4=CC=C(C=C4Cl)C#N,MedChem Express,HY-15699A,1.58938466,-1.00484691,-2.30984601,63.39094415,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378773-01,Glucocorticoid receptor agonist,363678190,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1245526-82-2,,12.58925412,0,-4.9,75.38072554,3,3,,122.7085663,105.256355,1,0.999988288,2908,NR3C1,CC(C)(C[C@@](O)(CC1=CC2=C([NH]1)C=NC=C2)C(F)(F)F)C3=CC(=CC=C3O)F,MedChem Express,HY-14234,-1.10142267,0.41769042,105.256355,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00379182-01,CYM 50358 hydrochloride,363678403,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,,,10,0,-5,56.56719995,3,3,,78.32464455,73.77567141,1,0.999996517,,,CC1=C(NC(=O)C2=CC=C(O2)C3=C(Cl)C=CC(=C3)Cl)C(=CC(=C1)CN)C,Tocris,4679,0,2.03931204,73.77567141,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386903-01,NCGC00386903-01,363680492,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,12.58925412,0,-4.9,39.35714432,3,4,,51.32340804,47.21702862,0.044123267,0.998797888,,,O=C(CS\C1=N\C2=C(C=CC=C2)C(=O)N1C3=CC=CC=C3)NC4=CC5=C(CCC5)C=C4,Evotec,MLS002699430,1.5059161,0.58878215,-0.2734019,47.21702862,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380717-01,NCGC00380717-01,363678734,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,1.258925412,1,-5.9,148.2734063,3,4,,96.4619182,35.56669705,1,0.999987061,,,C/C=C(C)/C(=O)OC1C(C)C2(O)C3\C=C(C)/C(=O)C3C\C(=C/C2C4C(C)(C)C14OC(C)=O)CO,Analyticon,NP-018352,1.23092073,2.53439537,82.25199812,35.56669705,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00484055-01,Chlorphenoxamine,363681149,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,77-38-3,,10,0,-5,68.85144648,3,4,,108.1809612,93.75172034,0.011943361,0.999912013,,,CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=C(Cl)C=C2,MedChem Express,HY-B1607,-1.92,-0.79671036,6.06444351,93.75172034,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385948-01,NCGC00385948-01,363680021,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,,,3.16227766,1,-5.5,56.73913421,2.2,4,,44.90703892,44.7391055,0.022207121,0.999695871,,,OC1CC2N3CC(\C2=C\C1O)C4=CC5=C(OCO5)C=C4C3,Analyticon,NP-018106,0.46722356,-0.11820331,31.74603175,44.7391055,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378705-01,HBX 19818,363678159,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1426944-49-1,,12.58925412,0,-4.9,73.67470274,3,3,,110.1870476,99.14285714,1,0.999902048,,,CN(CCCNC(=O)C1=CC=C2N=C3CCCCC3=C(Cl)C2=C1)CC4=CC=CC=C4,MedChem Express,HY-17540,0,-0.61111111,99.14285714,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00388561-04,VK-II-86,363680733,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,955371-84-3,,12.58925412,0,-4.9,78.59864309,3,3,,113.2194857,103.1142857,1,0.999944425,,,COC1=C(OCCNCC(O)CCOC2=CC=CC3=C2C4=C([NH]3)C=CC=C4)C=CC=C1,Glixx,GLXC-03770,0.45798031,0.05555556,103.1142857,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00485432-01,(-)-Umbellulone,363681336,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,546-78-1,,12.58925412,0,-4.9,24.79434051,3,4,,41.82359904,34.99208975,0.017149514,0.999818733,,,CC(C)[C@]12C[C@H]1\C(=C/C2=O)C,SIGMA,SML0782,-0.6093274,-0.27889681,0.55982294,34.99208975,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384170-01,RU-SKI 43,363679174,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,1043797-53-0,,12.58925412,0,-4.9,65.79179843,3,4,,104.9773022,93.85034404,0.017288026,0.99981562,55733,HHAT,CCC(C)CNCC(=O)N1CCC2S\C=C/C2C1COC3=CC=CC(=C3)C,XcessBio,M60100-2s,-0.83533909,-1.20567376,-1.97210197,93.85034404,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387228-01,TC-G 1003,363680582,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[1021912-42-4],,12.58925412,0,-4.9,70.01650074,3,3,,108.8403429,97.22857143,1,0.999783953,,,CC1=CC(=CC(=C1)C)C2=C(OCCCN)C3=CC(=C(Cl)C=C3N=C2)C4=CC=CC(=C4)O,Tocris,5080,-0.45798031,-1.66666667,97.22857143,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370714-02,ML211,363677821,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,N/A,,10,0,-5,30.97655931,3,3,,44.69292564,41.11733448,1,0.999983703,,,CC(C)(C)C1CCN(CC1)C(=O)[N]2N=CC(=N2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4,Aobious,AOB1350,-0.18357045,1.2039312,41.11733448,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00387419-01,KP372-1,377020300,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,329710-24-9,,0.501187234,1,-6.3,51.11529151,3,4,,81.65588973,-3.04610318,1,0.99998951,,,[O]=[C]1C2=C(C=CC=C2)C3=NC4=NN=N[N]4N=C13.[O]=[C]5C6=C(C=CC=C6)C7=N[N]8N=NN=C8N=C57,Stemgent,04-0044,1.29824561,75.28571429,-3.6419836,-3.04610318,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485881-01,Duloxetine metabolite Para-Naphthol Duloxetine,363681390,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,949095-98-1,,12.58925412,0,-4.9,31.01772348,3,4,,47.07696409,39.54445664,0.020514722,0.999740531,,,CNCCC(C1=CC=CS1)C2=C3C=CC=CC3=C(O)C=C2,MedChem Express,HY-G0005,0.43274854,-0.0952381,0.60475742,39.54445664,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384450-03,JTV519 Hemifumarate,363679204,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,145903-06-6,,6.309573445,1,-5.2,108.0078266,3,4,,108.7595735,98.90230516,0.028679955,0.999492343,,,COC1=CC=C2SCCN(CC2=C1)C(=O)CCN3CCC(CC3)CC4=CC=CC=C4,Glixx,GLXC-06158,2,-0.47619048,0.20158581,98.90230516,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00370782-01,TC-E 5006,363677853,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,4898,,11.22018454,0,-4.95,38.49888975,3,3,,61.98123746,55.2,1,0.999965446,,,CC1CCN(CC1)C(C2=CC=C(F)C=C2)C3=C(C=C(C=C3)C(C)C(O)=O)C4=CC=C(C=C4)C(F)(F)F,Tocris,4898,-0.82436455,-0.11111111,55.2,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00015500-24,Haloperidol,434146944,Dopamine D2 Antagonist,DPI_SARS-CoV-2_General,,52-86-8,,25.11886432,0,-4.6,39.09928382,2.1,20,,113.4348647,89.3315508,7.31E-07,0.935096204,,,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3,Selleck,S1920,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00167972-05,Ciclesonide,,Glucocorticoid receptor Agonist,DPI_SARS-CoV-2_General,,126544-47-6,,14.12537545,0,-4.85,25.07462175,1.2,20,,55.27398196,59.98906805,0.000229461,0.853340424,,,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6,MedChem Express,HY-B0625,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00651732-01,ROC-325,406861861,,DPI_SARS-CoV-2_General,,1859141-26-6,,3.548133892,1,-5.45,102.0800124,1.1,20,,121.2751885,64.19786096,7.25E-07,0.948378211,,,CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4,Selleck,S8527,,,,,,,,,,,,,,,,2.90E-08,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,,,,,
NCGC00095196-07,TILORONE,,,DPI_SARS-CoV-2_General,,"27591-69-1, 27591-97-5 [tilorone]",,22.38721139,0,-4.65,51.57284465,2.1,20,,117.3253002,93.35298847,5.50164E-05,0.88169548,,,CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC,Microsource,2300009,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00346943-03,GSK-923295,384568975,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1088965-37-0,,12.58925412,0,-4.9,21.96245455,3,4,,42.00165708,36.79753657,0.102539595,0.993463588,,CENPE,CC(C)OC1=CC=C(C=C1Cl)C(=O)N[C@H](CNC(=O)CN(C)C)CC2=CC=C(C=C2)C3=C[N]4C=CC=C([C@H](C)O)C4=N3,Adooq,A11435,-1.60585998,0.75941677,-2.81989514,36.79753657,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345834-05,TAK-715,363677378,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,303162-79-0,,12.58925412,0,-4.9,36.00926284,3,4,,61.29271679,54.26847218,0.073736405,0.996632515,,MAPK14,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C,MedChem Express,HY-10456,-0.67132484,-0.35109144,-3.70924319,54.26847218,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015478-17,GW-5074,384567854,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,220904-83-6,,7.079457844,1,-5.15,60.03356505,2.2,4,,72.59956762,62.36385046,0.013444158,0.999888534,,BRAF,OC1=C(Br)C=C(C=C1Br)\C=C2/C(=O)NC3=C2C=C(I)C=C3,MedChem Express,HY-10542,-0.2055076,0.74797741,19.20430751,62.36385046,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00484067-03,Entrectinib,363681159,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1108743-60-7,,2.511886432,1,-5.6,77.61410846,3,4,,62.73076452,-3.66499853,1,0.999991422,,NTRK1,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=N[NH]C4=C3C=C(CC5=CC(=CC(=C5)F)F)C=C4)NC6CCOCC6,Selleck,S7998,-0.36991369,0.22897268,54.20281185,-3.66499853,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378974-02,DCC-2618,377020266,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1225278-16-9,,12.58925412,0,-4.9,53.64343299,3,4,,62.90014903,58.77794337,0.053977848,0.99819916,,PDGFRA,C[N]1C=C(C=N1)C2=CC(=CC=N2)OC3=C(F)C=C(NC(=O)C4(CC4)C(=O)NC5=CC=CC=C5)C(=C3)F,MedChem Express,HY-15240,3.23570432,1.52671756,0.54578532,58.77794337,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379161-04,ML-228,363678392,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1357171-62-0,,1,1,-6,120.3900876,2.4,4,,83.94807923,31.72381978,1,0.999968093,,HIF1A,C(NC1=C(N=NC(=N1)C2=NC=CC=C2)C3=CC=CC=C3)C4=CC=C(C=C4)C5=CC=CC=C5,Cayman,14568,-2.66630016,28.4008843,74.21720733,31.72381978,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00475733-01,E-7820,384569233,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,289483-69-8,,14.12537545,0,-4.85,41.63994705,3,4,,31,30.05382775,0.055870197,0.998073514,,,CC1=CC=C(N[S+]([O-])(=O)C2=CC=CC(=C2)C#N)C3=C1C(=C[NH]3)C#N,ActiveBioChem,A-1283,5.14865845,4.70444478,3.92156863,30.05382775,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00420704-02,AT-IAP,384569224,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,11.22018454,0,-4.95,72.39487322,3,4,,99.28325359,87.05143541,0.018213819,0.999795346,,XIAP,C[C@@H]1CN(CC(=O)N2CC(C)(C)C3=C2C=C(CC4=CC=C(F)C=C4)C=N3)[C@H](CN1)CN5CCOC[C@H]5C,WuXi,AT-IAP,1.6968818,0.36658011,3.92156863,87.05143541,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00179250-03,Halofantrine,170465140,antimalarial agents,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,36167-63-2,; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine,11.22018454,0,-4.95,67.3585044,3,4,,116.728529,89.8923445,0.011215107,0.999922419,,,Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F,"Prestwick Chemical, Inc.",Prestw-1031,-1.89992748,-1.95509394,9.1404983,89.8923445,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263190-11,KU-0064,384568655,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,587871-26-9,,10,0,-5,60.89167739,2.4,4,,90.54698788,69.62742176,0.138214072,0.988031701,,ATM,O=C/1\C=C(/OC(=C1)/C2=C3SC4=C(SC3=CC=C2)C=CC=C4)N5CCOCC5,MedChem Express,HY-12016,-3.20781032,6.82532555,17.5560946,69.62742176,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346547-03,PHT-427,384568833,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1191951-57-1,,12.58925412,0,-4.9,81.45722184,3,4,,126.5393373,114.1281669,0.024645375,0.999625179,,PDPK1,CCCCCCCCCCCCC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NN=CS2,Selleck,S1556,-1.70153417,0.95794043,-0.24257126,114.1281669,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263172-10,DCC-2036,384568642,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1020172-07-9,,12.58925412,0,-4.9,41.0894315,3,4,,44.296771,42.71690486,0.372791692,0.903172229,,ABL1,CNC(=O)C1=CC(=CC=N1)OC2=CC(=C(NC(=O)NC3=CC(=N[N]3C4=CC5=C(C=C4)N=CC=C5)C(C)(C)C)C=C2)F,Adooq,A11200_CM1,0.87682082,12.28043379,-2.37629719,42.71690486,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167496-01,Methylene blue,144206050,antimalarial agents,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,61-73-4,"; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue",11.22018454,0,-4.95,35.73371515,3,4,"Methylene Blue Hydrate;Chromosmon;3,7-bis(Dimethylamino)phenazathionium chloride;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride;Urolene Blue;CIPLUS_682274;L+ ffler's alkaline methylene blue stain solution;chlorure de methylthioninium;Methylthioninium Chloride;Methylene Blue - potassium hydroxide solution;Methylene Blue N;Blue N, Methylen;Methylene Blue zinc chloride double salt monohydrate;Blue, Swis;Methylene blue hydrate;CIPLUS_148989;AB02540576-01;Ehrlich's reagent III;Cloruro de metiltioninio;Methylene blue;METHYLTHIONINIUM CHLORIDE;Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride, trihydrate;Methylene Blue solution alkaline according to L+ ffler;Yamamoto Methylene Blue B;Azure II;Methylene Blue zinc chloride double salt;Blue, Methylen;methylthioninii chloridum;Chlorure de methylthioninium;LS-268;Methylene Blue solution;Basic Blue 9;Methylene Blue;Taylor's Blue;1,9-Dimethyl-Methylene Blue;Tetramethylthionine chloride;Methylene blue trihydrate;Methylthioninii chloridum;LS-1619;METHYLENE BLUE;Methylene Blue hydrate;3,7-bis(dimethylamino)phenothiazin-5-ium chloride trihydrate;N, Methylene Blu;CIPLUS_657740;",51.46470217,45.17321016,0.088464057,0.995144436,,,[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,Labotest,LT00032971,1.29595718,-2.58201701,0.66600538,45.17321016,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00244257-02,Momelotinib,384568509,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1056634-68-4,CYT387,12.58925412,0,-4.9,30.3425766,3,4,,38.19391483,34.39799823,0.191969922,0.976580553,3716,JAK1,O=C(NCC#N)C1=CC=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,NCGCChem,DYD03-070,2.91820797,-0.50373989,-3.52976369,34.39799823,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00344081-06,STF-62247,384568717,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,315702-99-9,,1,1,-6,227.6647532,2.3,4,,126.8737707,40.55427252,1,0.999969301,,,CC1=CC=CC(=C1)NC2=NC(=CS2)C3=CC=NC=C3,SIGMA,S7448,4.39498521,49.24058323,125.8466771,40.55427252,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346514-07,Bafetinib,,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,859212-16-1,,6.309573445,1,-5.2,70.54859907,3,4,,61.0685544,57.85394933,0.055453174,0.998099167,,ABL1,CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5,Adooq,A10119,2.9846583,3.56234097,0.97028502,57.85394933,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00345807-02,CAA-0225,384568753,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1173928-09-0,,0.316227766,1,-6.5,250.4012568,1.1,4,,102.6036396,99.68240219,0.024431048,0.999631712,,CTSL1,OC1=CC=C(CCNC(=O)[C@H]2O[C@@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NCC4=CC=CC=C4)C=C1,EMD Chemicals,219502,16.80101824,89.26225752,101.0076703,99.68240219,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167739-08,GW-4064X,384568331,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,278779-30-9,,11.22018454,0,-4.95,43.4066137,3,4,,66.52645845,56.11256343,0.028923667,0.999483829,,NR14H,CC(C)C1=C(COC2=CC=C(\C=C\C3=CC=CC(=C3)C(O)=O)C(=C2)Cl)C(=NO1)C4=C(Cl)C=CC=C4Cl,MedChem Express,HY-50108,-0.65970313,0.86956522,3.63892807,56.11256343,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00182851-05,Meprednisone,384568411,Glucocorticoid steroid,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1247-42-3,,12.58925412,0,-4.9,46.23990075,3,4,,34.83959749,34.36661699,0.287989074,0.945142324,,NRC31,C[C@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,MedChem Express,HY-B0243,7.9776848,1.0178117,-0.75803517,34.36661699,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167751-05,SSR-69071,384568334,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,344930-95-6,,8.912509381,1,-5.05,29.90992406,3,4,,44.70659134,37.37120989,0.112237697,0.992156194,,ELA2,COC1=CC(=C2C(=O)N(COC/3=C/C(=O)N4\C=C/C=C(OCCN5CCCCC5)\C4=N3)[S+]([O-])(=O)C2=C1)C(C)C,Axon Medchem,1269,-1.73996438,2.36605098,6.82022136,37.37120989,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510481-01,GSK-682753A,384569444,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1334294-76-6,,11.22018454,0,-4.95,62.36488277,3,4,,79.27295589,68.16308507,0.140664652,0.987596655,,GPR183,ClC1=CC=C(C=C1)/C=C/C(=O)N2CCC3(CC2)CN(CC4=CC=C(Cl)C(=C4)Cl)C(=O)O3,MedChem Express,HY-101192,-0.2055076,8.44145932,8.6449297,68.16308507,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378788-02,SB 699551 dihydrochloride,363678201,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,791789-61-2,,2.511886432,1,-5.6,46.04295041,3,3,,74.82073328,-4.28571429,1,0.999988223,,,CN(C)CCN(CC1=CC=C(C=C1)C2=CC=C(CNCCC3=CC=CC=C3)C=C2)C(=O)CCC4CCCC4,Axon Medchem,1469,0.50377834,68.11111111,-4.28571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00347065-03,KUC107887N,363677570,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1346528-06-0,,12.58925412,0,-4.9,18.3507134,3,4,,35.0068719,31.35475934,0.118205475,0.99129204,,VCP,C1CCC2=C(C1)N=C(N=C2NCC3=CC=CC=C3)N4CCOC5=C4C=CC=C5,Bio Vision,2697,-2.08905992,1.42962417,-1.0719323,31.35475934,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165768-05,BML-277,363676640,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,516480-79-8,,10,0,-5,48.85797585,3,4,,66.49820574,58.82177033,0.009149641,0.999948377,,CHEK2,NC(=O)C1=CC2=C([NH]C(=N2)C3=CC=C(OC4=CC=C(Cl)C=C4)C=C3)C=C1,MedChem Express,HY-13946,0.39158811,0.76370857,4.80613298,58.82177033,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00095264-04,Chloroxine,170465084,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,773-76-2,; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine,12.58925412,0,-4.9,56.72082762,3,4,,77.37222414,71.16573447,0.043753844,0.99881756,,,Oc1c(Cl)cc(Cl)c2cccnc12,Vitas,STK075368,0.80832991,2.36605098,-0.26921926,71.16573447,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263138-10,Regorafenib,384568616,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1019206-88-2,,14.12537545,0,-4.85,33.7287197,3,4,,33.5,30.24727701,0.037396946,0.999137839,,KDR,CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F,MedChem Express,HY-10331A,2.91820797,2.9461151,2.30332037,30.24727701,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00490687-03,GSK621,,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,1346607-05-3,,10,0,-5,68.57122874,3,4,,96.86145523,87.56860593,0.009772226,0.999941099,,,COC1=CC(=CC=C1)N2C(=O)NC3=C([N](C(=C3)Cl)C4=CC=C(C=C4)C5=C(O)C(=CC=C5)OC)C2=O,Selleck,S7898,0.1754386,-0.57142857,4.39457062,87.56860593,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510491-01,Elafibranor,384569453,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,923978-27-2,,31.6227766,0,-4.5,31.05499267,3,4,,111.5737185,83.3592535,0.006252573,0.999975888,,PPARA,CSC1=CC=C(C=C1)C(=O)/C=C/C2=CC(=C(OC(C)(C)C(O)=O)C(=C2)C)C,MedChem Express,HY-16737,-1.34051962,-1.69958659,-1.63312919,83.3592535,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00387446-03,ARN272,363680613,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,488793-85-7,,10,0,-5,33.49560413,3,3,,49.1488463,45.00809498,1,0.999969852,2166,FAAH,OC1=CC=C(C=C1)C2=NN=C(NC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4)C5=CC=CC=C25,Glixx,GLXC-04009,-0.3675626,1.50357407,45.00809498,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00408892-01,BHPI,363681076,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,56632-39-4,,1,1,-6,85.5629771,1.4,3,,36.64616712,31.43550998,1,0.877929734,,,CC1=CC=CC2=C1NC(=O)C2(C3=CC=C(O)C=C3)C4=CC=C(O)C=C4,Glixx,GLXC-06156,9.78635424,43.25856544,31.43550998,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00379228-03,RU-SKI 43 (hydrochloride),363678433,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,,,12.58925412,0,-4.9,68.90250701,3,3,,106.6549333,95.4,1,0.999679059,,,CCC(C)CNCC(=O)N1CCC2=C(C=CS2)C1COC3=CC(=CC=C3)C,MedChem Express,HY-18366A,-0.32058621,-1.94444444,95.4,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00159569-02,CGP 53353,29215546,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,10,0,-5,60.23906325,3,4,"DAPH 2;CGP 53353;NCGC00159569-02;5,6-Bis[(4-fluorophenyl)amino]-2H-isoindole-1,3-dione;CGP53353;",78.61986828,73.87486279,0.036533409,0.999175998,,,FC1=CC=C(NC2=C(NC3=CC=C(F)C=C3)C=C4C(=O)NC(=O)C4=C2)C=C1,SigmaAldrich,C7866,1.50877193,-1,2.67437172,73.87486279,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015708-19,Maprotiline hydrochloride,363676460,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,10347-81-6,,12.58925412,0,-4.9,75.61898141,3,4,,106.2489886,95.58250325,0.064314264,0.997440164,,,CNCCCC12CCC(C3=CC=CC=C13)C4=C2C=CC=C4,Selleck,S2517,2.80016971,-2.68825416,-1.56414498,95.58250325,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380955-01,NCGC00380955-01,363678884,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,3.981071706,1,-5.4,49.91017365,2.2,4,,46.42029443,45.29018535,0.034067574,0.999283902,,,C[C@H]1[C@@H](CC\C2=C\C(=O)[C@@]3(O[C@@H]3[C@]12C)C(C)=C)OC(C)=O,Analyticon,NP-000295,0.03683241,-0.31378228,23.15467795,45.29018535,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163505-09,Go-6983,384568244,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,133053-19-7,,12.58925412,0,-4.9,30.72072701,3,4,,41.15952084,36.22225364,0.19329828,0.976241733,,PRKCA,COC1=CC=C2[N](CCCN(C)C)C=C(C2=C1)C/3=C(/C(=O)NC3=O)C4=C[NH]C5=C4C=CC=C5,MedChem Express,HY-13689,3.05417358,-2.55703568,-3.38291047,36.22225364,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263151-07,JNJ-7706621,384568625,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,443797-96-4,,12.58925412,0,-4.9,34.62538781,3,4,,37.71639642,34.51710697,0.239262985,0.962976227,,AURKA,NC1=NC(=N[N]1C(=O)C2=C(F)C=CC=C2F)NC3=CC=C(C=C3)[S+](N)([O-])=O,MedChem Express,HY-10329,4.55381134,-0.54987017,-3.45916679,34.51710697,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346510-06,MGCD-265,384568812,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,875337-44-3,,3.548133892,1,-5.45,31.06574969,2.4,4,,49.54815443,31.947452,0.200102373,0.974495366,,MET,C[N]1C=NC(=C1)C2=CC3=NC=CC(=C3S2)OC4=CC=C(NC(=S)NC(=O)CC5=CC=CC=C5)C=C4F,MedChem Express,HY-10991,-3.79012869,8.2175042,15.91216724,31.947452,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378594-02,Btk inhibitor 1 (R enantiomer hydrochloride),363678113,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1553977-42-6,,12.58925412,0,-4.9,37.30194959,3,3,,58.08190476,51.94285714,1,0.999679854,,,NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCNC5,MedChem Express,HY-13036B,-0.22899015,-1.11111111,51.94285714,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00345806-02,Cathepsin S Inhibitor,384568752,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,302566-08-1,Cathepsin S Inhibitor,10,0,-5,79.01277668,2.1,4,,121.9980154,96.073903,0.004910585,0.999985127,,CTSS,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)C=O,EMD Chemicals,219393_cm1,-1.26778419,-0.57715674,15.51650843,96.073903,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181016-19,Bexarotene,384568387,Retinoid RXR Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[153559-49-0],,12.58925412,0,-4.9,46.35402264,3,4,,53.80050242,48.00057745,0.083640424,0.99566241,,RXRA,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C3=CC=C(C=C3)C(O)=O,Tocris,5819,3.53556781,-0.18329006,2.25597834,48.00057745,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378704-01,AG 045572,363678158,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,[263847-55-8],,11.22018454,0,-4.95,23.71119172,3,3,,37.60063048,34.37668645,1,0.999982672,,,COC1=CC(=C(NC(=O)C2=CC=C(CC3=CC4=C(C=C3C)C(C)(C)CCC4(C)C)O2)C(=C1)OC)OC,Tocris,2730,-0.5513439,-0.27113631,34.37668645,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370868-01,UVI 3003,363677897,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,3303,,10,0,-5,31.5208554,3,3,,40.67215326,38.72099298,1,0.999995319,,,CCCCCOC1=CC2=C(C=C1C3=C(O)C=CC(=C3)\C=C\C(O)=O)C(C)(C)CCC2(C)C,Tocris,3303,0.45945325,1.55287158,38.72099298,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00482953-01,LP-533401,384569262,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1040526-12-2,,12.58925412,0,-4.9,41.17566408,3,4,,42.2539267,40.83769633,0.131406815,0.989204538,,TPH2,N[C@H](CC1=CC=C(C=C1)C2=NC(=NC(=C2)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)N)C(O)=O,DC Chemicals,DC9243,2.73231623,4.99329259,0.26486168,40.83769633,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00189393-09,NCGC00189393,363677130,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1430213-30-1,,1.122018454,1,-5.95,61.23744996,1.4,4,,43.51677963,32.57457939,0.378192017,0.899938343,,BLM,FC1=C(C=C(NC(=O)NC2=NN=C(S2)C3=CC=NC=C3)C=C1)C(F)(F)F,MedChem Express,HY-12342,-0.87064677,4.48629613,51.47273258,32.57457939,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263171-03,Serdemetan,384568641,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,881202-45-5,,8.912509381,1,-5.05,26.89532032,3,4,,37.36501711,34.86357731,0.096209296,0.994252603,,MDM2,C(CC1=C[NH]C2=CC=CC=C12)NC3=CC=C(NC4=CC=NC=C4)C=C3,Selleck,S1172,0.84853627,-2.41331908,0.51135509,34.86357731,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00508823-01,BG-15a,384569360,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,8.912509381,1,-5.05,39.87761235,3,4,,41.073903,37.10546574,0.021508172,0.999714871,,,CC1(C)N(CC2=CC=C(C=C2)C3=C[NH]N=N3)C(=S)N(C1=O)C4=CC=C(C#N)C(=C4)C(F)(F)F,NCI,BG-15a,2.11297366,1.7618469,7.89287233,37.10546574,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015608-22,Loperamide hydrochloride,384567873,mu-Opioid Antagonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,34552-83-5,,12.58925412,0,-4.9,94.05426025,3,4,,109.5223433,98.03311165,0.056047551,0.998057544,,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4,MedChem Express,HY-B0418A,6.42163662,1.38619764,4.8852266,98.03311165,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159510-16,Aripiprazole,384568183,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,129722-12-9,,12.58925412,0,-4.9,63.84546227,3,4,,80.69743312,73.94934201,0.094817173,0.994414389,,HTR2A,ClC1=CC=CC(=C1Cl)N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2,MedChem Express,HY-14546,3.56449376,1.86316888,-2.61918776,73.94934201,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263233-01,IPFK2,137276077,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1332307-32-0,IPFK2,31.6227766,0,-4.5,30.14720169,3,4,,86.71337259,65.28937314,0.052425192,0.998301327,5208,PFKFB2,NC1=CC=C(C=C1)C(=O)C2=CC3=C([NH]2)C=CC4=CC=CC=C34,NCGCChem,IPFK2,1.06796117,-2.250708,-0.67686875,65.28937314,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00094994-10,MEFLOQUINE,384568139,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,53230-10-7,,11.22018454,0,-4.95,66.44122066,3,4,,72.48676428,64.69673406,0.105034732,0.993134793,,,OC(C1CCCCN1)C2=C3C=CC=C(C3=NC(=C2)C(F)(F)F)C(F)(F)F,Microsource,1503070,5.79049198,-0.41341295,5.13269175,64.69673406,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387824-01,CUDC-305,384569163,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1061318-81-7,,1.122018454,1,-5.95,118.8470535,1.3,4,,85.27273675,84.11326379,0.051854137,0.998337976,,HSP90AB1,CN(C)C1=CC2=C(OCO2)C=C1SC3=NC4=C(C=CN=C4N)[N]3CCNCC(C)(C)C,ChemieTek,CT-CU305,-2.92887029,11.34560695,79.44208611,84.11326379,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00389621-01,Tivantinib (ARQ 197),384569177,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,905854-02-6,,12.58925412,0,-4.9,17.18442052,3,4,,50.61547891,42.20566319,0.02707437,0.999547848,,,O=C1NC(=O)[C@@H]([C@@H]1C2=C[NH]C3=CC=CC=C23)C4=C[N]5CCCC6=C5C4=CC=C6,APExBIO,A8325,-3.48675035,-3.53240533,-4.27531837,42.20566319,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00185756-04,Estramustine,384568425,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,52205-73-9,,10,0,-5,16.33045495,2.4,4,,31.9728334,26.52757079,0.020339137,0.999745194,,,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P]([O-])([O-])=O,MedChem Express,HY-13627,-1.19944212,-1.22736117,0.60642814,26.52757079,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263093-04,Apilimod,384568585,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,541550-19-0,,12.58925412,0,-4.9,502.5538045,5,4,,-105.2980753,16.60208644,0.138001344,0.988067346,,PIKFYVE,CC1=CC=CC(=C1)\C=N\NC2=NC(=NC(=C2)N3CCOCC3)OCCC4=CC=CC=N4,MedChem Express,HY-14644,111.0739191,99.23664122,103.3959976,16.60208644,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090774-12,Nitazoxanide,384568086,antiprotozoal agent,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,55981-09-4,,11.22018454,0,-4.95,67.30142718,3,4,,98.37799043,80.44258373,0.022744162,0.99968084,,,CC(=O)OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O,Enzo,AC3203,0.07251632,1.89399725,8.10850656,80.44258373,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00480919-01,GSK-503?EZH2 inhibitor,384569251,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1346572-63-1,,12.58925412,0,-4.9,70.24057039,3,4,,114.8964516,102.1348791,0.027188189,0.999543805,,,CC(C)[N]1C=C(C)C2=C1C=C(C=C2C(=O)NC\C3=C(C)\C=C(C)/NC3=O)C4=CC=C(N=C4)N5CCN(C)CC5,Glixx,GLXC-06400,-1.28524046,-0.99525341,-3.03295421,102.1348791,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00480794-01,LP-533401,384569246,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,945976-43-2,,11.22018454,0,-4.95,50.56107595,3,4,,90.92698339,75.49925484,0.031768852,0.999377065,,TPH2,N[C@@H](CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=CC=C(C=C3)C4=CC=CC(=C4)F)C(F)(F)F)C(O)=O,Adooq,A14325,-2.87308229,-0.59871277,2.69860522,75.49925484,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00507875-01,XMD8-87,384569346,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1234480-46-6,,8.912509381,1,-5.05,42.94749055,3,4,,69.16670558,64.08257543,0.021413125,0.999717144,,TNK2,COC1=CC(=CC=C1NC2=NC3=C(NC(=O)C4=C(C=CC=C4)N3C)C=N2)N5CCN(C)CC5,Selleck,S8272,-2.20619431,-0.88590194,1.8649421,64.08257543,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163469-09,Monensin sodium salt (Coban),,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,0.125892541,1,-6.9,89.15291594,1.4,4,,40.70854827,28.43303091,0.484486727,0.82000744,,,[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C,Selleck,S2324,0.57724024,48.68091378,34.35825106,28.43303091,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00185736-03,Posaconazole,384568424,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,171228-49-2,,1.412537545,1,-5.85,74.01572308,3,4,,51.22967277,9.57659738,1,0.99976095,,CYP51A1,CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5CO[C@@](C5)(C[N]6C=NC=N6)C7=C(F)C=C(F)C=C7)C=C4,Enzo,AC3226,-0.28172982,3.67557716,49.89372254,9.57659738,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345836-13,SMI-4a,384568760,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,327033-36-3,,12.58925412,0,-4.9,67.14889518,3,4,,70.21954607,65.98816226,0.144211294,0.986952097,,PIM1,FC(F)(F)C1=CC=CC(=C1)/C=C/2SC(=O)NC2=O,Bio Vision,2211,7.21255834,-0.15274171,-0.69183336,65.98816226,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346896-03,MCOPPB,384568966,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1108147-88-1,,1.258925412,1,-5.9,115.858927,1.4,4,,80.6096053,75.84295612,0.082429471,0.995785897,,OPRL1,CC1(CCCCCCC1)N2CCC(CC2)[N]3C4=C(C=CC=C4)N=C3[C@@H]5CCCNC5,Cayman,12037,-1.577687,8.01944107,82.40045345,75.84295612,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00188865-05,Pazopanib,384568453,VEGFR-1/2/3 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,635702-64-6,,12.58925412,0,-4.9,40.51727251,3,4,,43.66117162,41.84574625,0.026840232,0.999555736,,FLT1,C[N]1N=C2C=C(C=CC2=C1C)N(C)C3=NC(=NC=C3)NC4=CC=C(C)C(=C4)[S+](N)([O-])=O,Selleck,S1035,2.47979175,2.36605098,1.79479509,41.84574625,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510503-01,Elacestrant,384569464,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1349723-93-8,,2.238721139,1,-5.65,73.034792,3,4,,58.79317977,-6.84292379,1,0.999938689,,ESR1,CCNCCC1=CC=C(CN(CC)C2=CC(=CC=C2[C@@H]3CCC4=CC(=CC=C4C3)O)OC)C=C1,MedChem Express,HY-19822A,-1.20232172,-0.04593477,52.63925343,-6.84292379,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378942-03,LY-2090314,384569077,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,603288-22-8,,12.58925412,0,-4.9,38.12404848,3,4,,42.49965582,39.1080365,0.181499266,0.979131287,,GSK3B,FC1=CC2=C3[N](CCN(CC3=C1)C(=O)N4CCCCC4)C=C2C/5=C(C(=O)NC5=O)\C6=CN=C7C=CC=C[N]67,ActiveBioChem,A-1239,3.82244143,1.51121966,-2.75201914,39.1080365,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263094-05,AMG-900,384568586,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,945595-80-2,,12.58925412,0,-4.9,23.49530273,3,4,,54.60376311,46.26042698,0.051540622,0.998358673,,AURKA,CC1=CSC(=C1)C2=NN=C(NC3=CC=C(OC4=C(C=CC=N4)C5=CC=NC(=N5)N)C=C3)C6=C2C=CC=C6,APExBIO,A4119,-2.08678828,-4.08819476,-4.14114902,46.26042698,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159456-30,Imatinib,384568179,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[220127-57-1],,10,0,-5,69.61511201,3,4,,117.5107087,97.04510109,0.014051135,0.99987821,,ABL1,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5,Tocris,5906,-2.39082366,-3.16949931,7.72820064,97.04510109,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00182390-05,NCGC00182390-05,406861849,,DPI_SARS-CoV-2_General,,,,11.22018454,0,-4.95,59.06041517,2.2,20,,100.3955999,61.51954086,2.40437E-05,0.912318188,,,C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O,NCGCChem,SPA014-029,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00090782-17,Nelfinavir Mesylate,406861837,HIV Protease Inhibitors,DPI_SARS-CoV-2_General,,159989-65-8,,1.77827941,1,-5.75,102.1138051,1.1,20,,94.57729372,-2.70053476,2.32E-08,0.977967398,,,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C,APExBIO,A3653,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00408801-01,XL-888,363681051,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1149705-71-4,,0.630957345,1,-6.2,108.861426,1.4,4,,59.93785936,46.23205742,0.406331246,0.881993087,,HSP90AB1,CC[C@@H](C)NC1=CC(=C(C)C=C1C(N)=O)C(=O)NC2C[C@@H]3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5,Glixx,GLXC-90165,0.36258158,35.19169085,69.79212738,46.23205742,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00483925-02,Glesatinib,384569266,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,936694-12-1,,1.412537545,1,-5.85,56.35359141,2.4,4,,43.7776268,27.64963917,0.49096808,0.813842468,4233,FLT1,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=S)NC(=O)CC5=CC=C(F)C=C5)C=C4,ChemieTek,CT-MG265_cm1,-1.23439667,-0.7601729,56.32725132,27.64963917,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509936-02,CCT-251545,384569385,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1661839-45-7,,10,0,-5,59.9713731,2.2,4,,96.17596917,76.60208644,0.012584935,0.999902314,,CDK8,C[N]1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl,Glixx,GLXC-07110,-1.70153417,-0.50890585,10.61249242,76.60208644,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242504-01,Cortivazol,137275858,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1110-40-3,Cortivazol,12.58925412,0,-4.9,23.79390837,2.4,4,,31,23.41996002,0.0317503,0.999379448,,NRC31,C[C@@H]1C[C@H]2[C@@H]3\C=C(C)/C4=C/C5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=N[N]5C6=CC=CC=C6,NCGCChem,Cortivazol,0.9895547,1.51805453,3.86459803,23.41996002,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378713-03,Nirogacestat,384569064,g-Secretase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,12.58925412,0,-4.9,25.9935767,3,4,,49.53021729,43.75919929,0.046244041,0.998679402,,NOTCH1,CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C,Tocris,5751,-2.20578161,-0.25950237,-1.28626982,43.75919929,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510909-01,Acolbifene,384569493,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,182167-02-8,,11.22018454,0,-4.95,68.02910815,3,4,,111.5578289,90.4768643,0.012958523,0.99989642,,ESR1,C\C1=C(\[C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5,SantaCruz Bio,sc-480110,-1.51178918,-0.37263378,6.4743967,90.4768643,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378324-03,Bruceantin,384569047,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,41451-75-6,,0.794328235,1,-6.1,123.1425601,5,4,,-94.66001896,-5.71671148,0.043023061,0.998856781,,MYC,COC(=O)[C@@]12OC[C@@]34[C@@H](C[C@H]5\C(=C(\O)C(=O)C[C@]5(C)[C@H]3[C@@H](O)[C@@H]1O)C)OC(=O)[C@H](OC(=O)\C=C(/C)C(C)C)[C@@H]24,MedChem Express,HY-N0840,73.80027739,37.72544343,6.73925839,-5.71671148,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159337-04,Efavirenz,170464810,Reverse Transcriptase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,154598-52-4," Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer",10,0,-5,54.39837109,3,4,,82.90837094,77.75119617,0.048116909,0.998569437,7015,TERT,FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23,Vitas,STK582240,-2.30601885,1.25248205,1.85758514,77.75119617,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00344508-02,NPS-R568,384568718,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[177172-49-5],,12.58925412,0,-4.9,61.69714358,3,4,,99.43334256,89.02511962,0.005195965,0.999983349,,CASR,COC1=CC(=CC=C1)[C@@H](C)NCCCC2=CC=CC=C2Cl,Tocris,3815,-1.2617839,-1.37467542,-0.94353531,89.02511962,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386429-04,PI-3065,384569139,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,955977-50-1,,12.58925412,0,-4.9,50.98103845,3,4,,69.47683585,62.12834854,0.134440174,0.988686269,5293,PIK3CD,FC1=C(C2=NC3=C(SC(=C3)CN4CCN(CC4)CC5CC5)C(=N2)N6CCOCC6)C7=C([NH]C=C7)C=C1,Selleck,S7623,3.54843129,-2.24393222,-4.21776847,62.12834854,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263232-01,GLS-968,137276076,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,311795-38-7,GLS968,11.22018454,0,-4.95,83.38671138,3,4,,113.1150721,103.9299382,0.006291933,0.999975582,27165,GLS,CN(C)C1=C(Br)C=C(C=C1)C\2NC3=C(\C4=C2C(=O)CC(C)(C)C4)C5=CC=CC=C5C=C3,NCGCChem,GLS968,1.30154816,0.71744772,2.69219264,103.9299382,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378568-07,SKLB1002,377020287,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,1225451-84-2,,12.58925412,0,-4.9,47.51981886,3,4,,77.2976484,66.11615745,0.013107923,0.999894031,,,COC1=CC2=NC=NC(=C2C=C1OC)SC3=NN=C(C)S3,SIGMA,SML1164,-0.37492677,-1.10511437,-0.23920079,66.11615745,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390601-01,LPA2 antagonist 1,363680922,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1017606-66-4,,12.58925412,0,-4.9,27.34868912,3,3,,35.5,31.88571429,1,0.999616117,,,C[C@@H](CN1CCN(CC1)[S+]([O-])(=O)C2=CC(=C(Cl)C=C2)Cl)NC3=NC=NC4=C3SC=C4C,MedChem Express,HY-18075,0.96175864,0.55555556,31.88571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00179162-03,DEOXYGEDUNIN,377020271,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,21963-95-1,,12.58925412,0,-4.9,41.44234092,3,4,,70.49567032,58.57418112,0.009430451,0.999945158,,,CC(=O)O[C@@H]1CC2C(C)(C)C(=O)\C=C/[C@]2(C)C3CC[C@@]\4(C)[C@@H](OC(=O)\C=C4[C@]13C)C5=COC=C5,Microsource,100432,-0.77714286,-1.0537137,0.54875475,58.57418112,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387684-01,S14161,377020355,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,883046-50-2,,12.58925412,0,-4.9,28.7755153,3,4,,37.46023299,33.8127427,0.096508551,0.994217724,,,CCOC1=C2OC(C3=CC=C(F)C=C3)\C(=C/C2=CC=C1)[N+]([O-])=O,Cayman,14187,0.09374268,3.06786489,1.60135399,33.8127427,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485206-01,Lometrexol hydrate,363681254,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,106400-81-1 (anhydrous),,3.981071706,1,-5.4,51.74734967,2.4,4,,40,31.51157774,0.270711393,0.951992959,,,NC/1=N/C(=O)/C2=C(NC[C@H](CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C2)\N1,SIGMA,SML0040,2.76540895,12.98419585,17.25035803,31.51157774,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385658-01,NCGC00385658-01,363679861,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,3.548133892,1,-5.45,90.98861635,3,4,,82.18246656,68.10455649,0.050086009,0.998449798,,,C[C@H]1CC[C@@]2(OC1)O[C@H]3CC4[C@@H]5CC[C@@H]6C[C@H](CC[C@]6(C)C5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](CO[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@@H](O[C@@H]%10O[C@H](CO)[C@H](O)[C@H](O)[C@H]%10O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O,Analyticon,NP-007473,0.80198309,-1.28856839,-2.26318245,68.10455649,,,,,,,,,,,,4.00E-08,2.00E-07,0.000001,5E-06,,,,,,,,,,,
NCGC00485908-01,Adarotene,363681407,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,496868-77-0,,11.22018454,0,-4.95,28.95152442,3,4,,58.03640393,48.65525672,0.0487295,0.998533171,,,OC(=O)\C=C\C1=CC=C(C=C1)C2=CC=C(O)C(=C2)C34CC5CC(CC(C5)C3)C4,MedChem Express,HY-14808,-2.7727979,-0.46482801,-0.01301914,48.65525672,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387258-04,UNC3230,363680599,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1031602-63-7,,12.58925412,0,-4.9,50.17876733,3,3,,51.236,46.6,1,0.995345274,23396,PIP5K1C,NC(=O)C1=C(NC(=O)C2CCCCC2)SC(=N1)NC3=CC=CC=C3,Aobious,AOB2832,4.39661095,1.5,46.6,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00185859-01,NCGC00185859-01,124896684,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,2.818382931,1,-5.55,102.2838831,3,4,,89.95966838,-1.76902057,1,0.999990992,,,COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCCCC3)NC4CCN(C)CC4,UNC,UNC00000122A,-0.64539261,-0.15494267,71.93073819,-1.76902057,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370751-02,PG-01,363677835,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,853138-65-5,,12.58925412,0,-4.9,59.14106566,3,4,,85.36374896,69.47426369,0.042899698,0.998863379,1080,CFTR,CC(C)C1=CC=C(NC(=O)C(N(C)C(=O)CC2=C[NH]C3=C2C=CC=C3)C4=CC=CC=C4)C=C1,SIGMA,P0024,0.50285714,3.26394243,5.22020543,69.47426369,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00096028-06,PIPLARTINE,,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,20069-09-4 ,,11.22018454,0,-4.95,26.52116496,3,4,,45.41510234,34.24167355,0.052982375,0.998266514,,,COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CC\C=C/C2=O,Microsource,MS-01505135,-1.19507909,0.64250835,5.05135782,34.24167355,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370702-02,FAUC-365,363677812,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,474432-66-1,,12.58925412,0,-4.9,69.52919136,3,4,,102.7692419,89.95320672,0.043206242,0.998846902,,,ClC1=CC=CC(=C1Cl)N2CCN(CCCCNC(=O)C3=CC4=C(S3)C=CC=C4)CC2,SynKinase,SYN-5116,-0.50285714,3.10974043,2.01210075,89.95320672,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00381306-01,NCGC00381306-01,363679079,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,1,1,-6,87.83571539,3,4,,46.15086207,17.84925891,1,0.999988084,,,CC(=O)OC[C@]12C[C@H](OC(C)=O)\C(=C/[C@H]1O[C@@H]3[C@H](O)[C@@H](O)[C@@]2(C)[C@]34CO4)C,Analyticon,NP-006503,2.60431655,6.93848355,47.38984674,17.84925891,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00485026-01,"5??-Cholanic acid-3?,12?-diol 3-acetate methyl ester",363681194,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,27240-83-1,,12.58925412,0,-4.9,44.42859857,3,4,,71.28005936,58.80914713,0.113558824,0.991963279,,,COC(=O)CC[C@@H](C)C1CCC2C3CCC4C[C@@H](CCC4(C)C3C[C@H](O)C12C)OC(C)=O,SIGMA,C2525,-1.91227441,4.36938333,3.29384195,58.80914713,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371145-02,Walrycin B,363678059,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,878419-78-4,,10,0,-5,27.90244544,3,3,,45.86856601,37.90033032,1,0.999857325,937776,walR,CN1/N=C(\N=C/2C(=O)N(C)C(=O)/N=C12)C3=CC=C(C=C3)C(F)(F)F,MedChem Express,HY-18219,-0.78017439,3.02211302,37.90033032,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00346633-03,SNX-2112,,,DPI_SARS-CoV-2_General,,908112-43-6,,0.501187234,1,-6.3,110.9478204,1.2,20,,52.07939146,55.25441064,0.002019192,0.79089214,,HSP90AB1,CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4,Adooq,A11189,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00483210-07,NCGC00483210-07,,,DPI_SARS-CoV-2_General,,,,25.11886432,0,-4.6,18.94855364,2.2,20,,51.92972824,39.01069519,1.14352E-05,0.905589661,,,CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6,NCGCChem,YSM025-049,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00345849-02,NIBR-17,377020186,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,(944396-88-7),,1,1,-6,66.72320247,2.4,4,,38.3611234,12.67942584,1,0.999906105,,PIK3CA,COC1=CC=C(NC2=CC(=NC(=N2)N3CCOCC3)C4=CN=C(N)N=C4)C=N1,SynKinase,SYN-1145,0.91370558,14.26607607,37.62347044,12.67942584,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263209-09,ML-141,363677266,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,71203-35-5,,11.22018454,0,-4.95,52.61058325,3,4,,92.23719167,71.44138756,0.061422541,0.997666182,,CDC42,COC1=CC=C(C=C1)C2CC(=N/N2C3=CC=C(C=C3)[S+](N)([O-])=O)\C4=CC=CC=C4,Aobious,AOB1515,-2.56707759,1.61906217,6.63423264,71.44138756,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485971-01,Itraconazole metabolite Hydroxy Itraconazole,363681452,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,112559-91-8,,3.16227766,1,-5.5,47.00632661,2.2,4,,38.41823673,38.24248526,0.013916196,0.999880636,,,CC(O)C(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4,MedChem Express,HY-12772,0.16732401,1.02262163,24.72334331,38.24248526,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387272-01,TA 01,363680606,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,3.548133892,1,-5.45,42.16903979,2.4,4,,41.5,30.91109276,0.065234006,0.997370714,,,[F]C1=CC=C(C=C1)C2=C([NH]C(=N2)C3=C([F])C=CC=C3[F])C4=CC=NC=C4,Tocris,5383,0.18285714,7.99280391,18.61544956,30.91109276,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485293-01,Cytochalasin H from Phomopsis sp.,363681279,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,53760-19-3,,14.12537545,0,-4.85,51.99935664,3,4,,36.83973655,34.11086718,0.314575823,0.933638858,,,C[C@H]1C/C=C/C2[C@H](O)C(=C)[C@@H](C)C3[C@H](CC4=CC=CC=C4)NC(=O)[C@@]23[C@@H](OC(C)=O)\C=C\[C@](C)(O)C1,SIGMA,C0889,4.59649123,12.61904762,8.50692111,34.11086718,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384607-01,NCGC00384607-01,363679268,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,4.466835922,1,-5.35,43.52028859,3,4,,36.53428936,37.54082067,0.028051286,0.99951483,,,C\C=C(C)/C(=O)OC1CC2(C)OC(=C/C2=O)/C(=C)CC3OC(=O)C(=C)C13,Analyticon,NP-018762,1.83296378,0.94087909,5.59808612,37.54082067,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00385252-01,NCGC00385252-01,363679618,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,,,1.995262315,1,-5.7,111.9531817,3,3,,81.68257637,75.17539126,1,0.999937195,,,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)CO[C@H]2OC(=O)[C@]34CCC(C)(C)C[C@H]3C/5=C/CC6[C@@]7(C)C[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@@](C)(CO)C7[C@H](O)C[C@@]6(C)[C@]5(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O[C@@H]9OC[C@@H](O)[C@H](O[C@H]%10OC[C@](O)(CO)[C@H]%10O)[C@H]9O,Analyticon,NP-012060,-0.59728923,-0.86270643,75.17539126,,,,,,,,,,,,,1.36E-07,6.80E-07,3.4E-06,,,,,,,,,,,,
NCGC00380715-01,NCGC00380715-01,363678732,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,3.548133892,1,-5.45,85.53321409,2.2,4,,70.32568675,62.3184237,0.011415255,0.999919644,,,CCC(C)C(=O)OC12C(OC(C)=O)C(C)C3(O)C(\C=C(CO)/CC4(O)C3\C=C(C)/C4=O)C1C2(C)C,Analyticon,NP-018351,1.78111085,2.88193368,20.27079807,62.3184237,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00380615-01,NCGC00380615-01,363678672,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,0.794328235,1,-6.1,73.62057837,5,4,,-33.97350994,-3.31125828,0.39180822,0.999945297,,,CC(C)CC(=O)O[C@H]\1C[C@@]2(COC(C)=O)[C@H](O[C@@H]3[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@@]34CO4)\C=C1C,Analyticon,NP-002483,43.35251799,26.44253696,-1.36494253,-3.31125828,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00381227-01,NCGC00381227-01,363679036,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,3.981071706,1,-5.4,95.49582873,2.2,4,,92.7552194,78.58719647,0.019902952,0.999755628,,,CCC(C)C(=O)OC1CC(O)C23C4OCC5(C(O)CC2C1(C)C(O)O4)C3C(=O)CC6(C)C(CC7OC567)C8=COC=C8,Analyticon,NP-008037,-0.67625899,1.59752027,19.32471264,78.58719647,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00385048-01,NCGC00385048-01,363679504,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,6.309573445,1,-5.2,79.57455207,3,4,,90.53438786,87.66224079,0.025989259,0.999583195,,,C\C=C(C)/C(=O)O[C@H]1[C@@H]2[C@H](C)C(=O)O[C@@H]2C[C@@H](C)[C@@H]3\C=C/C(=O)[C@@]13C,Analyticon,NP-013136,-1.30579614,0.8377214,1.89978627,87.66224079,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00387483-01,NHI 2,363680637,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[1269802-97-2],,11.22018454,0,-4.95,31.57847935,3,3,,48.34783054,41.8,1,0.999994876,,,COC(=O)C1=CC2=C(C=C(C=C2[N]1O)C3=CC=CC=C3)C(F)(F)F,Tocris,5363,-0.18319212,1.33333333,41.8,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386570-01,ABT 239 tartrate,363680333,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,460748-71-4,,12.58925412,0,-4.9,34.96190602,3,3,,49.59426492,44.30652995,1,0.996626207,,,C[C@@H]1CCCN1CCC2=CC3=CC(=CC=C3O2)C4=CC=C(C=C4)C#N,Axon Medchem,1510,0.96485183,-1.84865664,44.30652995,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00385002-01,NCGC00385002-01,363679479,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,0.125892541,1,-6.9,96.60323968,1.4,4,,44.05283545,36.28649504,0.243832346,0.961464202,,,CC(C)CC(=O)O[C@H]\1C[C@@]2(COC(C)=O)[C@H](O[C@@H]3[C@H](O)C[C@@]2(C)[C@]34CO4)\C=C1C,Analyticon,NP-019199,0.21513087,45.21227146,37.87267283,36.28649504,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00371015-01,JNJ 5207787,363677995,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,4018,,12.58925412,0,-4.9,52.52279767,3,3,,66.73933649,60.82148499,1,0.999968417,,,CC(=O)N1CCC2=CC=C(C=C12)N(C3CCN(CCC4CCCC4)CC3)C(=O)\C=C\C5=CC=CC(=C5)C#N,Tocris,4018,1.74391923,1.99017199,60.82148499,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00371053-01,GSK 9027,363678009,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,4116,,12.58925412,0,-4.9,89.52359407,3,3,,111.6207238,103.9350855,1,0.999810136,2908,NR3C1,[O-][S+](=O)(CC1=CC=CC=C1)NC2=CC(=C(C=C2)C3=CC=C4[N](N=CC4=C3)C5=CC=C(F)C=C5)C(F)(F)F,Tocris,4116,3.21248279,1.99017199,103.9350855,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00371012-01,JNJ 5207852 dihydrochloride,363677992,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,4020,,11.22018454,0,-4.95,28.56550542,3,3,,39.10297285,34.48226339,1,0.999950235,,,C1CCN(CC1)CCCOC2=CC=C(CN3CCCCC3)C=C2,Tocris,4020,0.50481872,1.64619165,34.48226339,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00180572-02,NCGC00180572-02,363677039,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,1,1,-6,50.73581678,1.4,4,,30.01244019,27.82905012,0.187478851,0.977702469,,,C\C1=C\C2OC3[C@H](O)C[C@@](C)([C@]34CO4)[C@@]2(CO)[C@H](O)C1=O,Analyticon,NP-004844,0,9.47900576,33.3492823,27.82905012,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384608-01,NCGC00384608-01,363679269,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.548133892,1,-5.45,29.63636527,2.4,4,,33.3059867,27.94263808,0.033896275,0.99929172,,,CC[C@@H]1C[C@H]2CC[C@H](O2)[C@H](C)C(=O)O[C@@H](C)C[C@@H]3CC[C@@H](O3)[C@@H](C)C(=O)O[C@H](C)C[C@H]4CC[C@H](O4)[C@H](C)C(=O)O[C@@H](C)C[C@@H]5CC[C@@H](O5)[C@@H](C)C(=O)O1,Analyticon,NP-014336,-1.92165558,-1.07901149,0.04784689,27.94263808,,,,,,,,,,,,5.28E-08,2.64E-07,0.00000132,6.6E-06,,,,,,,,,,,
NCGC00378842-04,Lu AE58054 (Hydrochloride),363678230,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,467458-02-2,,11.22018454,0,-4.95,46.23602593,3,3,,74.25532031,66.18996222,1,0.999978234,,,FC(F)C(F)(F)COC1=CC=CC(=C1)CNCCC2=C[NH]C3=C2C=CC(=C3)F,MedChem Express,HY-14338A,-1.01079715,0.07394627,66.18996222,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00179578-11,Mometasone furoate,384568377,Corticosteroid,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,83919-23-7,,11.22018454,0,-4.95,40.86734115,3,4,,59.46834524,47.45813397,0.079058196,0.996127209,,,C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)CCl,MedChem Express,HY-13693,-0.59463379,2.96318925,6.92908742,47.45813397,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379060-01,NVP-LCQ195,363678333,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,902156-99-4,,10,0,-5,14.32415299,3,4,,44.2338096,35.61602871,0.020231125,0.999747669,,CDK1,C[S+]([O-])(=O)N1CCC(CC1)NC(=O)C2=C(NC(=O)C3=C(Cl)C=CC=C3Cl)C=N[NH]2,MedChem Express,HY-15241,-3.7853517,-3.05483428,-0.70765148,35.61602871,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346684-02,AG-1024,384568908,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,65678-07-1,,1.412537545,1,-5.85,40.3191519,1.4,4,,32.81047199,23.95334928,0.359971841,0.910523851,,EGFR,CC(C)(C)C1=C(O)C(=CC(=C1)C=C(C#N)C#N)Br,Selleck,S1234,-1.55184917,-0.06109669,37.80038331,23.95334928,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345085-02,(-)-Indolactam V,384568733,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,90365-57-4,,2.238721139,1,-5.65,146.8475056,2.3,4,,97.58831322,94.71592582,0.064730556,0.997406894,,,CC(C)[C@@H]1N(C)C2=C3C(=C[NH]C3=CC=C2)C[C@@H](CO)NC1=O,SIGMA,I0661,4.97328401,3.73988704,48.25007478,94.71592582,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00246387-06,Arbidol,434146926,,DPI_SARS-CoV-2_General,,131707-23-8,,8.912509381,1,-5.05,67.428184,1.1,20,,86.35191637,80.27338515,2.87E-08,0.957388406,,,CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br,MedChem Express,HY-14904A,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00015264-24,Clomipramine hydrochloride,384567835,,DPI_SARS-CoV-2_General,,17321-77-6,,12.58925412,0,-4.9,49.19695565,1.1,20,,92.98793889,90.19029751,0.000266981,0.992214424,,SLC6A4,CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2,MedChem Express,HY-B0457,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00253909-02,PRT-060318,137275916,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1194961-19-7,PRT-318?; PRT-060318;PRT-060318,12.58925412,0,-4.9,48.95341522,3,4,,76.55878002,68.59889721,0.023573878,0.999657137,6850,SYK,CC1=CC(=CC=C1)NC2=C(C=NC(=N2)N[C@@H]3CCCC[C@@H]3N)C(N)=O,NCGCChem,DYD07-064,-0.26257601,-0.8421375,-1.51647711,68.59889721,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346962-03,HMSL10077,377020391,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1469988-75-7,,3.16227766,1,-5.5,61.36632859,2.2,4,,52.99832982,49.97877459,0.02400424,0.999644611,,BTK,C[N]1C=C(C=N1)C2=CC=C3N=CC\4=C(N(C(=O)\C=C4)C5=CC6=C(CCN6C(=O)C=C)C=C5)C3=C2,MedChem Express,HY-80003,0.04160888,-0.43225518,13.12536786,49.97877459,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00182055-09,Bazedoxifene,384568408,Selective Estrogen Receptor Modulators (SERM),SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,198481-33-3,,3.981071706,1,-5.4,59.42186941,2.4,4,,44.54438051,44.96957691,0.133496237,0.98885159,,ESR1,CC1=C([N](CC2=CC=C(OCCN3CCCCCC3)C=C2)C4=CC=C(O)C=C14)C5=CC=C(O)C=C5,MedChem Express,HY-A0036,3.70319001,-1.05827992,24.4555621,44.96957691,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345813-03,Icaritin,384568757,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,118525-40-9,,12.58925412,0,-4.9,39.07932301,3,4,,35.22401553,33.79085892,0.197527601,0.975164106,,,COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C(=C3O2)CC=C(C)C,SIGMA,SML0551,5.28432732,1.14771203,-0.67686875,33.79085892,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00241982-07,GSK-269962A,384568481,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[850664-21-0],,12.58925412,0,-4.9,29.15217058,3,4,,66.8552328,54.51555024,0.026320341,0.999572602,,ROCK1,CC[N]1C2=C(C=NC(=C2)OC3=CC(=CC=C3)NC(=O)C4=CC=C(OCCN5CCOCC5)C=C4)N=C1C6=NON=C6N,Tocris,4009_CM1,-3.35025381,-2.07728731,-2.27038184,54.51555024,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00185994-09,10058-F4,384568432,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,403811-55-2,,12.58925412,0,-4.9,61.0955594,3,4,,70.68975097,62.82722513,0.105437831,0.993081546,,MYC,CCC1=CC=C(C=C1)\C=C/2SC(=S)NC2=O,SIGMA,F3680,5.33980583,-0.31301237,1.03001766,62.82722513,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386518-01,Cannabidiol,377020361,Cannabinoid Receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,13956-29-1,,14.12537545,0,-4.85,36.84279194,3,4,,37.5,32.94184237,0.115616747,0.991674452,,CNR1,CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O,Axon Medchem,1234,3.95284327,2.10165449,0.94173043,32.94184237,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00480785-05,BLU-9931,377020469,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1538604-68-0,,12.58925412,0,-4.9,51.36376837,3,4,,46.29584248,43.65898487,0.265212208,0.953968756,,FGFR4,COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=CN=C(NC4=C(C)C=CC=C4NC(=O)C=C)N=C3C=C2)OC,MedChem Express,HY-12823,8.16749585,-1.66896341,-1.370662,43.65898487,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346514-04,Bafetinib,384568814,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,887650-05-7,,12.58925412,0,-4.9,57.59897711,3,4,,81.99477316,70.69045056,0.06464026,0.997414422,,ABL1,CN(C)[C@H]1CCN(C1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=C(C=N4)C5=CN=CN=C5,MedChem Express,HY-12039,-0.10995052,4.14148858,3.07475317,70.69045056,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00344053-04,Purmorphamine,384568716,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,483367-10-8,,12.58925412,0,-4.9,33.43646321,3,4,,38.39963364,32.8672358,0.181565885,0.979123667,,,C1CCC(CC1)[N]2C=NC3=C2N=C(OC4=CC=CC5=C4C=CC=C5)N=C3NC6=CC=C(C=C6)N7CCOCC7,Selleck,S3042,3.68543636,-1.9996947,1.22644331,32.8672358,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00381563-08,XL019,,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,945755-56-6,,4.466835922,1,-5.35,77.21378571,2.2,4,,68.47390301,64.84988453,0.02003188,0.999752484,,,O=C(NC1=CC=C(C=C1)C2=CC=NC(NC3=CC=C(C=C3)N4CCOCC4)=N2)[C@@H]5CCCN5,APExBIO,A3937,1.38047612,3.61482382,32.46421992,64.84988453,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346606-02,Cyclovirobuxin D,363677475,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,860-79-7,,3.16227766,1,-5.5,82.67424797,3,4,,68.58063217,52.96381832,0.138125683,0.98804917,,,CN[C@@H](C)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)[C@H](CC[C@@]45C[C@@]35CC[C@]12C)NC,Selleck,S2402,4.39498521,-2.39975699,-0.58098342,52.96381832,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,,,,,,,,,,,
NCGC00390402-02,NSC-23925,363680887,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,858474-14-3,,12.58925412,0,-4.9,53.50092075,3,4,,78.02550219,65.16043568,0.147582536,0.986323943,,ABCBA,COC1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(O)C4CCCCN4,SynKinase,SYN-5211,-1.30154816,7.34239047,4.27759497,65.16043568,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016786-18,Mycophenolic acid,384567959,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,24280-93-1,,7.943282347,1,-5.1,31.3318888,2.4,4,,45.67448437,33.80924345,0.06204958,0.997620653,,IMPDH1,COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2,Selleck,S2487,-1.3837512,2.12181346,11.60634161,33.80924345,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250389-02,CDIBA,384568542,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,479422-22-5,,12.58925412,0,-4.9,42.9572841,3,4,,75.27897829,66.73264527,0.028406782,0.999502046,,PLCG1,CC1=C(CCOC2=CC=C(C=C2)C(O)=O)C3=CC(=CC=C3[N]1C(C4=CC=CC=C4)C5=CC=CC=C5)Cl,Axon Medchem,1609,-1.644555,-1.20961568,-2.68299796,66.73264527,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386313-08,Berzosertib,384569124,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1232416-25-9,,2.238721139,1,-5.65,112.6440451,1.4,4,,77.79357356,81.08565278,0.088593066,0.99512792,,ATR,CNCC1=CC=C(C=C1)C2=NOC(=C2)C3=C(N)N=CC(=N3)C4=CC=C(C=C4)[S+]([O-])(=O)C(C)C,ActiveBioChem,A-1613,-1.20945574,6.8238762,72.04513399,81.08565278,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00389197-01,HSP-990,363680736,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,934343-74-5,,1.122018454,1,-5.95,142.7148131,2.4,4,,31.29267559,16.41403205,1,0.99982224,,HSP90AB1,COC1=CC=CC(=N1)C2=C(C=CC(=C2)F)C3CC4=C(C(=NC(=N4)N)C)C(=O)N3,APExBIO,B4797,19.99717155,24.68306094,51.43630621,16.41403205,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00482810-01,BMS-202,384569261,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1675203-84-5,,3.16227766,1,-5.5,63.15477453,3,4,,43.08292844,-6.71286271,1,0.979775219,,,COC1=NC(=CC=C1CNCCNC(C)=O)OCC2=C(C)C(=CC=C2)C3=CC=CC=C3,DC Chemicals,DC8381,5.03464856,-0.30548343,34.92254474,-6.71286271,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386692-01,UNC-569,363680398,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1350547-65-7,,5.011872336,1,-5.3,63.07449903,3,4,,71.5749915,67.25478469,0.019077566,0.999775491,558,MERTK,CCCCNC1=NC=C2C(=N1)[N](C[C@H]3CC[C@H](N)CC3)N=C2C4=CC=C(F)C=C4,Axon Medchem,2086,-2.53807107,-1.31357874,-1.14993366,67.25478469,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00167328-03,Aloxistatin,363676654,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,88321-09-9,,3.548133892,1,-5.45,49.48132427,2.2,4,,48.58638016,46.49690904,0.012392071,0.999905321,,CAPN1,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,Selleck,S7393,-1.27414714,-0.68691803,26.41340114,46.49690904,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263108-02,Vorapaxar,384568595,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,618385-01-6,,10,0,-5,31.66886154,3,4,,54.19363874,45.20164851,0.032448229,0.999350393,,PAR1,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\C4=CC=C(C=N4)C5=CC=CC(=C5)F,Axon Medchem,1755,-1.73996438,-0.29003206,3.61950344,45.20164851,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00483926-01,Sitravatinib,363681145,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1123837-84-2,,2.238721139,1,-5.65,98.81602956,3,4,,72.94682651,-6.25864985,1,0.999897074,3815,FLT1,COCCNCC1=CC=C(N=C1)C2=CC3=NC=CC(=C3S2)OC4=C(F)C=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4,ChemieTek,CT-MG516,0.16492578,1.96020634,67.08039492,-6.25864985,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263015-01,NCGC00263015,137275919,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,n,NCGC00263015-01,12.58925412,0,-4.9,24.07642222,3,4,,38.0200486,32.11701309,0.168295086,0.982132204,7099,TLR4,CN(CC(O)COC1=CC=C(Cl)C=C1)CC2=C(C)[N](CC3=C(Cl)C=CC=C3)N=C2C,NCGCChem,BTM10-092,1.60585998,-3.76670717,-1.99801615,32.11701309,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345823-02,"Akt-I-1,2",363677370,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,(473382-50-2),,12.58925412,0,-4.9,61.70993049,3,4,,96.82365845,86.32829068,0.026608359,0.999563088,,AKT1,CC(C)(N)C1=CC=C(C=C1)C2=NC3=C(C=CC=C3)N=C2C4=CC=CC=C4,SynKinase,SYN-1006,-0.09673853,-2.09768795,-1.57480315,86.32829068,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370917-01,JHW 007 hydrochloride,363677933,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,4351,,10,0,-5,61.33754329,3,3,,94.88271582,88.05112739,1,0.999983354,,,CCCCN1[C@H]2CC[C@@H]1CC(C2)OC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4,Tocris,4351,-1.56034878,0.85995086,88.05112739,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00169080-02,NCGC00169080-02,363676765,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,,,11.22018454,0,-4.95,35.64388914,3,3,,53.07798165,44.68429574,1,0.999958562,,,C[C@H]1C[C@H]2OC(=O)C(=C)[C@H]2C\C3=C(/C)C(=O)C[C@@H]13,Analyticon,NP-009712,0.09189065,2.78530934,44.68429574,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00385053-01,NCGC00385053-01,363679508,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,10,0,-5,29.85212333,3,4,,37.52025816,31.77045879,0.234681812,0.964458013,,,CC(=O)OCC1(O)C2CCC(=C)C3CC(O)C(=C)C3C2OC1=O,Analyticon,NP-001392,-1.2668818,5.36101642,-0.22132535,31.77045879,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00380760-01,NCGC00380760-01,363678765,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.16227766,1,-5.5,54.57667453,2.2,4,,48.02164043,47.19579725,0.036282566,0.999187617,,,CC(=O)OC[C@]12C[C@H](O)\C(=C/[C@H]1O[C@@H]3[C@H](O)[C@@H](O)[C@@]2(C)[C@]34CO4)C,Analyticon,NP-019350,0.17738359,-1.28785242,16.55502392,47.19579725,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00485901-01,CMK,363681403,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,821794-90-5,,12.58925412,0,-4.9,46.78658368,3,4,,73.33816995,63.84294549,0.074192515,0.996590219,6197,,CC1=CC=C(C=C1)C2=C([N](CCCO)C3=NC=NC(=C23)N)C(=O)CCl,MedChem Express,HY-52101,-1.29078523,3.00588782,0.37755501,63.84294549,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00481602-01,EGF816,377020292,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,11.22018454,0,-4.95,25.34148451,3,4,,38.2,30.51591658,0.05566983,0.998086263,,,CN(C)C\C=C\C(=O)N1CCCCC(C1)[N]2C(=NC3=CC=CC(=C23)Cl)NC(=O)C4=CC=NC(=C4)C,APExBIO,B5889,0.52631579,-1,2.70124983,30.51591658,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159563-02,BIBU 1361 dihydrochloride,377020276,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,[793726-84-8],,12.58925412,0,-4.9,44.94711832,3,4,,63.16588454,57.71130626,0.032270827,0.999357317,,,CCN(CC)CC1CCN(CC1)C2=NC3=C(NC4=CC(=C(F)C=C4)Cl)N=CN=C3C=N2,Tocris,2417,0.66666667,0.76190476,-0.60475742,57.71130626,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384766-01,NCGC00384766-01,363679345,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,10,0,-5,37.78950258,3,4,,45.71097445,38.15830968,0.031485268,0.99938859,,,C[C@H]1[C@H]2OC(=O)[C@@H]1[C@@]3(C)C([C@H]2O)[C@@]4(C)[C@H](O)C(=O)\C=C(C)/[C@@H]4[C@@H](O)C3=O,Analyticon,NP-015943,0.47482014,1.45445875,0.69444444,38.15830968,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00386705-01,PX 20350,363680408,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1198085-23-2,,12.58925412,0,-4.9,34.63552064,3,3,,46.03877639,39.62372541,1,0.99996979,,,CN(CC1=CC=C(C=C1)C(O)=O)C2=C(N=C(OCC3=C(ON=C3C4=C(Cl)C=CC=C4Cl)C5CC5)C=C2)C(F)(F)F,Axon Medchem,2152,1.14731528,1.84275184,39.62372541,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370952-01,PG 01037 dihydrochloride,363677953,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,3887,,12.58925412,0,-4.9,32.07407043,3,3,,52.7739616,46.80453827,1,0.999859003,,,ClC1=CC=CC(=C1Cl)N2CCN(CC2)C\C=C\CNC(=O)C3=CC=C(C=C3)C4=NC=CC=C4,Tocris,3887,-0.68838917,-0.95823096,46.80453827,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386822-01,NCGC00386822-01,363680449,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,12.58925412,0,-4.9,36.28187591,3,4,,54.93511056,46.92645445,0.064605252,0.99741803,,,ClC1=CC=C(C=C1)C(=O)N2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl,Evotec,MLS003179195,1.09074031,-1.57142857,-0.68539175,46.92645445,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00344511-04,SB 612111  hydrochloride,363677333,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,371980-98-2,,12.58925412,0,-4.9,65.43549954,3,3,,75.14799656,67.34166308,1,0.997021461,,,CC1=C2CC[C@@H](C[C@H](O)C2=CC=C1)CN3CCC(CC3)C4=C(Cl)C=CC=C4Cl,Axon Medchem,1413,4.40569068,1.10565111,67.34166308,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00018254-09,Bifonazole,406861835,Cytochrome P450 51 Inhibitor,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,60628-96-8,,12.58925412,0,-4.9,54.18715737,3,4,,84.82452564,72.58507135,0.017165732,0.999818239,,,C1=CC=C(C=C1)C([N]2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4,Selleck,S1854,0.12865497,-0.95238095,0.38973256,72.58507135,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379200-06,ML277,363678412,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1401242-74-7,,11.22018454,0,-4.95,36.74150384,3,3,,57.8985442,50.82579348,1,0.99996755,,,COC1=CC=C(C=C1)C2=CSC(=N2)NC(=O)[C@H]3CCCCN3[S+]([O-])(=O)C4=CC=C(C)C=C4,Glixx,GLXC-02396,-0.50481872,0.56511057,50.82579348,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386831-01,NCGC00386831-01,363680455,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,12.58925412,0,-4.9,61.18575105,3,4,,86.53715938,76.08037435,0.044543478,0.99877439,,,CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=C(C=C(Br)C(=C2)Cl)C(O)=O,Evotec,MLS003337117,0.11716462,3.26394243,2.49050232,76.08037435,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351982-01,NCGC00351982-01,440681235,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,4.466835922,1,-5.35,52.49182471,2.2,4,,54.43795871,51.33498486,0.020396716,0.99974343,,,C[C@@H]1C[C@H](C)CN(CCCNC(=O)C2CCN(CC2)CC3=COC(=N3)C4=CC(=C(F)C=C4)C)C1,KUCMLD,KUC114060N,-1.09714286,1.2079157,23.00548755,51.33498486,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386578-02,JNJ 26854165 dihydrochloride,363680337,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,881202-16-0,,12.58925412,0,-4.9,29.14952424,3,3,,43.80009613,39.31462493,1,0.999516139,,,C(CC1=C[NH]C2=CC=CC=C12)NC3=CC=CC(=C3)NC4=CC=NC=C4,Axon Medchem,1586,0.09189065,-0.76411141,39.31462493,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00389741-01,MK 0893,363680844,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,870823-12-4,,10,0,-5,45.61063079,3,3,,60.08285715,56.85714286,1,0.999981603,,,COC1=CC2=C(C=C1)C=C(C=C2)C3=CC(=N[N]3C(C)C4=CC=C(C=C4)C(=O)NCCC(O)=O)C5=CC(=CC(=C5)Cl)Cl,APExBIO,A3608,0.50377834,2.11111111,56.85714286,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370813-01,ARL 17477 dihydrochloride,363677864,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3319,,11.22018454,0,-4.95,69.02277739,3,3,,104.7673478,92.88571429,1,0.999977341,4842,NOS1,ClC1=CC=CC(=C1)CNCCC2=CC=C(NC(=N)C3=CC=CS3)C=C2,Tocris,3319,-0.45798031,1.55555556,92.88571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00162399-04,KN-93,406861844,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,139298-40-1,,12.58925412,0,-4.9,67.7045036,3,4,,102.6459894,86.59510047,0.018399722,0.999791145,,,COC1=CC=C(C=C1)[S+]([O-])(=O)N(CCO)C2=C(CN(C)C/C=C/C3=CC=C(Cl)C=C3)C=CC=C2,MedChem Express,HY-15465,0.77714286,-0.64250835,2.06838328,86.59510047,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384581-01,NCGC00384581-01,363679257,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.548133892,1,-5.45,38.32364784,3,4,,35.53521511,34.89990061,0.011367297,0.999920376,,,CC(C)CC(=O)OC1C\C(=C\CC\C(=C\C2OC(=O)C(=C)C12)COC(C)=O)C=O,Analyticon,NP-017818,0.02956393,-0.10442047,2.48803828,34.89990061,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00386857-03,ML299,363680467,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1426916-00-8,,12.58925412,0,-4.9,27.0352515,3,3,,39.01714286,35.68571429,1,0.999592195,,,C[C@@H](CN1CCC2(CC1)N(CNC2=O)C3=CC(=CC=C3)F)NC(=O)C4=CC=C(Br)C=C4,Glixx,GLXC-03617,0.18319212,-0.33333333,35.68571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370900-01,SNAP 94847 hydrochloride,363677920,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,3347,,12.58925412,0,-4.9,72.33441417,3,3,,102.260405,89.1713342,1,0.999971881,,,CC(C)C(=O)NC1=CC=C(C)C(=C1)C2CCN(CC2)CC3=CC=C(OC4=CC(=C(F)C=C4)F)C=C3,Tocris,3347,1.33088573,1.94103194,89.1713342,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00379163-01,Atiprimod,363678393,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[130065-61-1],,2.818382931,1,-5.55,186.6975171,3,4,,149.6460957,-6.51913876,1,0.998822347,,,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1,Tocris,4580,1.95794054,-2.77989919,126.96447,-6.51913876,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165726-04,AM1241,363676639,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,444912-48-5,,12.58925412,0,-4.9,68.31574004,3,3,,106.0981655,95.25714286,1,0.999989754,,,CN1CCCCC1C[N]2C=C(C(=O)C3=C(I)C=CC(=C3)[N+]([O-])=O)C4=C2C=CC=C4,Selleck,S1544,-0.77856652,-0.5,95.25714286,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00346713-05,AZD-4547,363677532,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1035270-39-3,,12.58925412,0,-4.9,39.29841206,3,4,,49.43544185,44.48846753,0.149743912,0.985917241,,FGFR3,COC1=CC(=CC(=C1)OC)CCC2=CC(=N[NH]2)NC(=O)C3=CC=C(C=C3)N4C[C@@H](C)N[C@@H](C)C4,ChemieTek,CT-A4547,3.48127601,-1.65449396,-2.41318423,44.48846753,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00408843-01,Revaprazan HCl,363681062,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,178307-42-1,,12.58925412,0,-4.9,90.78602196,3,3,,113.3546857,105.5142857,1,0.999951981,476,ATP1A1,CC1N(CCC2=CC=CC=C12)C3=NC(=NC(=C3C)C)NC4=CC=C(F)C=C4,Glixx,GLXC-06691,3.06846806,2.77777778,105.5142857,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370691-03,M8-B,363677809,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,883976-12-3,,10,0,-5,28.83287133,3,4,,47.1838877,35.4803193,0.067339438,0.997195607,,,COC1=CC(=CC=C1OCC2=CC=CC=C2)CN(CCN)C(=O)C3=CC=CS3,SynKinase,SYN-5110,-1.55428571,1.2079157,7.78106093,35.4803193,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346683-02,YM-201636,384568907,PIKfyve Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,371942-69-7,,1.584893193,1,-5.8,74.07235164,1.4,4,,38.08475574,36.39450969,0.243055158,0.961717632,,PIKFYVE,NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6,Selleck,S1219,4.6185853,3.92010732,46.26250736,36.39450969,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485044-01,"2,5-Dimethyl-celecoxib",363681203,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,457639-26-8,,12.58925412,0,-4.9,35.05883452,3,4,,52.79469347,47.92182769,0.066160192,0.997291757,,,CC1=CC(=C(C)C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S+](N)([O-])=O)C(F)(F)F,SIGMA,D7196,-0.50285714,1.72192238,-0.97087379,47.92182769,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378760-01,DMP 777,363678183,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,157341-41-8,,12.58925412,0,-4.9,82.58589079,3,3,,120.1992984,109.4711279,1,0.999964439,,,CCC[C@@H](NC(=O)N1[C@@H](OC2=CC=C(C=C2)C(=O)N3CCN(C)CC3)C(CC)(CC)C1=O)C4=CC5=C(OCO5)C=C4,MedChem Express,HY-75957,0.22972663,0.02464876,109.4711279,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386484-01,(R)-(-)-LY 426965 dihydrochloride,363680300,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,228418-85-7,,10,0,-5,61.59718679,3,3,,84.87576054,81.96179808,1,0.999991255,,,COC1=CC=CC=C1N2CCN(CC2)CC[C@@](C)(C(=O)C3CCCCC3)C4=CC=CC=C4,Axon Medchem,1095,-0.09178522,0.90909091,81.96179808,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00381256-01,NCGC00381256-01,363679053,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,3.16227766,1,-5.5,58.84470813,3,4,,47.91985277,6.5045502,1,0.99801116,,,CC1CCC2\C(=C/C3C(O)C(C)(C)CC123)C(O)=O,Analyticon,NP-015639,1.83877415,0.0239349,37.4257896,6.5045502,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370827-02,A 943931,363677872,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,1027330-97-7,,8.912509381,1,-5.05,51.43297069,3,3,,68.24716675,64.8407987,1,0.999976654,,,N[C@@H]1CCN(C1)C2=C3CCCC4=C(C=CC=C4)C3=NC(=N2)N,Axon Medchem,1990,0.09189065,3.82055706,64.8407987,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00347904-03,AZ-11645373,384568988,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,227088-94-0,,12.58925412,0,-4.9,23.01252393,3,4,,47.68925721,42.00153965,0.12430903,0.990352001,,P2RX7,[O-][N+](=O)C1=CC(=CC=C1)C2=CC=C(OCC(CCC3=CC=NC=C3)N4C(=O)CSC4=O)C=C2,SIGMA,A7231,-3.23989294,1.73147023,-1.88465354,42.00153965,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387273-01,TA02,363680607,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,11.22018454,0,-4.95,32.47271538,3,4,,42.36027691,37.30012735,0.283288372,0.947037392,,MAPK14,[F]C1=CC=C(C=C1)C2=C([NH]C(=N2)C3=C([F])C=CC=C3)C4=CC=NC=C4,Tocris,5384,-1.51178918,8.0339842,4.06121248,37.30012735,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385321-01,NCGC00385321-01,363679674,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,,,1.995262315,1,-5.7,133.037757,3,3,,91.98992965,85.6988667,1,0.998929787,,,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)CO[C@H]2OC(=O)[C@]34CCC(C)(C)C[C@H]3C/5=C/CC6[C@@]7(C)C[C@H](O)[C@H](O[C@@H]8O[C@H](CO[C@@H]9OC[C@H](O)[C@H](O)[C@H]9O)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)C7CC[C@@]6(C)[C@]5(C)C[C@H]4O)[C@H](O)[C@H](O[C@@H]%10OC[C@](O)(CO)[C@H]%10O)[C@H]1O[C@@H]%11OC[C@H](O)[C@H](O[C@@H]%12OC[C@@H](O)[C@H](O)[C@H]%12O)[C@H]%11O,Analyticon,NP-019451,1.56214105,-1.20778901,85.6988667,,,,,,,,,,,,,1.36E-07,6.80E-07,3.4E-06,,,,,,,,,,,,
NCGC00386479-01,GMC 2-113,363680297,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,256227-77-7,,12.58925412,0,-4.9,90.55719531,3,3,,136.4417714,118.2571429,1,0.99998677,3352,HTR1D,CN1CCN(CC1)C2=CC(=CC=C2O)NC(=O)C3=CC=C(C=C3)C4=CC=C(C=C4C)C5=NN=C(C)O5,Axon Medchem,1083,0.32058621,1.61111111,118.2571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00387119-01,SK1-I,377020333,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,[1072443-89-0],,1.995262315,1,-5.7,40.98573652,3,4,,32.81657143,9.60638591,1,0.999232423,,,CCCCCC1=CC=C(\C=C\[C@H](O)[C@@H](CO)NC)C=C1,Tocris,3711,-1.09714286,0.53970702,30.01266357,9.60638591,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386337-05,Darapladib,363680220,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,356057-34-6,,2.511886432,1,-5.6,46.37087033,3,3,,69.73846178,-2.69832704,1,0.999989876,,,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN\3/C4=C(CCC4)\C(=O)\N=C3SCC5=CC=C(F)C=C5,Glixx,GLXC-90192,1.33241443,63.02686714,-2.69832704,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00347562-02,NCGC00347562-02,363677623,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,7.079457844,1,-5.15,77.11058876,3,4,,85.055005,79.88073264,0.041751219,0.99892342,,,CC(C)C(=O)O[C@H]1[C@@H]2[C@H](C)C(=O)O[C@@H]2C[C@@H](C)[C@@H]3\C=C/C(=O)[C@@]13C,Analyticon,NP-013135,-0.23651146,2.76646538,3.06220096,79.88073264,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00485321-01,Naltrindole isothiocyanate hydrochloride,363681285,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,126876-64-0,,12.58925412,0,-4.9,81.84279254,3,4,,129.8951489,111.9185246,0.014154565,0.999876406,,,OC1=C2O[C@H]3C4=C(C[C@@]5(O)[C@H]6CC(=C2[C@@]35CCN6CC7CC7)C=C1)C8=C([NH]4)C(=CC=C8)N=C=S,SIGMA,N157,-1.07791447,0.43690568,0.91459125,111.9185246,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384864-01,NCGC00384864-01,363679404,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,1.995262315,1,-5.7,135.7459165,3,4,,96.17019568,89.65360073,0.047232239,0.998621578,,,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)CO[C@H]2OC(=O)[C@]34CCC(C)(C)C[C@H]3C/5=C/CC6[C@@]7(C)CC[C@H](O[C@@H]8O[C@H](CO[C@@H]9OC[C@H](O)[C@H](O)[C@H]9O)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)C7CC[C@@]6(C)[C@]5(C)C[C@H]4O)[C@H](O)[C@H](O)[C@H]1O[C@@H]%10OC[C@H](O)[C@H](O[C@@H]%11OC[C@@H](O)[C@H](O)[C@H]%11O)[C@H]%10O,Analyticon,NP-019453,-0.59084195,2.29302438,-1.15185708,89.65360073,,,,,,,,,,,,2.72E-08,1.36E-07,6.80E-07,3.4E-06,,,,,,,,,,,
NCGC00378545-01,SR 59230A hydrochloride,363678085,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,[1135278-41-9],,12.58925412,0,-4.9,58.27528107,3,3,,90.71611462,81.54344307,1,0.999993467,,,CCC1=C(OC[C@@H](O)CN[C@H]2CCCC3=C2C=CC=C3)C=CC=C1,Tocris,1511,-0.68917988,-0.61621888,81.54344307,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386477-01,GMC 2-29,363680295,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,148672-15-5,,12.58925412,0,-4.9,89.3103,3,3,,118.9976571,109.7428571,1,0.99981014,3352,HTR1D,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3C)C4=NN=C(C)O4)C=C1N5CCN(C)CC5,Axon Medchem,1080,2.06091138,0.83333333,109.7428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370679-04,VK-II-36,363677807,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,955371-66-1,,10,0,-5,84.2486929,2.3,3,,104.0935429,87.97142857,1,0.999968423,,,COC1=CC=CC=C1OCCN2CC(COC3=CC=CC4=C3C5=C([NH]4)C=CC=C5)OCC2=O,Glixx,GLXC-01507,2.70208381,13.88888889,87.97142857,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00379180-02,CCT 031374 hydrobromide,363678402,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1219184-91-4,,12.58925412,0,-4.9,74.73948164,3,3,,75.95045239,72.16716932,1,0.993230888,,,O=C(CN\1C2=C(C=CC=C2)N3CC/N=C13)C4=CC=C(C=C4)C5=CC=CC=C5,Axon Medchem,2161,6.37907297,0.07371007,72.16716932,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00371074-02,CP-809101 (hydrochloride),363678018,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1215721-40-6,,12.58925412,0,-4.9,41.30844914,3,3,,35.80331754,33.6492891,1,0.990300264,,,ClC1=CC(=CC=C1)COC2=NC(=CN=C2)N3CCNCC3,MedChem Express,HY-15543A,4.63515374,1.54791155,33.6492891,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00507888-01,NCB-1026,384569352,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1792999-26-8,,4.466835922,1,-5.35,88.82559401,2.1,4,,88.78240538,81.37721958,0.022591709,0.999685108,,TNIK,O[C@H]1CC[C@H](CC1)OC2=CC=CC3=C2N=C(NC4=CC=C5N=C[NH]C5=C4)N=C3,Selleck,S8392,-1.18795078,4.2156713,40.18649421,81.37721958,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00246387-08,Arbidol,384568511,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,131707-23-8,,11.22018454,0,-4.95,79.22101882,3,4,,117.9254944,96.93951205,0.031012129,0.999406363,,,CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br,MedChem Express,HY-14904A,-0.22627634,2.53551245,7.97112348,96.93951205,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346625-03,CAY10505,384568865,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1218777-13-9,,6.309573445,1,-5.2,47.00705827,2.2,4,,62.1355386,55.64280216,0.019678638,0.999761159,,PIK3CG,FC1=CC=C(C=C1)C2=CC=C(O2)\C=C/3SC(=O)NC3=O,Adooq,A11196,-1.38047612,-1.70109356,14.49624486,55.64280216,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165902-08,SU-MI-2,384568297,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,658084-23-2,,12.58925412,0,-4.9,68.23121647,3,4,,87.93567902,80.3503091,0.081997198,0.99583038,,MET,CN1CCN(CC1)C(=O)C2=C(C)[NH]C(=C2C)\C=C3/C(=O)NC4=CC=C(C=C34)[S+]([O-])(=O)N(C)C5=CC(=CC=C5)Cl,Bio Vision,1938,3.79504042,0.01526485,-2.18366736,80.3503091,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00249391-11,NVP-BHG712,384568526,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,940310-85-0,,1.258925412,1,-5.9,194.7323484,2.3,4,,128.9819257,21.97447332,1,0.999972368,,BRAF,C[N]1N=CC2=C1N=C(N=C2NC3=CC(=CC=C3C)C(=O)NC4=CC=CC(=C4)C(F)(F)F)C5=CC=CN=C5,MedChem Express,HY-13258,-0.19241341,14.9889462,127.7291961,21.97447332,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00249417-03,Ataciguat,384568527,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,254877-67-3,,12.58925412,0,-4.9,26.80813715,3,4,,52.74995258,46.55889145,0.057394411,0.997963682,,GUCY1A2,[O-][S+](=O)(NC1=CC=C(Cl)C=C1C(=O)NC2=CC=C(C=C2)[S+]([O-])(=O)N3CCOCC3)C4=CC=C(Cl)S4,Cayman,16371,-2.78912523,-0.15188335,-1.0911152,46.55889145,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00481082-01,BMS-595,363681116,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,0.354813389,1,-6.45,155.3151035,1.4,4,,72.64163924,-5.66676479,1,0.999977209,,CSNK2A1,COC(=O)NC1=CC(=C(Cl)C(=C1)NC2=N[N]3C(=CN=C3C(=C2)NC4CC4)C#N)N5CCN(C)CC5,Piramal,BMS-595 lot1,5.71311139,59.33445276,68.6209991,-5.66676479,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015599-10,L-165041,384567870,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,79558-09-1,,8.912509381,1,-5.05,26.18375695,3,4,,41.8835248,36.56157218,0.049704643,0.998474434,,PPARG,CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(=C1O)C(C)=O,SIGMA,L2167,-0.51133223,-2.15893431,2.39136775,36.56157218,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015256-17,Chloroquine,363676447,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,50-63-5,,1.122018454,1,-5.95,52.37213671,3,4,,34.1957515,34.63259708,0.123735266,0.990446802,,,CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl,Selleck,S4157,-1.75364163,2.19948068,5.71514513,34.63259708,,,,,,,,,,,,3.20E-08,1.60E-07,8.00E-07,0.000004,,,,,,,,,,,
NCGC00346712-05,Verteporfin,384568927,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,129497-78-5,,0.562341325,1,-6.25,131.5208931,1.4,4,,69.67509646,-0.65091269,1,0.999933793,,,COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC,Aobious,AOB5623,-2.39944521,56.86391415,67.68687463,-0.65091269,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00241112-04,RWJ-67657,384568477,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[215303-72-3],,10,0,-5,47.65083442,3,4,,53.98873971,47.04778403,0.020821425,0.999732672,,MAPK14,OCCC#CC1=NC(=C([N]1CCCC2=CC=CC=C2)C3=CC=NC=C3)C4=CC=C(F)C=C4,Tocris,2999,1.97991797,2.74935085,7.88088434,47.04778403,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00016622-11,Hycanthone,434146889,,DPI_SARS-CoV-2_General,,3105-97-3,,4.466835922,1,-5.35,70.34863985,1.2,20,,73.94959874,-1.84491979,0.000007502,0.926781438,,,CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3,Prestwick,Prestw-355,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00167972-02,Ciclesonide,384568343,Glucocorticoid receptor Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,126544-47-6,,12.58925412,0,-4.9,32.49292547,3,4,,58.45870522,51.67795113,0.077365022,0.996291409,,,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6,Prestwick,Prestw-1801,-1.63036032,0.4732102,-3.29045767,51.67795113,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00508900-01,VU-0364849,384569371,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[1206711-14-9],,4.466835922,1,-5.35,87.98800861,3,4,,82.69815019,79.96761849,0.029382803,0.999467178,,TGFBR1,C1CN(CCO1)CCOC2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6,Tocris,5580,1.16454309,-1.02274462,3.20071792,79.96761849,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00346634-02,WAY-600,384568870,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1062159-35-6,,1,1,-6,93.36850722,2.4,4,,58.60459607,-3.16966181,1,0.99989909,,MTOR,C1CN(CCO1)C2=NC(=NC3=C2C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C6=CC7=C([NH]C=C7)C=C6,Selleck,S2689,-0.48543689,14.59233865,58.35785756,-3.16966181,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346963-01,HMSL10083,174006744,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,n,HMSL10083,11.22018454,0,-4.95,29.62957373,3,4,,39.13987548,36.08320362,0.022153911,0.999697451,1436,CSF1R,CCN(CC)CCCCNC1=NC=C2CN(C(=O)N(C)C2=N1)C3=C(Cl)C(=CC(=C3Cl)OC)OC,LINCS,HMSL10083,0.7073509,0.01490535,1.20659211,36.08320362,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247877-09,CNF-2024,384568518,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,848695-25-0,,7.943282347,1,-5.1,71.26851369,2.2,4,,62.34679583,53.56184799,0.024435223,0.999631752,,HSP90AB1,COC1=C(C)C=NC(=C1C)C[N]2C=NC3=C(Cl)N=C(N)N=C23,MedChem Express,HY-10212,4.32357043,7.42403832,21.46755609,53.56184799,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386948-01,AMG-837,363680520,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1291087-14-3,,11.22018454,0,-4.95,72.23051448,3,4,,103.704103,90.24108561,0.025846678,0.999587755,,FFAR1,CC#C[C@@H](CC(O)=O)C1=CC=C(OCC2=CC(=CC=C2)C3=CC=C(C=C3)C(F)(F)F)C=C1,Axon Medchem,2405,1.10309716,-1.03864365,3.85020304,90.24108561,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00159574-16,ZM-447439,384568190,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,331771-20-1,,11.22018454,0,-4.95,42.61948308,3,4,,79.30532096,68.05234796,0.007016361,0.99996964,,AURKA,COC1=C(OCCCN2CCOCC2)C=C3N=CN=C(NC4=CC=C(NC(=O)C5=CC=CC=C5)C=C4)C3=C1,MedChem Express,HY-10128,-2.47922243,-2.15674362,-0.58098342,68.05234796,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00013841-13,Cyclobenzaprine hydrochloride,384567790,5-HT2A Receptor Ligands,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,"6202-23-9, 303-53-7 [cyclobenzaprine]",,10,0,-5,44.21770121,3,4,,80.90930157,66.38953041,0.025212615,0.999607793,,HTR2A,CN(C)CCC=C1C2=C(C=CC=C2)\C=C/C3=C1C=CC=C3,Microsource,1503207,-2.14114664,-3.49331713,3.58509282,66.38953041,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00161679-02,MG-132,26755342,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,133407-82-6,MG-132,0.398107171,1,-6.4,56.0709216,5,4,NCGC00161679-02;Z-Leu-Leu-Leu-al;MG132;CIPLUS_684965;MG-132;LS-172868;benzyloxycarbonylleucyl-leucyl-leucine aldehyde;benzyloxycarbonyl-leucyl-leucyl-leucinal;,-68.76486771,-2.74515353,0.060529305,0.997734291,5707,PSMD1,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O,BIOMOL,BIOMOL_PI-102,54.04993065,17.48397675,1.79517363,-2.74515353,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346435-07,Niraparib,384568775,PARP Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1038915-60-4,,12.58925412,0,-4.9,53.29441099,3,4,,79.16406119,66.57344716,0.13669364,0.988297767,,PARP1,NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4,MedChem Express,HY-10619,-1.46595424,6.88444512,3.52976369,66.57344716,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015214-07,ML-9,90340625,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,12.58925412,0,-4.9,45.40583488,3,4,,68.31610005,61.2716763,0.036840309,0.999162161,,,[O-][S+](=O)(N1CCCNCC1)C2=CC=CC3=C(Cl)C=CC=C23,SigmaAldrich,Lopac-C-1172,0.50285714,-1.00231303,-1.39299282,61.2716763,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370778-01,L 760735,363677850,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,4013,,12.58925412,0,-4.9,32.89720383,3,3,,56.48,50.2,1,0.999868505,,,C[C@@H](O[C@H]1OCCN(CC2=C(CN(C)C)[NH]N=N2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,Tocris,4013,-1.09915274,-1.5,50.2,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00489873-03,CCT-251921,384569285,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1607837-31-9,,8.912509381,1,-5.05,43.59211626,2.4,4,,58.78559937,45.26052399,0.083049874,0.995724427,,CDK8,C[N]1N=CC2=C1C=CC(=C2)C3=CN=C(N)C(=C3N4CCC5(CCNC5=O)CC4)Cl,MedChem Express,HY-19984,-0.75352788,3.67882766,13.04217768,45.26052399,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378818-01,FIIN 1 hydrochloride,363678218,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,[1256152-35-8],,12.58925412,0,-4.9,72.53701216,3,3,,117.0985786,98.1042654,1,0.999989369,,,CCN(CC)CCCCNC1=NC=C2CN(C(=O)N(CC3=CC=CC(=C3)NC(=O)C=C)C2=N1)C4=C(Cl)C(=CC(=C4Cl)OC)OC,Tocris,4002,-0.45892611,1.00737101,98.1042654,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00480754-01,PF 06260933 dihydrochloride,377020362,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,3.981071706,1,-5.4,35.14406352,2.4,4,,32.22857143,31.86059276,0.051403188,0.998368908,,,NC1=NC=C(C=C1)C2=CN=C(N)C(=C2)C3=CC=C(Cl)C=C3,Tocris,5752,0.25527965,-0.19047619,15.46835103,31.86059276,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387877-01,Voruciclib,363680717,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1000023 -04 - 0,,10,0,-5,47.82815169,3,4,,79.82150977,72.85604311,0.010767926,0.999928488,,CDK1,CN1CC[C@H]([C@@H]1CO)C2=C3OC(=C/C(=O)C3=C(O)C=C2O)\C4=C(Cl)C=C(C=C4)C(F)(F)F,ChemieTek,CT -VORU,-1.8875898,-2.39975699,-0.18421426,72.85604311,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263017-01,CPG-52364,137275921,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1093135-60-4,CPG-52364,12.58925412,0,-4.9,54.76343554,3,4,,63.7639551,60.848839,0.131034507,0.989261017,51284,TLR7,COC1=C(OC)C=C2C(=NC(=NC2=C1)C3=CC=C(C=C3)N4CCN(C)CC4)NCCN5CCOCC5,NCGCChem,BTM10-096,1.59428257,7.11864407,0.33850494,60.848839,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345803-02,AVN944,384568751,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,297730-17-7,,3.16227766,1,-5.5,72.6430883,2.2,4,,72.8405619,58.56072388,0.013137154,0.999893575,,IMPDH1,CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC=CC(NC(=O)NC2=CC=C(C3=CN=CO3)C(OC)=C2)=C1,ChemieTek,CT-AVN944_cm1,-1.34051962,10.33532384,35.87051619,58.56072388,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390724-02,E-7449,384569209,PARP Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1140964-99-3,,6.309573445,1,-5.2,45.19093175,2.2,4,,31.5,30.70044709,0.014586315,0.999869013,,PARP1,O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13,MedChem Express,HY-12418,3.59832636,4.64002395,14.0388114,30.70044709,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346595-02,Oridonin,363677470,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,28957-04-2,,12.58925412,0,-4.9,73.43113109,3,4,,119.7536696,102.8614009,0.019538734,0.999764465,,NFE2L3,CC1(C)CC[C@H](O)[C@]23CO[C@](O)([C@@H](O)[C@H]12)[C@@]45[C@H](O)[C@@H](CCC34)C(=C)C5=O,Selleck,S2335,-1.36680614,0.23948511,-0.18192844,102.8614009,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00511383-01,RAF-709,384569500,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1628838-42-5,,12.58925412,0,-4.9,46.26519489,3,4,,72.36063588,65.10167464,0.02370558,0.999653304,,BRAF,CC1=NC=C(NC(=O)C2=CC(=CC=C2)C(F)(F)F)C=C1C3=CC(=C(OC4CCOCC4)N=C3)N5CCOCC5,Glixx,GLXC-10326,-0.39158811,-0.51932183,-1.47427392,65.10167464,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00013226-25,Trifluoperazine hydrochloride,384567788,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,440-17-5,,12.58925412,0,-4.9,75.94543888,3,4,,110.4321286,101.2017532,0.036483791,0.99917814,,DRD2,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1,MedChem Express,HY-B0532A,-0.67716971,2.61828204,0.29163021,101.2017532,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346700-13,A-803467,384568920,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,944261-79-4,,12.58925412,0,-4.9,30.6509462,3,4,,36.63997644,33.70564117,0.116308199,0.991571577,,SCN10A,COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(Cl)C=C3)OC,MedChem Express,HY-11079,2.50138198,-0.65839841,-0.67074949,33.70564117,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346553-10,BS-181,384568838,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1092443-52-1,,8.912509381,1,-5.05,58.25651545,3,4,,84.96406579,77.4366617,0.020163204,0.999749189,,CDK7,CC(C)C1=C2N=C(NCCCCCCN)C=C(NCC3=CC=CC=C3)[N]2N=C1,MedChem Express,HY-13266,-0.69735007,-2.06555905,5.15463918,77.4366617,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250403-11,Linifanib,377020321,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,796967-16-3,,11.22018454,0,-4.95,13.50684011,2.4,4,,30.84100418,23.72578241,0.023664248,0.999655176,,KDR,CC1=CC=C(F)C(=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=N[NH]C4=CC=C3)N,MedChem Express,HY-50751,-1.53417015,-1.0178117,0.57610673,23.72578241,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015819-17,Propafenone hydrochloride,384567894,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,34183-22-7,,12.58925412,0,-4.9,59.55746272,3,4,,73.89285659,67.74938646,0.098438533,0.993976356,,,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2,Selleck,S2500,4.04468958,0,-2.01534065,67.74938646,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386129-03,ADW-742,363680114,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,475488-23-4,,12.58925412,0,-4.9,61.7167394,3,4,,88.11313816,80.37356728,0.03670611,0.999168146,,IGFR1,NC1=NC=NC2=C1C(=C[N]2[C@@H]3C[C@H](C3)CN4CCCC4)C5=CC(=CC=C5)OCC6=CC=CC=C6,MedChem Express,HY-10252,0.31900139,1.83335818,-0.64743967,80.37356728,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509912-01,BLU-554,384569378,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1707289-21-1,,12.58925412,0,-4.9,33.56922402,3,4,,63.84180101,56.15248749,0.05474314,0.998147588,,FGFR4,COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=C(C=C2)N=C(N[C@@H]4COCC[C@@H]4NC(=O)C=C)N=C3)OC,Selleck,S8503,-2.75380189,0.07632423,-2.03410111,56.15248749,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510921-01,Lucanthone,384569494,DNA Topoisomerase II Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,548-57-2,,12.58925412,0,-4.9,69.77518107,3,4,,70.69728643,63.67836004,0.200527573,0.974353928,,TOP2A,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,SantaCruz Bio,sc-396381,9.16419177,-2.13838399,0.39103625,63.67836004,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247785-11,Metarrestin (KUC109088N),384568516,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,12.58925412,0,-4.9,10.52820326,2.4,4,,35.47052189,29.1468168,0.029491651,0.999463802,,,OC1CCC(CC1)N2\C=N/C3=C(C2=N)C(=C([N]3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6,Evotec,MLS003678589,-2.80016971,-2.56606079,-3.30876824,29.1468168,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263214-02,HC-067047,363677270,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[883031-03-6],,12.58925412,0,-4.9,48.12483286,3,4,,69.82735415,63.12799043,0.055673517,0.99808379,,TRPV4,CC1=C(C=C([N]1CCCN2CCOCC2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C(F)(F)F,Tocris,4100,1.05873822,-0.4276768,-2.09346897,63.12799043,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00018261-09,Perhexiline,384568001,mitochondrial carnitine palmitoyltransferase-1 inhbitior,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,"6724-53-4, 6621-47-2 [perhexiline]",,2.818382931,1,-5.55,121.8549689,3,4,,99.61145501,-5.72748268,1,0.998062186,,,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,Microsource,1503227,1.0987463,-3.0072904,83.76080487,-5.72748268,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00185849-01,NCGC00185849-01,124896673,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,3.16227766,1,-5.5,77.74518386,3,4,,64.76165838,-2.9363337,1,0.995533576,,,COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCCCC3)NC4CCN(CC4)CC5=CC=CC=C5,UNC,UNC00000113A,2.5380117,-1.19047619,49.84545088,-2.9363337,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00249351-01,NCGC00249351-01,377020500,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,7.943282347,1,-5.1,40.67389151,3,4,,42.75384978,38.88583974,0.109787108,0.992498014,,,CCN1CCN(CC1)C2=CC=C(NC3=CC=C([N]4N=CN=C34)C5=CC=C(C=C5)C(N)=O)C=C2,NCGCChem,JKJ17-075,2.46783626,-1.04761905,8.64131165,38.88583974,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00025065-10,Cyclopiazonic acid from Penicillium cyclopium,,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,18172-33-3,,12.58925412,0,-4.9,46.65088474,3,4,,54.05104281,48.49066959,0.063721591,0.997488471,489,ATP2A3,CC(=O)\C1=C(/O)[C@@H]2[C@@H]3[C@@H](CC4=C5C(=CC=C4)[NH]C=C35)C(C)(C)N2C1=O,SIGMA,C1530,3.26315789,0.42857143,2.53998119,48.49066959,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378775-01,LY 272015 hydrochloride,363678191,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[172895-15-7],,12.58925412,0,-4.9,30.58457017,3,3,,44.15238095,39.42857143,1,0.997666893,,,COC1=CC=C(CC2NCCC3=C2[NH]C4=CC=C(C)C=C34)C=C1OC,Tocris,3077,0.64117243,-1.38888889,39.42857143,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00386703-01,CpdD hydrochloride,363680406,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,N.A.,,11.22018454,0,-4.95,76.91910555,3,3,,110.4145182,104.1428571,1,0.999993232,,,CCN(CC)CCC[S+]([O-])(=O)N[C@H](CCC1=CC=CC=C1)C2=NC(=NO2)CC3=CC=C(Br)C=C3,Axon Medchem,2147,-0.36638425,0.38888889,104.1428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370875-01,LU AA33810,363677903,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3562,,12.58925412,0,-4.9,47.42212707,3,3,,66.59142857,60.65714286,1,0.999797851,,,C[S+]([O-])(=O)NC[C@@H]1CC[C@H](CC1)NC2=NC3=C(CCSC4=CC=CC=C34)S2,Tocris,3562,0.64117243,0,60.65714286,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00387309-01,NCGC00387309-01,,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,12.58925412,0,-4.9,32.10443051,3,4,,45.80533166,36.90998902,0.097705108,0.994070654,,,CCN([C@H]1CN(N=C1C2=CC=C(Cl)C(=C2)Cl)\C(NC3=CC=CC(=C3)OC(F)F)=N/C#N)C(=O)CO,SGC,BAY-598,1.92982456,-1.38095238,0.79290418,36.90998902,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485648-01,S-15176 difumarate salt,363681372,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,148913-55-7,,3.548133892,1,-5.45,85.78488599,3,4,,80.99887094,64.24259056,0.010978535,0.999925669,,,COC1=CC=C(CN2CCN(CCCSC3=CC(=C(O)C(=C3)C(C)(C)C)C(C)(C)C)CC2)C(=C1OC)OC,SIGMA,S5944,-0.15204678,-0.80952381,-0.06719527,64.24259056,,,,,,,,,,,,4.00E-08,2.00E-07,0.000001,5E-06,,,,,,,,,,,
NCGC00185981-05,NCGC00185981-05,377020372,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,,,10,0,-5,16.42526681,2.4,4,,32.35610499,28.54882784,0.014496092,0.999870552,,,CN(CC1=CSC(=N1)C)C2=NC=NC3=C2C=C(C=C3)C4=CC=C5OCOC5=C4,NCGCChem,ASR08-066,-1.54675416,-1.20855284,-0.1692488,28.54882784,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385743-01,NCGC00385743-01,363679917,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,1.995262315,1,-5.7,144.2620061,3,4,,103.7221466,95.44350807,0.042474527,0.998885656,,,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)CO[C@H]2OC(=O)[C@]34CCC(C)(C)C[C@H]3C/5=C/CC6[C@@]7(C)CC[C@H](O[C@@H]8O[C@H](CO[C@@H]9OC[C@H](O)[C@H](O)[C@H]9O)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)C7CC[C@@]6(C)[C@]5(C)C[C@H]4O)[C@H](O)[C@H](O[C@@H]%10OC[C@](O)(CO)[C@H]%10O)[C@H]1O[C@@H]%11OC[C@H](O)[C@H](O[C@@H]%12OC[C@@H](O)[C@H](O)[C@H]%12O)[C@H]%11O,Analyticon,NP-019452,1.0936133,-1.27713921,-2.26318245,95.44350807,,,,,,,,,,,,2.72E-08,1.36E-07,6.80E-07,3.4E-06,,,,,,,,,,,
NCGC00384808-01,NCGC00384808-01,363679368,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,0.281838293,1,-6.55,152.4363781,1.4,4,,64.3062201,19.79270197,1,0.99991748,,,CCC(C)C(=O)OC1C(C)C2(O)C(\C=C(CO)/CC3(O)C2\C=C(C)/C3=O)C4C(C)(C)C14OC(=O)C(C)C,Analyticon,NP-018354,0.59127864,54.21991293,64.784689,19.79270197,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00485104-01,DCAP,363681223,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,500015-20-3,,12.58925412,0,-4.9,50.95457809,3,4,,79.79584464,69.36574141,0.060628841,0.997726307,,,OCC(CO)(CO)NCC(O)C[N]1C2=C(C=C(Cl)C=C2)C3=C1C=CC(=C3)Cl,SIGMA,SML0515,-1.00394407,2.51007127,-0.11717224,69.36574141,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163413-03,Lycorine HCl,434147015,,DPI_SARS-CoV-2_General,,2188-68-3,,0.630957345,1,-6.2,103.8223966,1.4,20,,59.03703255,8.90374332,0.055172481,0.739742271,,,O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23,Prestwick,Prestw-NAT-0046,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00167403-06,Pluripotin,384568310,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,839707-37-8,,12.58925412,0,-4.9,27.79479982,3,4,,43.36364911,37.12710307,0.224509438,0.967585642,,RASAL1,C[N]1N=C(C)C=C1NC2=NC=C3CN(C(=O)N(C)C3=N2)C4=C(C)C=CC(=C4)NC(=O)C5=CC=CC(=C5)C(F)(F)F,Cayman,10009557,2.69485904,-4.82315113,-4.95771362,37.12710307,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015155-14,Bepridil,384567817,Calcium Channel Blocker,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[68099-86-5],,10,0,-5,74.98257515,3,4,,111.9496353,93.80029806,0.010559681,0.999931222,,KCNT1,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,Tocris,4117,-0.41841004,-0.89806915,9.39963614,93.80029806,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346459-07,LY-2874455,384568783,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1254473-64-7,,12.58925412,0,-4.9,5.104523757,2.4,4,,37.41217352,25.59808612,0.016296861,0.999836395,,FGFR1,C[C@@H](OC1=CC2=C([NH]N=C2\C=C\C3=C[N](CCO)N=C3)C=C1)C4=C(Cl)C=NC=C4Cl,MedChem Express,HY-13304,-3.72733865,-4.09347793,-2.35883827,25.59808612,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00181767-12,Tolcapone,384568400,catechol-O-methyltransferase (COMT),SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[134308-13-7],,14.12537545,0,-4.85,23.51442256,3,4,,37.4648599,30.39728545,0.190511064,0.976951014,,COMT,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(=C2)[N+]([O-])=O)O,Tocris,5864,1.97622996,-3.72071658,-2.36220472,30.39728545,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485951-02,VBY-825,384569279,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1310340-58-9,,0.1,1,-7,393.8481293,1.3,4,,105.4931425,106.9325876,0.075973512,0.996426283,,CTSS,CC[C@H](NC(=O)[C@H](C[S+]([O-])(=O)CC1CC1)N[C@@H](C2=CC=C(F)C=C2)C(F)(F)F)C(=O)C(=O)NC3CC3,MedChem Express,HY-15958,67.74900671,98.29033735,103.3203709,106.9325876,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390660-02,LDN-214117,363680961,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1627503-67-6,,11.22018454,0,-4.95,27.29725702,3,4,,56.68120144,41.8361244,0.07666955,0.996359201,,ACVR1,COC1=C(OC)C(=CC(=C1)C2=CC(=CN=C2C)C3=CC=C(C=C3)N4CCNCC4)OC,Glixx,GLXC-05339,-2.91515591,0.39712846,4.57024915,41.8361244,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370979-01,AMG-548,363677973,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,3920,,12.58925412,0,-4.9,67.40577302,3,4,,115.3413792,100.3090963,0.004032939,0.999989968,,MAPK14,CN\1C(=O)/C(=C(\N=C1NC[C@@H](N)CC2=CC=CC=C2)C3=CC=NC=C3)C4=CC5=C(C=CC=C5)C=C4,Tocris,3920,-1.93177148,-2.24393222,-1.52557583,100.3090963,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00384249-01,CXC-195,384569108,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,11.22018454,0,-4.95,37.85871732,3,4,,64.37312532,54.62172505,0.02434526,0.999634378,,NOX1,CC1=C(C)N=C(CN2CCN(CC2)C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)C(=N1)C,ChemoGenics,CXC195,-0.75352788,-2.03022439,0.53843853,54.62172505,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509934-01,BAY-1125976,384569383,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1402608-02-9,,12.58925412,0,-4.9,23.35612165,3,4,,53.09724713,43.14100677,0.040786537,0.998973091,,AKT1,NC(=O)C1=N[N]2C(=NC(=C2C3=CC=CC=C3)C4=CC=C(C=C4)C5(N)CCC5)C=C1,ChemGood,C-1071,-1.82216742,-3.06823386,-2.99132516,43.14100677,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510233-01,BMS-986205,384569418,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1923833-60-6,,12.58925412,0,-4.9,47.67809877,3,4,,69.18264847,59.65756332,0.032021021,0.999367222,,IDO1,C[C@H]([C@H]1CC[C@H](CC1)C2=CC=NC3=CC=C(F)C=C23)C(=O)NC4=CC=C(Cl)C=C4,ChemGood,C-1360,1.20665742,-0.34282307,0.35314891,59.65756332,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00092289-01,DA-3003-1,26753179,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,383907-43-5,NSC-663284; DA-3003-1;DA-3003-1,3.16227766,1,-5.5,65.67609702,3,4,"NCGC00092289-02;NSC-663284;NSC663284;NSC 663284;6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione;",38,-5.66676479,1,0.956895632,5923,CDC25,ClC/1=C(NCCN2CCOCC2)/C(=O)C3=C(C=CC=N3)C1=O,Tocris,Tocris-1867,7.24756816,0.25950237,32.48579121,-5.66676479,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242057-03,GW-768505A,384568485,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,501693-25-0,,11.22018454,0,-4.95,37.76960806,3,4,,46.49085038,41.65769645,0.013546299,0.999886885,,TEK,COC1=CC=C(C=C1)C2=C(C3=CC=C(NC(=O)NC4=C(F)C=CC(=C4)C(F)(F)F)C=C3)C5=C(O2)N=CN=C5N,Aobious,AOB4188,1.26443101,1.42962417,3.44146685,41.65769645,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346716-20,Dabrafenib,384568929,Raf kinase B Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1195765-45-7,,12.58925412,0,-4.9,31.46138071,3,4,,35.51619062,32.62559809,0.161489066,0.983580997,,BRAF,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F,Selleck,S2807,3.26323423,-1.68015885,-0.11794191,32.62559809,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00094792-07,Tioguanine,384568135,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,"154-42-7, 5580-03-0 [hemihydrate]",,10,0,-5,29.96643815,3,4,,44.95400368,37.59815242,0.044574192,0.998773589,,HPRT1,NC/1=N/C2=C([NH]C=N2)C(=S)N1,Microsource,1500573,0.16903789,-1.33657351,3.38670823,37.59815242,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346543-05,NCGC00346543,384568829,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,334951-92-7,,12.58925412,0,-4.9,67.68380076,3,4,,79.05496536,71.93225558,0.016400212,0.999834099,,MAP2K1,CNC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC(=CC=C3)CN(C)C)C4=CC=CC=C4,MedChem Express,HY-12202,3.09902803,4.10085055,4.49199377,71.93225558,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510688-01,LGH-447,384569478,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1210608-43-7(free base),,8.912509381,1,-5.05,58.49157409,3,4,,90.39885755,81.37989538,0.032803826,0.999335758,,PIM1,C[C@@H]1C[C@H](N)C[C@@H](C1)C2=C(NC(=O)C3=CC=C(F)C(=N3)C4=C(F)C=CC=C4F)C=NC=C2,Selleck,S7985,-1.28524046,-3.65947022,5.01603966,81.37989538,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00162249-09,MK-886,384568221,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,118427-55-7,,10,0,-5,30.10019687,3,4,,42.09382308,36.45881447,0.086961284,0.995310786,,ALOX5AP,CC(C)C1=CC=C2[N](CC3=CC=C(Cl)C=C3)C(=C(SC(C)(C)C)C2=C1)CC(C)(C)C([O-])=O,Cayman,10133,0.98605437,-2.00486027,2.47980728,36.45881447,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242493-09,Quizartinib,384568499,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,950769-58-1,,2.511886432,1,-5.6,66.58902043,1.2,4,,43.88814207,45.19598132,0.007076709,0.999969125,,KIT,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=C[N]4C(=N3)SC5=C4C=CC(=C5)OCCN6CCOCC6,APExBIO,A5793,1.51178918,1.80354747,39.6115362,45.19598132,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380718-01,NCGC00380718-01,363678735,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,4.466835922,1,-5.35,97.45179918,2.4,4,,54.43391019,55.13948978,0.303289288,0.938631014,,,C/C=C(C)/C(=O)OC1C(C)C2(O)C(\C=C(CO)/CC3(O)C2\C=C(C)/C3=O)C4C(C)(C)C14OC(=O)C(C)C,Analyticon,NP-018353,6.18254497,18.64528483,18.14295892,55.13948978,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00370878-01,CYM 5442 hydrochloride,363677905,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,3601,,7.943282347,1,-5.1,89.65119076,2.3,3,,113.0312796,107.0371966,1,0.999979553,,,CCOC1=C(OCC)C=C(C=C1)C2=NC(=NO2)C3=C4CCC(NCCO)C4=CC=C3,Tocris,3601,0.32124828,12.30958231,107.0371966,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370788-02,Biphenyl-indanone A,363677856,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,866823-73-6,,12.58925412,0,-4.9,28.82578272,3,3,,49.12501019,43.27157834,1,0.999741916,,,CC1=C(C)C2=C(CC(C3CCCC3)C2=O)C=C1OCC4=CC(=CC=C4)C5=CC=C(C=C5)C(O)=O,Axon Medchem,1644,-0.78017439,-1.4004914,43.27157834,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00371047-02,A-867744,363678007,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1000279-69-5,,10,0,-5,63.90395023,3,3,,93.48194831,89.51601321,1,0.999991723,,,CCC(=O)C1=C(C)[N](C2=CC=C(C=C2)[S+](N)([O-])=O)C(=C1)C3=CC=C(Cl)C=C3,MedChem Express,HY-12149,-0.91785223,-0.02457002,89.51601321,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00346640-05,SNX-5422,384568874,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,908115-27-5,,8.912509381,1,-5.05,75.92068944,2.4,4,,94.67741545,73.74903772,0.148779374,0.986096529,,HSP90AB1,CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC=C(C(N)=O)C(=C3)NC4CCC(CC4)OC(=O)CN,MedChem Express,HY-10213,-1.69037893,10.72296476,25.20901233,73.74903772,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378614-02,Flumatinib mesylate,384569056,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,895519-91-2,,7.943282347,1,-5.1,84.36863317,2.3,4,,110.4938629,88.52963818,0.090262747,0.994941387,,ABL1,CN1CCN(CC1)CC2=CC=C(C=C2C(F)(F)F)C(=O)NC3=CC(=C(C)N=C3)NC4=NC=CC(=N4)C5=CC=CN=C5,MedChem Express,HY-13905,-2.50739541,7.38153098,27.81635256,88.52963818,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015554-13,ML-7,384567863,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,110448-33-4,,11.22018454,0,-4.95,37.60025466,3,4,,80.26514776,64.74282297,0.029115667,0.999476875,,MYLK,[O-][S+](=O)(N1CCCNCC1)C2=CC=CC3=C(I)C=CC=C23,MedChem Express,HY-15417,-3.84336476,-1.98564228,0.58970957,64.74282297,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00168785-05,Diclazuril,384568349,antiprotozoal agent,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,101831-37-2,,11.22018454,0,-4.95,13.64954821,2.4,4,,38.3131427,29.74595843,0.026462509,0.999568374,,,ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O,Selleck,S2028,-2.76095225,-2.06561361,-0.12753295,29.74595843,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00389251-02,AZ-191,384569172,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[1594092-37-1],,8.912509381,1,-5.05,55.86926843,3,4,,82.55208984,77.91788405,0.005259913,0.999982937,9149,DYRK1B,COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CN=C4)C=CC(=C1)N5CCN(C)CC5,Tocris,5232,-1.09950522,-1.45910096,2.08744711,77.91788405,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378548-01,AY 9944 dihydrochloride,363678086,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[366-93-8],,11.22018454,0,-4.95,63.77273437,3,3,,96.11667192,81.31428571,1,0.999991234,1717,DHCR7,ClC1=C(CNC[C@H]2CC[C@@H](CC2)CNCC3=C(Cl)C=CC=C3)C=CC=C1,Tocris,1639,-0.04579803,4.5,81.31428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370815-01,NPS ALX Compound 4a dihydrochloride,363677866,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,3285,,12.58925412,0,-4.9,75.4906528,3,3,,100.1310234,91.72770358,1,0.998948921,,,[O-][S+](=O)([N]1C=CC2=CC=C(C=C12)N3CCN4CCCC4C3)C5=C6C=CC=CC6=CC=C5,Tocris,3285,2.29463056,-0.76167076,91.72770358,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00388282-01,MK2 Inhibitor IV,377020527,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,1314118-94-9,,12.58925412,0,-4.9,66.75155902,3,4,,103.5468716,86.99231614,0.019054234,0.999776017,,,ClC1=CC=C(C=C1)C2=CC=C(O2)C(=O)N(CC3=NC=CC=C3)C4=CC=C(C=C4)N5CCNCC5,Cayman,14399,0.58018102,-1,1.35734444,86.99231614,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263208-09,TW-37,384568667,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,877877-35-5,,0.562341325,1,-6.25,76.76361463,1.2,4,,32.28845337,34.2719683,0.006735227,0.999972065,,BCL2L1,CC(C)C1=CC=CC=C1CC2=CC(=C(O)C(=C2O)O)C(=O)NC3=CC=C(C=C3)[S+]([O-])(=O)C4=C(C=CC=C4)C(C)(C)C,MedChem Express,HY-12020,4.39667129,23.47592786,33.63743378,34.2719683,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00378579-06,LCL-161,384569051,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1005342-46-0,,12.58925412,0,-4.9,29.78942432,3,4,,46.88230717,42.04722183,0.047909232,0.998582516,,XIAP,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(F)C=C4,MedChem Express,HY-15518,-0.42841349,0.5052825,-1.28317294,42.04722183,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00169033-03,NCGC00169033-03,363676750,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.548133892,1,-5.45,104.2257726,3,4,,94.30323725,94.05083061,0.008137696,0.999959155,,,CCCC(=O)O[C@@H]1C[C@@](C)(OC(C)=O)C\2C[C@H](OC(=O)\C(C)=C\C)\C(=C2[C@H]3OC(=O)[C@](C)(O)[C@]13O)C,Analyticon,NP-001595,0.0886918,0.38287504,7.36842105,94.05083061,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00346965-01,HMSL10087,174006428,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1001343-54-9,HMSL10087,10,0,-5,27.90776751,3,4,,42.05601227,36.02431783,0.084554808,0.995568231,2324,FLT4,COC1=CC(=CC=C1NC2=NC=C3N(C(C)C)C(=O)CCN(C4CCCC4)C3=N2)C(=O)NC5CCN(C)CC5,LINCS,HMSL10087,0.53897181,-2.3426734,1.7789443,36.02431783,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386712-01,TMP-195,363680410,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1314891-22-9,,11.22018454,0,-4.95,15.81703398,2.4,4,,30.75583368,21.8709398,0.032252627,0.999359627,9734,HDAC9,CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4,Axon Medchem,2180,-1.04652807,-0.18329006,3.24860881,21.8709398,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371126-06,Y-320,363678042,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,288250-47-5,,10,0,-5,77.12845571,2.4,3,,46.63771428,44.74285714,1,0.99999723,3600,IL15,CC1=C(C=N[N]1C2=CC=C(Cl)C=C2)C(=O)NC3=CC=C(N4CCC(CC4)N5CCOCC5)C(=C3)C#N,Glixx,GLXC-90088,50.51522785,11.05555556,44.74285714,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00351606-08,PRT-062607,384569020,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1370261-97-4,,8.912509381,1,-5.05,47.01104212,3,4,,69.43354417,63.24865281,0.011812682,0.999913945,,SYK,N[C@H]1CCCC[C@H]1NC2=NC=C(C(N)=O)C(=N2)NC3=CC=CC(=C3)[N]4N=CC=N4,MedChem Express,HY-15323,-1.18326525,-0.5164034,4.46365311,63.24865281,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015874-05,Quinacrine,170466085,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,6151-30-0,,1,1,-6,153.9788758,2.4,4,,71.91235418,-5.60788931,1,0.999959383,,PLA2G5,Cl.Cl.O.O.CCN(CC)CCCC(C)Nc1c3cc(OC)ccc3nc2cc(Cl)ccc12,Specs,AT-084/J177276,7.38457323,30.27018776,78.79150464,-5.60788931,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250410-11,GSK-650394,384568558,SGK1 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,890842-28-1,,11.22018454,0,-4.95,32.79947438,3,4,,44.03332391,34.75307769,0.079423837,0.996093591,,SGK1,OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5,MedChem Express,HY-15192,0.09708738,2.75748994,6.65097116,34.75307769,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386776-01,AGN-194204,384569146,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,220619-73-8,,8.912509381,1,-5.05,51.86467697,3,4,,64.18124729,58.03278689,0.047732746,0.998592523,,RXRA,CC(/C=C/[C@@H]1C[C@]1(C)C2=CC3=C(C=C2)C(C)(C)CCC3(C)C)=C\C(O)=O,Axon Medchem,2408,1.56206416,-0.83819787,7.27713766,58.03278689,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00024928-14,Tamoxifen,124886964,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,10540-29-1,"Soltamox; ""Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife",6.309573445,1,-5.2,83.21444721,2.3,4,,109.9917741,101.3570088,0.062009757,0.997620861,2099,ESR1,CCC(/C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(C)C)C=C3,SIGMA,T5648,-2.31933248,-0.33603177,64.12994435,101.3570088,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00178520-13,Bromhexine hydrochloride,384568357,Mucolytic Agent,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,611-75-6,,8.912509381,1,-5.05,84.88134,3,4,,103.6111824,100.2598528,0.031254895,0.999397018,,,CN(CC1=C(N)C(=CC(=C1)Br)Br)C2CCCCC2,MedChem Express,HY-B0372A,2.54560882,-0.36658011,5.29402918,100.2598528,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00025155-01,Omacetaxine mepesuccinate,11114076,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,26833-87-4, Ceflatonin; ; Omacetaxine mepesuccinate;Homoharringtonine,0.501187234,1,-6.3,80.83705779,2.4,4,"HOMOHARRINGTONINE HYDROCHLORIDE;HOMOHARRINGTONINE;Homoharringtonine;LS-52751;Ceflatonin;CIPLUS_214595;homoharringtonine;4'-METHYL-2'R-HYDROXY-2'-(4-HYDROXY-4-METHYLPENTYL)-BUTANEDIOATE CHLORIDE, 3R;homoharringtonine, 3H-labeled, (3(R))-isomer;NCGC00025155-01;",45.41407065,-5.43370596,1,0.99999688,,RPL3,O=C(OC)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]2C(OC)=CC53CCCN5CCc1cc4OCOc4cc1[C@H]23,Tocris,Tocris-1416,14.93758669,53.79341183,13.09593879,-5.43370596,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509985-02,Sufugolix,384569395,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,308831-61-0,,12.58925412,0,-4.9,71.63470998,3,4,,77.68944755,74.22248804,0.13459517,0.988659057,,GNRHR,CONC(=O)NC1=CC=C(C=C1)C2=C(CN(C)CC3=CC=CC=C3)C4=C(S2)N(CC5=C(F)C=CC=C5F)C(=O)N(C4=O)C6=CC=CC=C6,Glixx,GLXC-04354,4.07541697,8.55353597,-0.32434026,74.22248804,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263235-01,ACC1 BMS,137276079,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,n,ACC1 BMS,1.258925412,1,-5.9,55.29646928,1.4,4,,38.78451575,34.33912276,0.062691733,0.997571745,31,ACACA,CC(C)OC1=CC=C(OC2=CC=C(C=C2)C(C)NC(C)=O)C=C1,NCGCChem,ACC1 BMS,2.26058364,18.3941383,29.55429255,34.33912276,,,,,,,,,,,,3.20E-07,0.0000016,0.000008,4E-05,,,,,,,,,,,
NCGC00346633-02,SNX-2112,384568869,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,908112-43-6,,0.707945784,1,-6.15,93.59085981,1.4,4,,47.94225722,46.6562986,0.065583923,0.997339313,,HSP90AB1,CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4,APExBIO,A4068,2.55666114,26.81059562,47.85651794,46.6562986,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345793-01,EMD-1214063,174006592,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1100598-32-0,EMD-1214063,12.58925412,0,-4.9,76.02991964,3,4,,108.8480843,95.29195532,0.029973546,0.999445488,8731,MET,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4/N=C(\C=C/C4=O)C5=CC(=CC=C5)C#N,ChemieTek,CT-EMD063,0.73244887,2.77139795,1.42898804,95.29195532,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351599-03,Abemaciclib,384569017,CDK4/6 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1231930-82-7,,1.412537545,1,-5.85,55.86976665,1.4,4,,38.63864792,35.89932293,0.119610475,0.991075966,,CDK4,CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2,APExBIO,A1794,0.01370051,0.93115555,40.56236913,35.89932293,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00511354-01,TP-3654,384569498,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1361951-15-6,,1,1,-6,43.96318961,1.4,4,,32.29260333,28.91746411,0.099647296,0.993831853,,PIM1,CC(C)(O)[C@@H]1CC[C@H](CC1)NC2=N[N]3C(=NC=C3C4=CC(=CC=C4)C(F)(F)F)C=C2,Glixx,GLXC-05022,-1.49383611,5.52925004,31.90328763,28.91746411,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346630-05,MP-10,363677485,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,898562-94-2 (free base),,12.58925412,0,-4.9,56.9047955,3,4,,85.18058422,76.84145779,0.029995769,0.999444704,,PDE10A,C[N]1C=C(C2=CC=NC=C2)C(=N1)C3=CC=C(OCC4=NC5=CC=CC=C5C=C4)C=C3,Glixx,GLXC-90150,0.46728972,-1.19380987,-1.26939351,76.84145779,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00188380-05,Refametinib,384568448,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,923032-37-5,,11.22018454,0,-4.95,25.86114889,3,4,,52.07700308,44.64866393,0.079670022,0.996066448,,MAP2K1,COC1=CC(=C(F)C(=C1N[S+]([O-])(=O)C2(CC2)C[C@H](O)CO)NC3=C(F)C=C(I)C=C3)F,Aobious,AOB87134,-1.17468214,-4.76190476,-1.69145523,44.64866393,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00162073-12,H-89,384568218,AKT Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,130964-39-5,,14.12537545,0,-4.85,21.84514162,3,4,,39.50751879,31.84808612,0.098546326,0.993968546,,AKT1,[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23,MedChem Express,HY-15979A,0.42059463,-1.83290057,-2.50626566,31.84808612,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386261-01,XL-888,363680173,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1149705-71-4,,0.251188643,1,-6.6,83.66890288,1.4,4,,41.83014424,51.38357374,0.59191625,0.693307333,,HSP90AB1,CC[C@@H](C)NC1=C(C=C(C)C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C(N)=O,Selleck,S7122,0.34251267,42.23782629,21.26832187,51.38357374,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379246-01,Phortress (NSC-710305),363678445,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[328087-38-3],,12.58925412,0,-4.9,31.11844612,3,4,,55.48780708,49.10287081,0.046024404,0.998691763,,AHR,CC1=CC(=CC=C1NC(=O)[C@@H](N)CCCCN)C2=NC3=CC(=CC=C3S2)F,Tocris,4995,-1.46482959,-0.30548343,-2.32935279,49.10287081,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00492474-01,Compound 22d,384569289,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,1.412537545,1,-5.85,63.87540624,3,4,,41.06517935,9.41608935,1,0.999912416,,,[O-][S+](=O)(NC1=C2N=CC=CC2=C(C=C1)C3=CN=CC=C3)C4=CC=CC(=C4)C(F)(F)F,NCGCChem,PJM010-024,0.70480929,3.65947022,41.14902304,9.41608935,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346541-04,XL-765,384568827,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1349796-36-6,,11.22018454,0,-4.95,48.60839098,3,4,,78.57540753,64.01809699,0.019566594,0.999763843,,MTOR,COC1=CC(=CC(=C1)NC2=NC3=CC=CC=C3N=C2N[S+]([O-])(=O)C4=CC=C(NC(=O)C5=CC=C(C)C(=C5)OC)C=C4)OC,APExBIO,A5634,-1.06412383,0.04593477,4.9285506,64.01809699,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345848-02,AMG-1,363677390,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,(913376-84-8),,10,0,-5,39.17252536,3,4,,64.4209042,53.5291404,0.011583461,0.999917263,,MET,COC1=CC=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)\C4=C(C)\N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3F,SynKinase,SYN-1143,-1.31940627,-1.34119381,4.96473907,53.5291404,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250407-05,CHIR-265,384568555,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,927880-90-8,,1.584893193,1,-5.8,75.67278232,3,4,,65.68906487,-6.22612141,1,0.999933296,,BRAF,C[N]1C(=NC2=CC(=CC=C12)OC3=CC(=NC=C3)C4=NC(=C[NH]4)C(F)(F)F)NC5=CC=C(C=C5)C(F)(F)F,MedChem Express,HY-10248,-4.03606103,-0.43225518,59.6527369,-6.22612141,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510476-01,Sulfatinib,384569439,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1308672-74-3,,12.58925412,0,-4.9,38.06353809,3,4,,69.63440374,60.79110726,0.03363805,0.999301606,,KDR,CN(C)CCN[S+]([O-])(=O)CC1=CC=CC(=C1)NC2=NC=CC(=N2)OC3=CC4=C([NH]C(=C4)C)C=C3,MedChem Express,HY-12297,-1.30108895,-3.26867267,-2.52669574,60.79110726,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00481574-01,GSK-503,384569256,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,10,0,-5,61.24509953,3,4,,91.55033756,85.234796,0.005822579,0.999979091,,EZH2,CC(C)[N]1C=C(C)C2=C(C=C(C=C12)C3=CN=C(C=C3)N4CCN(C)CC4)\C(O)=N\CC5=C(O)N=C(C)C=C5C,APExBIO,B5833,-1.01422736,-1.27582017,1.45954372,85.234796,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263100-02,OSI-632,363677201,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,252003-65-9,,12.58925412,0,-4.9,11.46288103,3,4,,42.27044344,34.08401906,0.048217071,0.998564476,,KDR,NC(=O)C1=C(NC(=O)NCCCCN2CCCC2)SN=C1OCC3=C(F)C=C(Br)C=C3F,Axon Medchem,1662,-3.22443784,-3.60470444,-4.66235524,34.08401906,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00381751-04,Filanesib,363679167,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,885060-09-3,,12.58925412,0,-4.9,15.73856336,3,4,,39.5895728,32.97045101,0.087065196,0.995299523,,KIF11,CON(C)C(=O)N1/N=C(S[C@@]1(CCCN)C2=CC=CC=C2)/C3=CC(=CC=C3F)F,MedChem Express,HY-15187,-1.3681592,-4.24131067,-3.49956255,32.97045101,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167767-12,IKK-16,377020288,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,873225-46-8,,2.511886432,1,-5.6,158.7227284,3,4,,106.7725284,-6.92775343,1,0.999995926,,IKBKB,O=C(N1CCC(CC1)N2CCCC2)C3=CC=C(NC4=NC=CC(=N4)C5=CC6=C(S5)C=CC=C6)C=C3,MedChem Express,HY-13687,5.01658375,5.8643393,98.04607757,-6.92775343,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263121-03,MG-149,384568605,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1243583-85-8,,12.58925412,0,-4.9,67.10749159,3,4,,75.19205798,70.89288241,0.089665954,0.995008937,,HAT1,CCCCCCCC1=CC=C(CCC2=CC=CC(=C2C(O)=O)O)C=C1,Axon Medchem,1785,4.34119279,4.66537487,-0.32371984,70.89288241,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351592-01,Manassantin A,384569012,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,88497-87-4,Manassantin A,3.16227766,1,-5.5,66.40718785,2.4,4,,36.46830144,40.52033493,0.147527673,0.986342692,,HIF1A,COC1=CC=C(C=C1OC)[C@@H](O)[C@@H](C)OC2=C(OC)C=C(C=C2)[C@H]3O[C@@H]([C@H](C)[C@H]3C)C4=CC=C(O[C@H](C)[C@H](O)C5=CC(=C(OC)C=C5)OC)C(=C4)OC,Duke University,Manassantin A,6.04786077,1.09974034,28.48297214,40.52033493,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346483-11,AC480 (BMS-599626),406861852,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,714971-09-2,,12.58925412,0,-4.9,35.49045307,3,4,,73.60489788,63.98585268,0.046973945,0.998636816,,,CC1=C2N(C=C1NC(=O)OC[C@@H]3COCCN3)N=CN=C2NC4=CC5=C(C=C4)N(CC6=CC(F)=CC=C6)N=C5,APExBIO,A2822,-3.05112699,-1.90125276,-4.59802539,63.98585268,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250384-02,PHA-408,377020291,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,503555-55-3,,6.309573445,1,-5.2,39.11408087,2.2,4,,55.24394997,49.94611239,0.013498319,0.999887652,,IKBKB,CN1CCN(CC1)C2=CC(=C(Cl)C=N2)C(=O)NC3=CC=C4CCC5=C([N](N=C5C(N)=O)C6=CC=C(F)C=C6)C4=C3,Axon Medchem,1651,-1.91576278,-1.91373026,11.46379481,49.94611239,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00186009-04,AS-604850,363677107,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,648449-76-7,,12.58925412,0,-4.9,45.29009207,3,4,,67.04837508,57.61354888,0.048554317,0.99854352,,PIK3CG,FC1(F)OC2=C(O1)C=C(C=C2)\C=C\3SC(=O)NC3=O,Selleck,S2681,1.26778419,-1.0328068,-0.41093949,57.61354888,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386665-06,Bemcentinib,384569144,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1037624-75-1,,1,1,-6,133.4106921,2.4,4,,73.12881636,-5.93330446,1,0.999954559,,AXL,NC1=NC(=N[N]1C2=NN=C3C(=C2)CCCC4=CC=CC=C34)NC5=CC=C6CC[C@@H](CCC6=C5)N7CCCC7,MedChem Express,HY-15150,3.84669778,31.03711624,70.44668371,-5.93330446,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250377-09,NU-7441,384568537,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,503468-95-9,,1.412537545,1,-5.85,84.09303931,2.4,4,,33.39818018,0.33203407,1,0.999750286,,PRKDC,O=C1\C=C(OC2=C(C=CC=C12)C3=CC=CC4=C3SC5=C4C=CC=C5)\N6CCOCC6,MedChem Express,HY-11006,7.41055013,10.26424316,40.09625508,0.33203407,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00343768-05,Rabusertib,384568714,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,911222-45-2,,12.58925412,0,-4.9,24.38837359,3,4,,37.04616445,32.54630284,0.139581861,0.987800019,,CHEK1,CC1=NC=C(NC(=O)NC2=C(OC[C@@H]3CNCCO3)C=C(C)C(=C2)Br)N=C1,MedChem Express,HY-14720,1.3681592,-2.95513704,-1.95392243,32.54630284,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015888-06,Reserpine,384567902,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,50-55-5,,10,0,-5,59.94924112,3,4,,95.81519366,82.43264049,0.013992194,0.999879236,,,COC1C(CC2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)C3CC2C1C(=O)OC)OC(=O)C6=CC(=C(OC)C(=C6)OC)OC,APExBIO,N1867,-1.29595718,-2.2782503,4.63369704,82.43264049,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00408825-01,KT109,363681058,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1402612-55-8,,12.58925412,0,-4.9,48.1669628,3,3,,45.2199483,44.13327589,1,0.99808492,,,O=C(N1CCCCC1CC2=CC=CC=C2)[N]3C=C(N=N3)C4=CC=C(C=C4)C5=CC=CC=C5,Glixx,GLXC-01881,4.17622763,2.28501229,44.13327589,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00402348-02,PQ-10,363681034,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,927691-21-2,,10,0,-5,29.11921661,3,3,,43.05631236,41.11733448,1,0.999985994,,,COC1=CC2=NC=NC(=C2C=C1OC)N3CCC(C3)OC4=CN=C5C=CC=CC5=N4,Glixx,GLXC-04743,-0.45892611,-0.17199017,41.11733448,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00476094-01,Dexanabinol,384569239,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,112924-45-5,,10,0,-5,54.70053254,2.4,4,,74.38907557,62.88382623,0.126442994,0.990010221,,,CCCCCCC(C)(C)C1=CC2=C([C@H]3CC(=C/CC3C(C)(C)O2)\CO)C(=C1)O,Cayman,10006350,-1.45631068,5.97704576,10.35903473,62.88382623,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00509991-01,Pipequaline,384569399,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,77472-98-1,,12.58925412,0,-4.9,50.40419302,3,4,,63.56453101,58.8566479,0.095078476,0.994384167,,,C1CC(CCN1)CCC2=CC(=NC3=CC=CC=C23)C4=CC=CC=C4,MedChem Express,HY-100140,2.17790977,2.96318925,-1.74462325,58.8566479,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00090774-05,Nitazoxanide,170465090,antiprotozoal agent,DPI_SARS-CoV-2_General,,55981-09-4,Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide,3.981071706,1,-5.4,79.3920644,1.1,20,,84.12393274,47.45989305,2.50E-09,0.976965287,,,O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O,Vitas,STK395664,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00686694-01,Remdesivir,406861862,RNA-dependent RNA polymerase inhibitor,DPI_SARS-CoV-2_General,,1809249-37-3,,7.943282347,1,-5.1,97.31770708,1.1,20,,115.8272727,104.8930481,0,0.98367082,,,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4,MedChem Express,HY-104077,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00163432-03,Calpeptin,384568239,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[117591-20-5],,1.122018454,1,-5.95,190.8196528,1.1,4,,91.61270208,101.1239415,0.033626355,0.999301976,,,CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O,Tocris,448,8.98718129,37.7582017,94.27518776,101.1239415,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387146-01,IEM 1925 dihydrobromide,363680548,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,[258282-23-4],,12.58925412,0,-4.9,41.49051722,3,3,,45.77714286,43.08571429,1,0.997483922,,,NCCCCCNC1(CCCCC1)C2=CC=CC=C2,Tocris,4198,2.74788184,0.5,43.08571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00165863-16,PD-173074,384568291,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,219580-11-7,,14.12537545,0,-4.85,12.3737519,3,4,,38.92383638,30.18606797,0.105511322,0.993077634,,FGFR1,CCN(CC)CCCCNC1=NC=C2C=C(C(=NC2=N1)NC(=O)NC(C)(C)C)C3=CC(=CC(=C3)OC)OC,MedChem Express,HY-10321,-2.06157229,-2.10759027,-4.93653032,30.18606797,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00180796-04,Withaferin A,384568384,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,5119-48-2,,1.258925412,1,-5.9,85.50999158,3,4,,45.54024768,-6.30980861,1,0.999963071,,NFKB1,C[C@H]([C@H]1C\C(=C(CO)/C(=O)O1)C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)\C=C/C(=O)[C@]6(C)[C@H]4CC[C@]23C,SIGMA,W4394,3.37926033,8.88956774,48.85743771,-6.30980861,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00167488-03,Sorafenib,124893321,VEGFR-1/2/3 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,475207-59-1,;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar,0.707945784,1,-6.15,64.43498409,2.4,4,"4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE;BAY-439006;sorafenibum;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-, MONO(4-METHYLBENZENESULFONATE);Sorafenib base;BAY 43-9006;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID-4-METHYLBENZENESULFONATE;Nexavar;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N2-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;SORAFENIB;BAY-43-9006 TOSYLATE;Sorafenib Tosilate;BAY-439006 TOSYLATE;4-(4-(3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO)-PHENOXY)-PYRIDINE-2-CARBOXYLIC ACID;2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-;4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE;sorafenib;CIPLUS_789424;sorafenib tosylate;SORAFENIB TOSYLATE;Sorafenib tosylate;Sorafenib;4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE;",43.11594977,-6.54904306,1,0.999885551,2321,FLT1,CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2,Pharmeks,PHAR202191,-0.7106599,19.18435925,36.53250774,-6.54904306,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00015096-27,Amiodarone hydrochloride,384567808,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,19774-82-4,,8.912509381,1,-5.05,84.62545766,3,4,,105.6264745,98.58526834,0.028433888,0.999501026,,,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3,MedChem Express,HY-14188,1.92413414,-0.54532056,9.16784203,98.58526834,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371125-09,AR-A014418,363678041,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,487021-52-3,,12.58925412,0,-4.9,55.18520369,3,4,,72.81184372,68.40243385,0.111341254,0.992276477,,GSK3A,COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1,Glixx,GLXC-11026,-0.20804438,6.15590997,0.41200706,68.40243385,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346747-02,NCGC00346747,174007018,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,n,,11.22018454,0,-4.95,40.44664645,3,4,,52.8780574,45.46868373,0.011904347,0.999912635,4790,NFKB1,CC(O)(C#CC1=CC2=C(CCN2C3=NC(=NC=C3Cl)N)C=C1)C4=NC=CS4,NCGCChem,PRP02-095,1.14704256,1.11774613,3.93700787,45.46868373,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00498437-01,AZD-0156,384569300,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1821428-35-6,,3.548133892,1,-5.45,46.13819795,3,4,,43.79294266,39.64371554,0.007470035,0.999965609,,ATM,CN(C)CCCOC1=NC=C(C=C1)C2=CC3=C(C=C2)N=CC4=C3N(C5CCOCC5)C(=O)N4C,ChemieTek,CT-A0156,-0.51133223,-0.38278977,8.57392826,39.64371554,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00183808-01,ML324,85736407,JMJ Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1222800-79-4, NCGC00183808-01;NCGC00183808-01,12.58925412,0,-4.9,49.2534982,3,4,,61.37399179,57.0822131,0.038822028,0.999069559,3720,JARID2,CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O,NCGCChem,GRB09-026-A4,2.03883495,1.62468326,0.35314891,57.0822131,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00250406-03,Tipifarnib,384568554,Farnesyltransferase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,192185-72-1,,12.58925412,0,-4.9,23.96090451,3,4,,40.46919684,34.2719683,0.327998583,0.927231422,,COX10,C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3,MedChem Express,HY-10502,-2.92649098,7.70606648,0.61801059,34.2719683,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00165898-11,SD-208,384568296,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,627536-09-8,,11.22018454,0,-4.95,18.60486067,2.4,4,,34.22189224,25.1912805,0.04166692,0.998929878,,TGBR1,FC1=C(C=C(Cl)C=C1)C2=NC3=NC=CN=C3C(=N2)NC4=CC=NC=C4,MedChem Express,HY-13227,-1.01824353,0.06109669,3.33884795,25.1912805,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00163169-05,Pizotifen,170466311,Antimigraine drugs,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,15574-96-6, Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran,11.22018454,0,-4.95,62.98911411,3,4,,107.9334796,95.72368421,0.009734528,0.99994155,,CHRM1,CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23,BIOMOL,NS740,-2.71211022,-1.83290057,-0.50125313,95.72368421,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00180769-03,NCGC00180769-03,363677063,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,7.079457844,1,-5.15,76.80191331,3,4,,92.26151691,85.4603464,0.018878715,0.999780127,,,C\C=C(/C)C(=O)O[C@H]1\C=C(\CO)C(=O)[C@H](OC(C)=O)[C@H]1C(C)C,Analyticon,NP-009776,-1.23092073,0.31378228,1.1048425,85.4603464,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00090749-19,Diethylstilbestrol,384568080,Estrogen Receptor (ER) Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,56-53-1,,12.58925412,0,-4.9,29.69666731,3,4,,46.83270649,40.57684151,0.056412562,0.998033414,,ESR1,CCC(/C1=CC=C(O)C=C1)=C(/CC)C2=CC=C(O)C=C2,MedChem Express,HY-14598,-0.73244887,1.39335477,0.37911928,40.57684151,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00351608-02,Erastin,384569022,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,571203-78-6,,12.58925412,0,-4.9,43.73387051,3,4,,47.32837798,44.61289373,0.193348869,0.976224802,,VDAC2,CCOC1=CC=CC=C1N\2C(=O)C3=C(C=CC=C3)\N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(Cl)C=C5,Selleck,S7242,1.71256336,7.73927645,0.8674843,44.61289373,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346808-03,GNF-2,384568942,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,GNF 2,11.22018454,0,-4.95,38.57641231,3,4,,72.12873471,63.00014138,0.032710855,0.999339594,25,ABL1,NC(=O)C1=CC(=CC=C1)C2=NC=NC(=C2)NC3=CC=C(OC(F)(F)F)C=C3,NCGCChem,AED003-034,-1.86567164,-3.87383249,-1.48731409,63.00014138,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263225-01,AG-041R,137276069,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,199800-49-2,AG-041R,12.58925412,0,-4.9,44.61949568,3,4,,49.81418304,46.61469612,0.108938042,0.992612066,887,CCKB,CCOC(CN1C(=O)[C@](CC(=O)NC2=CC=C(C)C=C2)(NC(=O)NC3=CC=C(C)C=C3)C4=CC=CC=C14)OCC,Cayman,10010129,3.90326686,0.03054834,-0.30079711,46.61469612,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00390672-01,Seviteronel,363680966,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,1610537-15-9,,11.22018454,0,-4.95,48.42090247,3,4,,55.78891961,49.02232487,0.120816578,0.990891994,,CYP17A1,CC(C)[C@](O)(C1=CC2=CC(=C(OC(F)F)C=C2C=C1)OC(F)F)C3=C[NH]N=N3,MedChem Express,HY-15996,4.00056346,-1.48845687,3.72679609,49.02232487,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346477-02,Emricasan,384568791,Caspase Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,254750-02-2,,2.818382931,1,-5.55,38.65613872,2.2,4,,51.07228704,34.99254844,0.019061999,0.999776065,,CASP3,C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F,MedChem Express,HY-10396,-2.73361227,6.46609789,21.40691328,34.99254844,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346537-04,LY-2228820,384568826,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,862507-23-1,,1.412537545,1,-5.85,130.6054462,3,4,,93.82882829,33.22493991,1,0.999815184,,MAPK14,CC(C)(C)C[N]1C(=NC2=C1N=C(C=C2)C3=C(N=C([NH]3)C(C)(C)C)C4=CC=C(F)C=C4)N,APExBIO,A5566,-1.58927584,5.16000612,90.60950714,33.22493991,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00263142-04,Tiplasinin,363677226,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,393105-53-8,,12.58925412,0,-4.9,32.86824538,3,4,,58.0842604,48.9822434,0.034640449,0.999259473,,SERPINE1,OC(=O)C(=O)C1=C[N](CC2=CC=CC=C2)C3=CC=C(C=C13)C4=CC=C(OC(F)(F)F)C=C4,Glixx,GLXC-04469,-1.30108895,0.06109669,-0.66175365,48.9822434,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370814-01,SSR 146977 hydrochloride,363677865,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,264618-38-4,,12.58925412,0,-4.9,49.62684338,3,3,,75.08470345,68,1,0.999985261,,,CN(C)C(=O)NC1(CCN(CCC[C@@]2(CCCN(C2)C(=O)C3=CC=CC=C3)C4=CC=C(Cl)C(Cl)=C4)CC1)C5=CC=CC=C5,Tocris,3297,-0.32058621,-0.22222222,68,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00408813-01,GSK205,363681056,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1263130-79-5,,11.22018454,0,-4.95,47.21682935,3,3,,73.52002646,64.8427402,1,0.999961187,59341,TRPV4,CN(CCC1=CC=C(NC2=NC=C(S2)C3=CC=CN=C3)C=C1)CC4=CC=CC=C4,Glixx,GLXC-02524,-0.64249656,1.2039312,64.8427402,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00384350-01,NCGC00384350-01,363679203,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,5.623413252,1,-5.25,120.2374501,3,4,,120.0313621,113.7076796,0.012419436,0.999904853,,,CCC1=C(N\2C(=O)/C(=C\C(=C2C=C(C)C)C(=O)N3CCNCC3)C4=NC(=CS4)C5=CC=C(C=C5)C(F)(F)F)C(=CC=C1)CC,NCGCChem,SRK005-028,0.46865847,-0.79671036,0.74574363,113.7076796,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00371046-02,MS 245 oxalate,363678006,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,275363-58-1,,12.58925412,0,-4.9,58.83165624,3,3,,83.22952381,75.51428571,1,0.999293902,,,COC1=CC=C2[N](C=C(CCN(C)C)C2=C1)[S+]([O-])(=O)C3=CC=CC=C3,Axon Medchem,1849,0.96175864,-1.05555556,75.51428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00378929-01,gamma-secretase modulator 3,363678284,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1431697-84-5,,11.22018454,0,-4.95,54.68596796,3,3,,54.93171047,53.81301163,1,0.99999337,,,COC1=C(C=CC(=C1)NC2=NC3=C(CCCC3C4=CC=C(F)C=C4)S2)[N]5C=NC(=C5)C,MedChem Express,HY-50889,3.53373107,4.25061425,53.81301163,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00485375-01,Z-Gly-Leu-Phe-chloromethyl ketone,363681304,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,,,2.818382931,1,-5.55,107.9860965,3,4,,82.58836178,11.03183315,1,0.999987603,3002,GZMB,CC(C)C[C@H](NC(=O)CNC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)CCl,SIGMA,C9984,2.37426901,2.9047619,69.06329794,11.03183315,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00387786-01,[2-Chloro-4-[[4-(2-thienyl)-2-pyrimidinyl]amino]phenyl](4-methyl-1-piperazinyl)-methanone,363680667,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,1139875-74-3,,7.079457844,1,-5.15,65.78345389,2.2,4,,64.98133919,62.01975851,0.019288012,0.99977054,2932,GSK3B,CN1CCN(CC1)C(=O)C2=C(Cl)C=C(NC3=NC(=CC=N3)C4=CC=CS4)C=C2,Chemdea,CD0264,2.57600371,2.19047619,16.19405994,62.01975851,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00162463-03,Ionomycin(Calciumsalt),363676613,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,56092-82-1,,3.981071706,1,-5.4,75.86188022,3,4,,58.34892638,59.467618,0.307747455,0.936640177,,,C[C@@H](O)[C@]1(C)CC[C@@H](O1)[C@]2(C)CC[C@@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)/C([O-])=C/C(=O)[C@@H](C)C[C@@H](C)C[C@H](C)CCC([O-])=O)O2,Bio Vision,1566,-0.69005848,14.28571429,7.27052815,59.467618,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00485925-01,Genz-123346 (free base),363681420,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,491833-30-8,,12.58925412,0,-4.9,65.35350103,3,4,,95.62491011,82.9426147,0.006892853,0.999970697,7357,UGCG,CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C2=CC=C3OCCOC3=C2,MedChem Express,HY-12744,0.81271662,0.34087388,1.49720089,82.9426147,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380396-01,NCGC00380396-01,363678566,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,6.309573445,1,-5.2,37.95870551,2.2,4,,43.46168401,37.46452223,0.025147851,0.999610116,,,C[C@H]1[C@H](O)CC\C2=C\C(=O)[C@@]3(O[C@@H]3[C@]12C)C(=C)CO,Analyticon,NP-009218,0.07194245,0.59608965,13.38601533,37.46452223,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380759-01,NCGC00380759-01,363678764,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.548133892,1,-5.45,40.64434599,3,4,,44.09833544,42.42510294,0.014834789,0.999864322,,,CCC(C)CC(=O)OC1C2C(C/C(=C1/C(C)CCCOC(C)=O)C)OC(=O)C2=C,Analyticon,NP-019391,-1.59645233,-1.10939475,0.76555024,42.42510294,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00386990-01,Sitamaquine tosylate,363680522,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1019640-33-5,,12.58925412,0,-4.9,74.74706858,3,3,,110.1988952,99.48571429,1,0.999848431,,,CCN(CC)CCCCCCNC1=C2N=CC=C(C)C2=CC(=C1)OC,Axon Medchem,1515,0.27478818,-0.72222222,99.48571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00485940-01,FAS-IN-1,363681431,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,1375105-96-6,,10,0,-5,53.38409801,2.4,4,,68.50365979,56.81255161,0.082833005,0.995745638,,,[O-][S+](=O)(N1CCC2(CC1)CN(C3CC3)C(=O)CO2)C4=CC=C(C=C4)C5=CC=C6C=CC=NC6=C5,MedChem Express,HY-12648,-0.04571429,4.54895914,11.24243703,56.81255161,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380307-01,NCGC00380307-01,363678532,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,1.77827941,1,-5.75,52.06463524,1.2,4,,31,32.25421453,0.027885881,0.999520605,,,COC1=CC=C(C=C1)[C@H]2OC[C@H]3O[C@@H](O[C@@H]4[C@@H](O)CN[C@H]24)[C@H](O)[C@H]3O,Analyticon,NP-017754,1.33244504,0.93346099,26.50201852,32.25421453,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00282602-03,JNJ0966,406861850,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,315705-75-0,,7.943282347,1,-5.1,58.33593029,2.4,4,,61.46354091,56.91068603,0.051638144,0.998352344,,,COC1=CC=CC=C1NC2=NC(=CS2)C3=C(C)N=C(NC(C)=O)S3,SIGMA,SML2588,2.98792877,0.71273629,10.97513345,56.91068603,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00185768-03,Benidipine HCl,363677104,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,91599-74-5,,12.58925412,0,-4.9,43.5869648,3,3,,75.66070768,63.8374264,1,0.99997388,,,COC(=O)C\1=C(C)\N\C(=C(/[C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4)C,Selleck,S2017,-1.14731528,-0.56511057,63.8374264,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00384634-01,NCGC00384634-01,363679286,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,1.995262315,1,-5.7,63.95572234,1.2,4,,43.06424587,42.70818455,0.031283589,0.999396224,,,CO[C@H]1\C=C/2CCN3CC4=CC(=C(OC)C=C4[C@H]([C@@H]1O)[C@@H]23)OC,Analyticon,NP-010117,0.53951589,-0.6265516,33.99440037,42.70818455,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00385908-01,NCGC00385908-01,363679999,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,,,12.58925412,0,-4.9,58.66388058,3,3,,83.95085101,75.9579061,1,0.999846228,,,C[C@@H]1C[C@H]2OC(=O)[C@H](C)[C@H]2C(OC(C)=O)[C@@]3(C)[C@H]1\C=C/C3=O,Analyticon,NP-014339,0.59728923,-0.07394627,75.9579061,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370963-01,ER 50891,363677960,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3823,,11.22018454,0,-4.95,64.70221261,3,3,,94.76417735,89.11428571,1,0.999993839,,,CC(C)C1=C2N=C(C=C(C3=CC=CC=C3)C2=CC=C1)C4=CC=C([NH]4)C5=CC=C(C=C5)C(O)=O,Tocris,3823,-0.54957637,-0.16666667,89.11428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00408920-01,CM037,363681085,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,896795-60-1,,12.58925412,0,-4.9,28.54552065,3,3,,33,31,1,0.998742015,,,CCOC(=O)CSC/1=N/C2=C(SC3=C2C=CC=C3)C(=O)N1CCCN4CCCC4,Glixx,GLXC-06332,1.55713304,0.44444444,31,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00347801-02,NCGC00347801-02,363677689,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,7.079457844,1,-5.15,48.80961998,3,4,,50.85148297,48.66302036,0.10211894,0.993515576,,,C[C@H]1[C@@H](O)[C@H](O)C2[C@@]3(C)[C@H](O)C(=O)\C=C(\C)C3C[C@H]4OC(=O)[C@H](O)[C@]1(O)[C@@]24C,Analyticon,NP-015942,-0.24618415,1.32754043,5.19511048,48.66302036,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00386585-01,5-HT6 antagonist 29,363680341,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,497963-70-9,,12.58925412,0,-4.9,72.6868048,3,3,,120.1666359,100.3159558,1,0.999983325,,,C[N]1C=C(C2=CC=CC(=C12)N3CCNCC3)[S+]([O-])(=O)C4=CC=C(Cl)C=C4,Axon Medchem,1575,-0.826067,0.56511057,100.3159558,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370905-02,SGS 518,363677924,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,445441-26-9,,8.912509381,1,-5.05,82.67256942,3,3,,109.4233675,101.7808958,1,0.999970488,,,CN1CCC(CC1)C2=C[N](C)C3=CC=C(O[S+]([O-])(=O)C4=C(F)C=CC=C4F)C=C23,Axon Medchem,1927,0.13783598,8.79960562,101.7808958,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00160664-04,Nitroxoline,384568201,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,4008-48-4,,12.58925412,0,-4.9,43.12264405,3,4,,39.27973666,37.15537961,0.220791225,0.968701638,,METAP2,OC1=CC=C(C2=C1N=CC=C2)[N+]([O-])=O,Microsource,1506173,6.23272526,-0.10718114,-0.69991251,37.15537961,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242490-05,PD-166285,384568496,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[212391-63-4],,1.412537545,1,-5.85,43.17934415,3,4,,44.59350044,-5.7582756,1,0.994388206,,SRC,CCN(CC)CCOC1=CC=C(NC2=NC=C3\C=C(/C(=O)N(C)C3=N2)C4=C(Cl)C=CC=C4Cl)C=C1,Tocris,3785,-4.33863924,0.24301337,37.39549384,-5.7582756,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00247954-03,SSR-504734,384568521,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,615571-23-8,,12.58925412,0,-4.9,41.84621072,3,4,,69.05507247,61.32729588,0.034852366,0.999250224,,SLC6A9,FC(F)(F)C1=CC=CC(=C1Cl)C(=O)N[C@H]([C@@H]2CCCCN2)C3=CC=CC=C3,Axon Medchem,1549,-0.5963939,-1.14771203,-2.38375515,61.32729588,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00345850-02,AS-602801,384568765,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,(848344-36-5),,7.079457844,1,-5.15,52.69976001,2.4,4,,52.64668458,49.65361233,0.053716918,0.998216978,,MAPK8,N#CC(=C/1NC2=CC=CC=C2S1)\C3=NC(=NC=C3)OCC4=CC=C(CN5CCOCC5)C=C4,SynKinase,SYN-1147,2.50138198,0.5052825,12.65675124,49.65361233,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485045-01,N-Methylspiperone hydrochloride,363681204,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,87539-19-3,,6.309573445,1,-5.2,83.0082882,2.3,4,,91.74693429,84.90669594,0.053545959,0.998227571,,,CN1CN(C2=CC=CC=C2)C3(CCN(CCCC(=O)C4=CC=C(F)C=C4)CC3)C1=O,SIGMA,S128,1.46205616,-1.71428571,24.3381266,84.90669594,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00168931-02,NCGC00168931-02,363676726,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,,,10,0,-5,40.86785979,3,4,,57.20104958,48.7815367,0.0195784,0.999763621,,,C\C1=C2/[C@@H]3OC(=O)C(=C)[C@@H]3CC(=O)[C@@]2(C)CCC1,Analyticon,NP-010521,-0.01415829,0.77756833,5.57960558,48.7815367,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386701-02,SPD304,363680404,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,1049741-03-8,,2.511886432,1,-5.6,26.22305223,3,3,,48.34083454,-4.11428571,1,0.999996002,,,CN(CCN(C)CC1=C[N](C2=CC=CC(=C2)C(F)(F)F)C3=C1C=CC=C3)CC/4=C/OC5=CC(=C(C)C=C5C4=O)C,Chemdea,CD0206,-0.13739409,42.55555556,-4.11428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00379092-01,PI4KIII beta inhibitor 3,363678348,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1245319-54-3,,11.22018454,0,-4.95,168.2884769,2.4,3,,39.2632486,65.848054,1,0.999979439,5298,PI4KB,CC1=CC=C(NC(=O)N2CCN(CC2)C3=C4N=C(SC4=NC(=N3)N)C5=CC=CN=C5)C=C1,MedChem Express,HY-15679,30.01376778,30.68796069,65.848054,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00262398-01,NCGC00262398,161003999,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,n, NCGC00262398;NCGC00262398,11.22018454,0,-4.95,51.15235153,2.2,4,,32.5,31.35701146,0.039161093,0.999055032,9099,USP2,CC1=CC=C(C=C1)[S+]([O-])(=O)NC2=C(C=CC(=C2)Cl)C(=O)NC3=NC(=CS3)C4=CC=CC=C4,NCGCChem,RAP04-025,6.14424411,7.13966314,10.06474397,31.35701146,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00485262-01,WIN 51708 hydrate,363681271,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,144177-30-0 (anhydrous),,7.943282347,1,-5.1,38.80592539,3,4,,49.26216089,45.03293085,0.055491273,0.998097051,,,C[C@]12CC3=C[N]4C(=NC5=C4C=CC=C5)N=C3C[C@@H]1CC[C@@H]6[C@@H]2CC[C@@]7(C)[C@H]6CC[C@@]7(O)C#C,SIGMA,W103,0.6265955,-1.52380952,6.59857546,45.03293085,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00014352-10,GANT-61,384567791,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,500579-04-4,,5.011872336,1,-5.3,24.99183348,2.4,4,,31.22298767,28.91746411,0.037715618,0.999123008,,SHH,CN(C)C1=C(CN2CCCN(CC3=C(C=CC=C3)N(C)C)C2C4=CC=NC=C4)C=CC=C1,MedChem Express,HY-13901,-1.43582306,-0.15274171,10.23146101,28.91746411,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00241103-11,Masitinib,384568473,FGFR 3 Inhibitor,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,790299-79-5,,11.22018454,0,-4.95,48.11783215,3,4,,63.82741281,55.42725173,0.039787781,0.99902266,,FGFR3,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5,MedChem Express,HY-10209,1.77489787,-0.24301337,3.33002692,55.42725173,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00346617-03,AZD-5438,384568860,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,602306-29-6,,1.412537545,1,-5.85,63.03810183,1.4,4,,41.42407299,36.564313,0.214918004,0.97039722,,CDK1,CC(C)[N]1C(=NC=C1C2=NC(=NC=C2)NC3=CC=C(C=C3)[S+](C)([O-])=O)C,Selleck,S2621,0.95700416,1.53525116,46.05650383,36.564313,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00379253-01,DBM 1285 dihydrochloride,363678450,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,,,12.58925412,0,-4.9,60.4867926,3,3,,62.21142857,58.45714286,1,0.988589572,,,FC1=CC=C(C=C1)C2=C(SC(=N2)C3CCNCC3)C4=CC=NC(=N4)NC5CC5,Tocris,5095,5.44996565,-1.33333333,58.45714286,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00229512-05,BMS-509744,384568462,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,[439575-02-7],,12.58925412,0,-4.9,31.14057344,3,4,,47.07433173,42.414307,0.06742932,0.997186859,,ITK,COC1=C(C=C(SC2=CN=C(NC(=O)C3=CC=C(CNC(C)C(C)(C)C)C=C3)S2)C(=C1)C)C(=O)N4CCN(CC4)C(C)=O,Tocris,5009,0.27894003,0.17961383,-2.00121286,42.414307,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371151-06,Balicatib,363678065,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,354813-19-7,,1.584893193,1,-5.8,125.6853422,1.1,4,,81.08027422,81.27990431,0.034686722,0.999257207,,,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N,Glixx,GLXC-06343,1.60986222,3.60470444,83.4144184,81.27990431,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386106-01,NCGC00386106-01,363680108,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,12.58925412,0,-4.9,21.63350048,3,4,,39.10057955,33.88087416,0.074519461,0.996562452,,,C[C@@H]1CCC\C=C\[C@H]2CC(=O)C[C@@H]2[C@@H](O)\C=C\C(=O)O1,Analyticon,NP-020535,-0.21872266,-1.89016603,-2.58982734,33.88087416,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00386057-01,NCGC00386057-01,363680082,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,10,0,-5,39.91919748,3,4,,44.86450552,37.13755178,0.087675915,0.995232843,,,CC(C)=CCC/C(C)=C/COCC1OC(C(O)C1O)N2\C=C/C(=O)NC2=O,Analyticon,NP-007525,2.37678623,0.69748197,-0.629958,37.13755178,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00387166-03,NSC 33994,377020198,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,82058-16-0,,10,0,-5,74.12194273,3,4,,103.0130375,99.50603732,0.002816603,0.999995107,,,CCN(CC)CC1=CC(=CC=C1O)C(/CC)=C(\CC)C2=CC(=C(O)C=C2)CN(CC)CC,SIGMA,SML0069,-0.26900585,-0.14285714,0.76602607,99.50603732,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00347952-11,NSC-319726,384568997,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,71555-25-4,,3.16227766,1,-5.5,109.0458211,2.2,4,,65.66267943,71.29186603,0.035892935,0.99920473,,,CC(=N/NC(=S)N1CCC1)\C2=NC=CC=C2,MedChem Express,HY-18634,6.91805656,7.11776386,47.38316379,71.29186603,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00510444-01,Epiblastin A,384569436,,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,1.412537545,1,-5.85,46.68832239,2.4,4,,33.87718855,23.95688992,0.417477505,0.87435644,,CSNK1A1,NC1=NC2=C(N=C(C(=N2)N)C3=CC(=CC=C3)Cl)C(=N1)N,SIGMA,SML1647,0.22538386,-0.66828676,41.02309763,23.95688992,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00274067-09,Eltrombopag olamine,384568712,Thrombopoietin Receptor (TpoR) Agonist,SARS-CoV-2 cytopathic effect (CPE),Annotated/Bioactive Compound Collection,,,4.466835922,1,-5.35,50.8569203,2.4,4,,40.04033743,39.75088421,0.142906646,0.987199608,,MPL,CC1=CC=C(C=C1C)N2/N=C(C)\C(=N/NC3=CC=CC(=C3O)C4=CC=CC(=C4)C(O)=O)C2=O,Bio Vision,May-89,3.40846619,-0.95799558,18.75881523,39.75088421,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00370891-01,C 021 dihydrochloride,363677913,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,3581,,2.511886432,1,-5.6,37.14439408,3,3,,71.85927054,-4.31428571,1,0.999996821,,,COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCC(CC3)N4CCCCC4)NC5CCCCCC5,Tocris,3581,-1.28234486,63.72222222,-4.31428571,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00390638-01,Mutated EGFR-IN-1,363680943,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1421372-66-8,,12.58925412,0,-4.9,72.64948181,3,3,,104.1002911,94.02556369,1,0.999670194,,,COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(N)C(=C1)N(C)CCN(C)C,MedChem Express,HY-78869,0.87195961,-0.66339066,94.02556369,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00408808-01,(R)-P7C3-Ome,363681054,,SARS-CoV-2_CPE_SRI,2020_NPACT-11_CPE,1235481-43-2,,12.58925412,0,-4.9,46.11587135,3,3,,67.29297716,58.63851788,1,0.999984247,,,COC1=CC(=CC=C1)NC[C@@H](O)C[N]2C3=C(C=C(Br)C=C3)C4=C2C=CC(=C4)Br,Glixx,GLXC-90084,0.4130335,1.35135135,58.63851788,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370759-04,Pyrintegrin,363677839,,SARS-CoV-2_CPE_SRI,2020_NPACT-10_CPE,1228445-38-2,,3.16227766,1,-5.5,116.4163294,2.3,3,,86.73975111,3.96654074,1,0.999998421,3688,,OC1=CC2=C(C=C1)N(CCC2)C3=NC(=NC=C3)NC4=CC=C(C=C4)[S+]([O-])(=O)NCC5CC5,Bio Vision,1729,17.0457156,82.99235889,3.96654074,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00402261-03,Filastatin,363681003,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,431996-53-1,,12.58925412,0,-4.9,26.39420981,3,3,,36,31.65714286,1,0.999700573,,,CC1=C(Cl)C=C(C=C1)C(=O)N2CCN(CC2)C3=CC=C(C=C3)[N+]([O-])=O,Glixx,GLXC-03851,0.73276849,0.5,31.65714286,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00370950-02,GW 803430,363677951,,SARS-CoV-2_CPE_SRI,2020_NPACT-12_CPE,515141-51-2,,7.079457844,1,-5.15,83.55983276,2.3,3,,101.3738857,92.88571429,1,0.999969472,,,COC1=C(OCCN2CCCC2)C=CC(=C1)N3\C=N/C4=C(SC(=C4)C5=CC=C(Cl)C=C5)C3=O,Axon Medchem,1569,0,20.22222222,92.88571429,,,,,,,,,,,,,8.00E-07,0.000004,2E-05,,,,,,,,,,,,
NCGC00347372-02,NCGC00347372-02,363677579,,SARS-CoV-2_CPE_SRI,2020_NPACT-4_CPE,,,3.548133892,1,-5.45,105.8144453,3,4,,97.55321933,79.1096931,0.020551376,0.999739432,,,C[C@H]1CC[C@@]2(OC1)O[C@H]3CC4[C@@H]5CC[C@@H]6C[C@H](CC[C@]6(C)C5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O,Analyticon,NP-007474,0.18416206,-1.13444364,-0.72872591,79.1096931,,,,,,,,,,,,4.00E-08,2.00E-07,0.000001,5E-06,,,,,,,,,,,
NCGC00381331-01,NCGC00381331-01,363679092,,SARS-CoV-2_CPE_SRI,2020_NPACT-5_CPE,,,12.58925412,0,-4.9,32.50255433,3,4,,42.85621432,38.99746382,0.050077328,0.998451285,,,CCC(C)CC(=O)OC1C(C(C)C)C(O)\C=C(CO)/C1=O,Analyticon,NP-006766,1.38574284,-0.21541407,-0.04749466,38.99746382,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00371073-01,CP 465022 hydrochloride,363678017,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,2932,,8.912509381,1,-5.05,65.12942809,3,4,,97.4772976,92.5315367,0.012414498,0.999904934,,,CCN(CC)CC1=CC=CC(=N1)/C=C/C2=N/C3=CC=C(F)C=C3C(=O)N2C4=CC=CC=C4Cl,Tocris,2932,-2.02463542,-1.06382979,2.69360269,92.5315367,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380694-01,NCGC00380694-01,363678713,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,3.548133892,1,-5.45,94.93343888,3,4,,78.72185431,72.62693157,0.016339576,0.99983532,,,CC1(C)O[C@H]2C3CC[C@]4(O)[C@](C)(CC[C@@H]5O[C@H]6[C@H](OC6(C)C)[C@H]7O[C@@]457)[C@@]3(C)C8=C2C9=C%10C(=C(Cl)C=C9[NH]8)CC(=C)[C@H]%11C[C@H]1[C@@]%10%11O,Analyticon,NP-016277,0.9352518,1.93133047,3.4243295,72.62693157,,,,,,,,,,,,5.28E-08,2.64E-07,0.00000132,6.6E-06,,,,,,,,,,,
NCGC00386040-01,NCGC00386040-01,363680075,,SARS-CoV-2_CPE_SRI,2020_NPACT-8_CPE,,,3.548133892,1,-5.45,103.1386505,3,4,,88.16434762,74.67504642,0.067764653,0.997157334,,,CC1(C)CC[C@]23CO[C@@]4(CCC5[C@@]6(C)CC[C@H](O[C@@H]7OC[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]7O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O)[C@@](C)(CO)C6CC[C@@]5(C)[C@]4(C)C[C@H]2O)[C@@H]3C1,Analyticon,NP-001204,1.56022164,1.52500296,-2.49650023,74.67504642,,,,,,,,,,,,4.00E-08,2.00E-07,0.000001,5E-06,,,,,,,,,,,
NCGC00380400-01,NCGC00380400-01,363678568,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,0.891250938,1,-6.05,83.04084387,2.4,4,,56.21626795,11.89833878,1,0.99996276,,,CC(=O)O[C@@H]1[C@@H](O)[C@H]2O[C@@H]3\C=C(C)/[C@@H](O)C[C@]3(CO)[C@]1(C)[C@]24CO4,Analyticon,NP-015158,0.62084257,16.19154613,43.3492823,11.89833878,,,,,,,,,,,,1.07E-07,5.36E-07,0.00000268,0.0000134,,,,,,,,,,,
NCGC00481621-01,NCGC00481621-01,,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,12.58925412,0,-4.9,70.68434204,3,4,,105.1728385,96.14643545,0.063896338,0.997473439,,,CCCCOC(=O)C1=C2SC(=CC2=NC=C1)C(OCCN3CCCCC3)C4=C(C)C=CC=C4,NCGCChem,DJJ004-078,-1.10134739,3.67514778,-1.33671029,96.14643545,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00385268-01,NCGC00385268-01,363679628,,SARS-CoV-2_CPE_SRI,2020_NPACT-9_CPE,,,2.818382931,1,-5.55,106.827183,2.2,4,,87.18086435,78.08199541,0.028062668,0.999514024,,,CC(=O)O[C@@H]1C[C@H](O)[C@@]23CO[C@H](O)[C@]1(C)C2C[C@@H](O)[C@]4(C)C3C(=O)[C@H](OC(C)=O)[C@@]5(C)[C@@H](C[C@H]6O[C@@]456)C7=COC=C7,Analyticon,NP-005159,1.26008778,-0.44769086,12.26551227,78.08199541,,,,,,,,,,,,5.28E-08,2.64E-07,0.00000132,6.6E-06,,,,,,,,,,,
NCGC00384580-01,NCGC00384580-01,363679256,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,3.548133892,1,-5.45,47.50961801,3,4,,42.96915023,43.22021866,0.018409762,0.999791036,,,CCC(C)C(=O)OC1C\C(=C\CC\C(=C\C2OC(=O)C(=C)C12)COC(C)=O)C=O,Analyticon,NP-017819,-0.05912786,0.60384777,2.72727273,43.22021866,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00370729-08,MHY1485,,,SARS-CoV-2_CPE_SRI,2020_NPACT-1_CPE,,,8.912509381,1,-5.05,50.38921923,3,4,,70.11366444,64.43710432,0.020582377,0.999738676,,,[O-][N+](=O)C1=CC=C(NC2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)C=C1,APExBIO,B5853,-0.09373169,-1.15651503,4.68552132,64.43710432,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00242215-02,GSK 461364 analogue I,377020281,,SARS-CoV-2_CPE_SRI,2020_NPACT-3_CPE,929095-23-8,,1.77827941,1,-5.75,45.55758984,3,4,,36.93780731,-3.26477779,1,0.999930122,,,C[C@@H](OC1=C(SC(=C1)[N]2C=NC3=C2C=C(OC4CCN(C)CC4)C=C3)C(N)=O)C5=C(Cl)C=CC=C5,Axon Medchem,1625,-1.57762639,-0.15494267,34.35750553,-3.26477779,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380410-01,NCGC00380410-01,363678573,,SARS-CoV-2_CPE_SRI,2020_NPACT-6_CPE,,,2.238721139,1,-5.65,96.59594679,3,4,,71.99150335,17.59697256,1,0.999894584,,,CC/1=C/C2OC3CC(O)[C@](C)([C@@]2(C)C(O)C1=O)[C@]34CO4,Analyticon,NP-008410,-0.07194245,1.64520744,66.11590038,17.59697256,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00180170-02,NCGC00180170-02,363677003,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,5.623413252,1,-5.25,40.75003062,3,4,,45.26457132,40.77807752,0.020079344,0.999751412,,,COC1=CC2=C(C=C1)C3=C4[C@H](CC(C)(C)OO[C@H](C=C(C)C)[N]24)N5C(=O)[C@@H]6CCCN6C(=O)[C@]5(O)[C@H]3OCC=C(C)C,Analyticon,NP-005406,-0.88691796,-0.10442047,0.09569378,40.77807752,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00485229-01,Cholesteryl 3??-N-(di??methyl??amino??ethyl)??carbamate hydrochloride,363681264,,SARS-CoV-2_CPE_SRI,2020_NPACT-2_CPE,166023-21-8,,12.58925412,0,-4.9,47.35184979,3,4,,74.19538969,66.32821076,0.032479782,0.999348888,,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)OC(=O)NCCN(C)C,SIGMA,C2832,0.02320724,-1.66666667,-1.59924741,66.32821076,,,,,,,,,,,,1.60E-07,8.00E-07,0.000004,2E-05,,,,,,,,,,,
NCGC00380750-01,NCGC00380750-01,363678758,,SARS-CoV-2_CPE_SRI,2020_NPACT-7_CPE,,,0.794328235,1,-6.1,148.6210143,5,4,,-68.23179179,-2.64092006,0.105192996,0.993115559,,,CC(C)CC(=O)O[C@H]\1C[C@@]2(COC(C)=O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@@]2(C)[C@]34CO4)\C=C1C,Analyticon,NP-019198,52.29859571,33.31012879,14.73684211,-2.64092006,,,,,,,,,,,,8.00E-08,4.00E-07,0.000002,1E-05,,,,,,,,,,,
NCGC00180626-04,Cephaeline,434147234,,DPI_SARS-CoV-2_General,,483-17-0,,0.251188643,1,-6.6,77.60616544,-1.2,20,,-56.30992075,-2.27563283,9.72E-07,0.923502608,,,CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O,Carbosynth,FC19891,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00016000-18,Disulfiram,170464767,,DPI_SARS-CoV-2_General,,97-77-8, ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM,25.11886432,0,-4.6,36.79025483,2.2,20,,96.6604278,74.46524064,1.4471E-06,0.92889389,217,ALDH2,CCN(CC)C(=S)SSC(=S)N(CC)CC,Microsource,1500262,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00686670-01,GS-441524,,,DPI_SARS-CoV-2_General,,1191237-69-0,,1.995262315,1,-5.7,159.0356029,1.1,20,,117.1794425,107.6655052,5.30E-07,0.937795985,,,NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N,MedChem Express,HY-103586,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
NCGC00346519-03,Teicoplanin,,glycopeptide antibiotic,DPI_SARS-CoV-2_General,,,,14.12537545,0,-4.85,25.84294896,2.2,20,,30.21911015,34.92361297,0.00120297,0.808665177,,,CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl,MedChem Express,HY-A0097,,,,,,,,,,,,,,,,5.90E-08,1.17E-07,2.34E-07,4.69E-07,9.38E-07,0.000001875,0.00000375,0.0000075,0.000015,0.00003,,,,,
